data_2naw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2naw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.957 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -94.9 109.23 21.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.303 0.573 . . . . 0.0 111.541 -171.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.32 113.23 25.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -90.15 144.77 25.58 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.574 0.702 . . . . 0.0 112.283 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 10' ' ' LEU . 18.2 m -123.84 79.52 1.72 Allowed 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.571 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 79.1 -15.57 0.75 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.731 2.012 . . . . 0.0 111.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.8 tt -56.53 -44.68 81.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.303 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 50.9 m -112.91 -18.0 12.35 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.816 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.4 tttm 41.37 59.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.313 1.054 . . . . 0.0 112.516 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 11' ' ' SER . 96.3 mt-30 . . . . . 0 C--N 1.297 -1.69 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.334 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.37 -4.447 0 CA-C-O 122.739 1.257 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 59.44 4.09 0.47 Allowed 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 127.994 2.518 . . . . 0.0 113.699 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.14 -40.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.955 0.884 . . . . 0.0 109.148 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -71.63 -10.53 59.91 Favored 'General case' 0 C--O 1.197 -1.663 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.995 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.84 -34.73 7.97 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.6 t80 -54.57 -58.0 9.2 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.99 1.316 . . . . 0.0 111.886 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -67.34 -21.51 27.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.962 0.887 . . . . 0.0 111.09 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.87 -36.24 15.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.795 0.807 . . . . 0.0 109.479 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.22 -28.68 66.57 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.028 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.9 -36.92 85.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.244 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -73.87 -54.86 7.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.63 66.18 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.379 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.82 132.77 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.932 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.6 -132.27 0.04 OUTLIER Glycine 1 C--N 1.238 -4.899 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.416 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -83.74 84.0 7.71 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.684 -0.892 . . . . 0.0 111.482 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -89.97 -36.74 14.8 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.58 0.705 . . . . 0.0 109.705 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.1 m-85 -108.83 151.93 42.06 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.33 -46.27 32.34 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.584 2.856 . . . . 0.0 112.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -89.26 3.83 50.74 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.238 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 46.6 t -87.94 108.67 19.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.046 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -109.97 75.95 0.96 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.988 0.899 . . . . 0.0 109.455 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 C--N 1.293 -1.865 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.816 176.901 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.838 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -95.36 108.52 20.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -114.36 108.21 16.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -89.31 129.31 35.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.2 t -103.99 149.71 24.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 67.09 22.24 9.95 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.806 0.842 . . . . 0.0 111.532 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.71 -43.14 26.53 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 p -89.78 -15.73 31.75 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.885 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HE2' ' CE1' ' A' ' 35' ' ' PHE . 15.0 ttpp 56.9 30.58 18.2 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.421 1.488 . . . . 0.0 110.442 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.863 -178.823 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 1 N--CA 1.373 -4.324 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.99 6.68 4.85 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.291 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.1 -43.94 7.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -61.18 -27.75 68.64 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.767 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.9 t -104.96 -4.63 21.86 Favored 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -66.61 -65.06 0.73 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.448 ' H ' HD13 ' A' ' 23' ' ' ILE . 3.9 mp -66.07 -28.99 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.27 1.033 . . . . 0.0 108.793 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 29' ' ' ILE . 13.8 mm-40 -66.69 -33.11 74.91 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -73.27 -31.12 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.33 -32.49 72.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.939 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.77 -52.37 21.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.941 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.67 92.57 2.27 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.684 HD13 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -135.25 121.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 122.509 1.147 . . . . 0.0 109.129 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.29 90.78 1.12 Allowed Glycine 1 C--N 1.236 -4.992 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.819 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 54.91 77.9 0.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.564 1.545 . . . . 0.0 113.759 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -90.89 -18.62 24.46 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.9 m-85 -135.79 147.84 62.87 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -58.01 -39.4 86.33 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 123.481 2.787 . . . . 0.0 111.855 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' A' ' 12' ' ' LYS . 24.7 p90 -98.82 16.76 21.26 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.387 -173.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.68 117.58 29.87 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -94.81 37.03 1.15 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.405 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 t . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.653 -178.548 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.528 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -120.05 109.07 15.05 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.459 0.647 . . . . 0.0 111.533 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -116.49 120.81 39.95 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -115.16 113.97 24.66 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.969 0.414 . . . . 0.0 110.853 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 m -126.14 96.1 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.23 28.48 17.81 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.727 0.811 . . . . 0.0 110.576 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -69.17 -46.49 67.39 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -112.97 -14.15 13.04 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 62.75 21.38 12.73 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 125.701 1.6 . . . . 0.0 110.073 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.251 -178.91 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.388 -3.562 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 49.23 4.74 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 127.44 2.296 . . . . 0.0 116.294 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 16.9 m -107.95 -32.65 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 121.963 0.887 . . . . 0.0 108.716 173.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -68.18 -13.96 62.62 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.372 170.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -105.08 -32.16 8.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.514 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.601 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 42.7 t80 -57.11 -58.33 8.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.003 0.921 . . . . 0.0 112.013 -173.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 34.9 mm -66.02 -24.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.879 0.847 . . . . 0.0 110.654 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -86.19 -39.65 16.41 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.498 0.666 . . . . 0.0 109.981 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -68.8 -27.11 65.57 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.191 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.4 tp -62.92 -29.47 70.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.645 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 60.0 mttp -83.98 -54.14 5.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.73 69.66 0.05 OUTLIER Glycine 0 CA--C 1.482 -1.998 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.332 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.37 125.57 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.438 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.68 -132.42 0.04 OUTLIER Glycine 1 C--N 1.251 -4.141 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.951 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -79.25 93.22 5.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.924 -0.75 . . . . 0.0 110.463 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -98.83 -42.41 7.19 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.696 0.76 . . . . 0.0 109.565 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 35.3 m-85 -104.85 146.45 32.67 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.29 -30.63 73.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.934 3.089 . . . . 0.0 112.616 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.62 20.85 18.22 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.854 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 53.4 t -91.93 94.99 9.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.3 1.048 . . . . 0.0 108.306 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -98.45 17.85 17.95 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.615 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.651 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.433 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -100.25 107.25 19.03 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -118.03 123.65 46.21 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -130.75 106.92 8.78 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.194 0.521 . . . . 0.0 111.528 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.5 m -84.14 92.88 8.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.521 0.677 . . . . 0.0 110.769 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 70.81 -0.65 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.681 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.2 -42.52 65.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -88.95 -17.12 30.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 tttp 54.78 20.27 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 C--N 1.299 -1.611 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.767 -179.395 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 19' ' ' VAL . 4.7 mp0 . . . . . 0 N--CA 1.393 -3.279 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 51.43 3.93 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 126.919 2.087 . . . . 0.0 114.324 -173.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 17' ' ' GLU . 13.2 p -109.24 -32.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -64.57 -21.46 66.7 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.481 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 32.1 t -104.86 -24.26 12.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.664 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.3 t80 -61.36 -63.97 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.813 -173.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.51 -38.26 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.17 -44.9 82.71 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.472 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.24 -32.71 74.29 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.297 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.36 -20.56 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.319 0.58 . . . . 0.0 111.405 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -92.42 -54.6 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.77 98.45 0.47 Allowed Glycine 0 CA--C 1.484 -1.896 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.623 HD11 ' SG ' ' A' ' 36' ' ' CYS . 2.3 pp -137.84 126.07 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.65 107.67 3.55 Favored Glycine 1 C--N 1.238 -4.913 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.819 172.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.0 m80 50.91 89.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -126.9 -6.91 6.11 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 72.5 m-85 -145.78 147.49 32.83 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.53 -47.62 25.27 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 123.418 2.746 . . . . 0.0 111.992 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -92.01 12.9 20.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.818 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 29' ' ' ILE . 49.0 t -95.32 110.84 22.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.761 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.75 75.29 0.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.352 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.124 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -100.01 109.4 21.73 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.08 103.9 11.02 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 t -131.69 139.98 49.19 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -112.66 152.92 28.43 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.33 13.28 7.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.857 1.263 . . . . 0.0 110.099 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -84.85 -42.76 14.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -88.22 -15.42 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.9 tttp 55.66 60.34 3.36 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.024 1.73 . . . . 0.0 114.308 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 . . . . . 0 C--N 1.267 -3.011 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 1 N--CA 1.374 -4.239 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 71.53 6.14 5.63 Favored 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 127.093 2.157 . . . . 0.0 111.134 -174.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.26 -53.54 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -58.85 -28.08 65.75 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.683 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -100.14 -19.41 16.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.021 0.528 . . . . 0.0 110.725 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 24.3 t80 -60.1 -60.17 4.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.951 0.405 . . . . 0.0 111.072 -171.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 23' ' ' ILE . 3.5 mp -67.71 -32.02 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -175.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -68.38 -39.21 81.83 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.914 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.5 t -64.97 -34.06 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.02 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.3 -19.0 63.11 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -80.53 -51.67 8.51 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.6 101.8 2.15 Favored Glycine 0 CA--C 1.468 -2.881 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.8 pp -137.23 129.15 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.657 0 CA-C-O 122.278 1.037 . . . . 0.0 109.829 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.12 111.1 3.21 Favored Glycine 1 C--N 1.235 -5.056 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.915 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.74 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.582 1.553 . . . . 0.0 113.867 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 63.23 -74.89 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.545 1.538 . . . . 0.0 113.389 -174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 39.6 m-85 -106.12 143.97 28.0 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.11 -33.04 95.05 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.808 3.005 . . . . 0.0 113.398 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -100.67 3.48 42.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.013 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' HD13 ' A' ' 29' ' ' ILE . 43.6 t -77.26 110.19 11.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.665 0.745 . . . . 0.0 110.683 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.37 75.22 4.53 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.409 1.099 . . . . 0.0 111.13 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.295 -1.795 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.813 176.091 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.076 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -95.51 109.65 21.83 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.083 0.468 . . . . 0.0 110.558 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -105.45 111.22 23.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.013 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -131.06 114.83 15.65 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -72.02 143.81 49.02 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.391 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 76.56 2.61 3.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.217 1.007 . . . . 0.0 111.555 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -70.69 -44.01 67.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -111.23 -15.78 13.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.262 20.7 pttp 42.98 58.94 3.07 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.708 1.203 . . . . 0.0 114.118 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 . . . . . 0 C--N 1.287 -2.109 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.028 -176.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.381 -3.903 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.27 6.05 1.27 Allowed 'General case' 0 C--N 1.261 -3.244 0 C-N-CA 127.181 2.193 . . . . 0.0 112.578 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.3 t -107.87 -38.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -66.11 -15.68 63.3 Favored 'General case' 0 C--O 1.188 -2.17 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.402 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -104.13 -23.28 13.3 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.666 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 48.0 t80 -69.07 -61.11 1.93 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.148 -173.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.73 -37.36 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.027 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' CB ' HG12 ' A' ' 29' ' ' ILE . 46.0 mm-40 -67.92 -41.01 83.29 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.867 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.3 -28.08 65.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.53 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.63 -12.59 60.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.51 -47.6 7.87 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 171.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.51 93.88 0.83 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.358 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.5 pp -138.25 123.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.698 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.97 90.68 1.67 Allowed Glycine 1 C--N 1.243 -4.625 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.556 172.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 56.72 90.93 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.25 1.42 . . . . 0.0 112.992 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -102.05 -26.7 13.29 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.242 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.9 m-85 -125.35 147.48 57.79 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.45 -28.36 63.52 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 123.7 2.934 . . . . 0.0 113.315 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -103.84 8.09 37.01 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.592 0.757 . . . . 0.0 111.535 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -88.12 112.87 23.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.47 35.43 4.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.685 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.7 t . . . . . 0 C--N 1.31 -1.132 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.192 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.243 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.1 m -94.82 109.23 21.22 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -77.65 103.88 7.85 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.275 0.56 . . . . 0.0 110.633 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 15.3 t -129.94 151.53 50.4 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 p -68.49 138.34 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.296 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.451 ' OD2' ' HG3' ' A' ' 12' ' ' LYS . 8.8 m-20 61.78 29.91 18.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.964 0.906 . . . . 0.0 110.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.8 tt -60.11 -46.15 90.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 t -112.14 -18.3 12.6 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 45.1 tttp 51.36 23.97 1.95 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.623 1.569 . . . . 0.0 111.287 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--N 1.298 -1.635 0 C-N-CA 124.056 0.943 . . . . 0.0 109.653 -179.216 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HA ' ' CE1' ' A' ' 35' ' ' PHE . 42.8 mt-10 . . . . . 0 N--CA 1.399 -2.975 0 CA-C-O 122.095 0.95 . . . . 0.0 109.007 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 75.59 6.12 3.98 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.88 -2.418 . . . . 0.0 112.033 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.54 -42.77 7.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.24 -35.21 62.23 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.668 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.7 -4.27 31.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.824 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -67.83 -65.1 0.73 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.702 0.287 . . . . 0.0 111.544 -171.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.78 -23.08 27.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.279 0.562 . . . . 0.0 110.083 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -68.45 -43.96 75.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.99 -13.82 62.27 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.787 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.31 -10.9 55.5 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.886 -0.508 . . . . 0.0 111.281 170.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -121.1 176.79 5.41 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.18 92.91 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 pp -130.33 115.26 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.616 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.78 90.74 0.97 Allowed Glycine 1 C--N 1.245 -4.501 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.758 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 62.92 88.82 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.856 0.836 . . . . 0.0 112.632 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.99 -37.31 12.91 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.702 -0.624 . . . . 0.0 110.802 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -118.88 154.1 52.86 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -51.9 -35.44 60.01 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.412 2.741 . . . . 0.0 113.298 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 17' ' ' GLU . 27.5 p90 -102.22 13.88 33.47 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.562 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.1 t -93.95 105.24 17.26 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -93.28 -1.68 55.82 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.537 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.441 -0.923 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.758 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.244 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 t -111.83 120.84 43.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -74.47 119.63 18.93 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.853 0.359 . . . . 0.0 110.512 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -117.19 123.65 47.2 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.462 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 10' ' ' LEU . 23.3 m -62.4 138.17 58.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.932 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 77.8 -30.04 0.16 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.227 1.811 . . . . 0.0 111.785 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 8' ' ' SER . 8.0 tt -71.34 -38.86 71.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -80.35 -15.45 56.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.105 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 47.75 58.77 4.68 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.845 1.658 . . . . 0.0 112.083 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 . . . . . 0 C--N 1.27 -2.85 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.945 178.872 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 1 N--CA 1.379 -4.025 0 CA-C-O 122.442 1.115 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.79 3.88 0.34 Allowed 'General case' 0 C--N 1.261 -3.262 0 C-N-CA 128.268 2.627 . . . . 0.0 114.298 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 14.6 p -108.62 -37.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -62.81 -20.4 65.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.582 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 52.8 t -105.54 -4.84 20.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.429 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 27.7 t80 -64.66 -59.71 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.836 0.351 . . . . 0.0 111.476 -170.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 ' H ' ' A' ' 23' ' ' ILE . 4.0 mp -75.1 -25.95 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.011 0.91 . . . . 0.0 108.769 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.95 -38.52 82.93 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.717 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -76.48 -18.02 58.98 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.3 mt -78.85 -6.55 56.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.307 0.575 . . . . 0.0 109.898 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -102.52 -54.39 2.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.0 78.54 0.64 Allowed Glycine 0 CA--C 1.488 -1.614 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.375 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.739 HD11 ' O ' ' A' ' 29' ' ' ILE . 2.6 pp -136.1 121.16 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-O 123.078 1.418 . . . . 0.0 109.689 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.7 146.64 16.09 Favored Glycine 1 C--N 1.215 -6.142 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.437 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' HA ' ' A' ' 37' ' ' HIS . 48.3 m-70 67.72 13.48 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.56 -39.12 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.207 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 43.8 m-85 -115.8 154.57 48.16 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.57 -21.39 18.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.878 3.052 . . . . 0.0 113.637 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -122.61 12.39 9.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.924 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 42.4 t -122.95 101.83 7.66 Favored 'General case' 0 CA--C 1.467 -2.222 0 C-N-CA 119.14 -1.024 . . . . 0.0 112.381 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.496 ' HA ' ' H ' ' A' ' 31' ' ' HIS . 9.1 m80 -128.96 75.69 1.67 Allowed 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.368 1.408 0 CA-C-O 120.919 0.39 . . . . 0.0 110.092 -178.87 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.768 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -95.15 109.06 21.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.106 0.479 . . . . 0.0 110.45 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -113.19 119.22 37.03 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m -132.0 143.33 50.0 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -57.98 123.23 15.14 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.539 0.524 . . . . 0.0 110.574 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t70 76.89 1.07 3.18 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.35 1.06 . . . . 0.0 112.429 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.6 -44.03 87.87 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.851 -0.531 . . . . 0.0 111.782 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 t -86.52 -17.06 35.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 42.91 59.91 2.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.314 1.445 . . . . 0.0 112.132 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 . . . . . 0 C--N 1.271 -2.811 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.865 178.183 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.384 -3.736 0 CA-C-O 122.655 1.217 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.5 3.31 1.85 Allowed 'General case' 0 C--N 1.251 -3.698 0 C-N-CA 127.738 2.415 . . . . 0.0 113.015 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.31 -39.33 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.943 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 171.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 4.8 mmp_? -68.33 -4.43 14.44 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.694 172.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.5 t -106.37 -45.17 4.34 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.046 0.451 . . . . 0.0 110.121 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 18.1 t80 -51.31 -68.18 0.19 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.109 1.364 . . . . 0.0 113.772 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 22' ' ' PHE . 2.8 mp -66.26 -35.19 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 121.722 0.772 . . . . 0.0 110.345 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.9 mm-40 -58.81 -52.45 65.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.042 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.0 t -64.01 -29.45 70.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.874 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 84.1 mt -58.89 -22.92 60.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 65.4 pttt -94.0 -7.72 41.99 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.259 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.27 53.11 0.85 Allowed Glycine 0 N--CA 1.427 -1.9 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.442 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.91 123.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -132.57 0.1 Allowed Glycine 1 C--N 1.247 -4.393 0 CA-C-N 113.191 -1.822 . . . . 0.0 114.108 175.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -76.8 83.98 3.39 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.128 -0.63 . . . . 0.0 111.33 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -101.71 -14.79 17.21 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.557 0.694 . . . . 0.0 110.025 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 78.2 m-85 -128.85 146.84 62.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.99 -44.22 43.38 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 123.703 2.935 . . . . 0.0 112.995 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -90.75 9.65 29.17 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.35 1.06 . . . . 0.0 112.13 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 31.4 t -94.28 101.84 13.82 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.741 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -97.29 -2.99 41.43 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.395 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.313 -0.981 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.203 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.9 m -142.1 123.44 14.8 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -70.59 118.79 13.83 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -117.13 107.55 14.62 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.241 0.543 . . . . 0.0 110.981 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 10' ' ' LEU . 51.4 m -144.33 128.39 17.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 73.75 -31.68 0.22 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.065 1.346 . . . . 0.0 111.889 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.3 tt -55.32 -44.67 76.05 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.357 1.063 . . . . 0.0 110.014 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -111.56 -17.57 13.02 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.2 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 56.34 18.38 3.37 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.85 1.26 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -174.358 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' CD ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 tp10 . . . . . 0 N--CA 1.393 -3.283 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 63.53 5.27 2.07 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 128.41 2.684 . . . . 0.0 112.95 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 17' ' ' GLU . 74.4 t -110.07 -50.71 6.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -64.21 -28.89 70.05 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.368 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.6 t -105.41 -2.33 23.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.81 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 58.5 t80 -57.0 -62.87 1.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.601 0.964 . . . . 0.0 113.601 -169.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 3.2 mp -68.93 -34.67 65.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 2.9 mm-40 -56.31 -54.26 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.652 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.5 t -69.83 -29.79 67.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.54 1.136 . . . . 0.0 111.135 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.7 tp -66.04 -25.88 67.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.581 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 29.1 mmmt -97.71 -58.57 1.96 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.98 110.71 0.7 Allowed Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 pp -139.63 135.63 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.779 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.04 -131.69 0.03 OUTLIER Glycine 1 C--N 1.242 -4.689 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.036 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -96.79 88.92 4.73 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.77 -1.43 . . . . 0.0 109.599 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -107.05 -31.45 8.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.289 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 24' ' ' GLU . 71.1 m-85 -116.19 133.57 22.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.896 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 -16.99 57.4 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.468 3.445 . . . . 0.0 113.496 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -112.69 -10.61 13.62 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.099 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.425 ' HA ' ' CD ' ' A' ' 17' ' ' GLU . 47.3 t -76.89 111.55 12.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.169 -171.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -99.43 -5.56 29.23 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.93 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.234 0.283 0 CA-C-O 121.971 0.891 . . . . 0.0 108.925 176.485 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.028 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.4 m -134.1 114.01 12.69 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.39 117.64 19.8 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.37 0.419 . . . . 0.0 110.101 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -100.25 111.07 23.33 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -77.2 138.37 39.4 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.045 0.938 . . . . 0.0 111.113 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 66.49 13.2 9.16 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 124.119 0.968 . . . . 0.0 111.838 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.8 -43.62 53.74 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 t -94.05 -12.44 28.56 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt 58.02 35.48 25.26 Favored 'General case' 0 C--N 1.348 0.53 0 CA-C-O 123.411 1.577 . . . . 0.0 110.197 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--N 1.284 -2.253 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.097 177.958 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 51.2 mt-10 . . . . . 0 N--CA 1.392 -3.329 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.04 4.21 2.96 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 126.432 1.893 . . . . 0.0 111.261 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 28.9 m -105.35 -6.24 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -82.93 -28.54 29.81 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.671 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.5 p -106.7 -4.14 19.79 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.257 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 41.0 t80 -56.72 -61.54 2.36 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.59 0.756 . . . . 0.0 112.582 -170.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.62 -28.31 27.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 7.3 mm-40 -59.1 -43.57 91.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.966 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -71.44 -32.86 68.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.733 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 85.4 mt -65.67 -27.28 68.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.432 0.634 . . . . 0.0 109.714 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' ' 24' ' ' GLU . 53.1 mtmt -83.39 -51.51 7.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.442 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.49 91.68 0.16 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.291 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.474 HD13 ' O ' ' A' ' 29' ' ' ILE . 2.2 pp -140.02 117.63 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.12 88.97 1.57 Allowed Glycine 1 C--N 1.252 -4.091 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.464 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 57.85 92.74 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.538 1.135 . . . . 0.0 112.505 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -111.64 -11.33 14.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.966 0.413 . . . . 0.0 111.426 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 77.7 m-85 -135.97 141.69 37.51 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -59.54 -37.58 87.99 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.434 2.756 . . . . 0.0 112.559 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 17' ' ' GLU . 17.2 p90 -93.23 14.8 17.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 124.172 0.989 . . . . 0.0 111.466 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.6 t -91.74 125.68 36.55 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -115.37 2.58 13.98 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.698 0.623 . . . . 0.0 112.295 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.067 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.829 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -95.57 121.62 37.46 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -106.84 144.53 33.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.7 m -128.43 108.18 10.35 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.73 0.776 . . . . 0.0 112.011 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 t -140.04 94.51 2.77 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.69 30.97 16.89 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.645 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.85 -44.35 61.49 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -110.7 -9.74 14.5 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.3 tttm 56.1 45.17 24.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.322 1.849 . . . . 0.0 110.977 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 . . . . . 0 C--N 1.281 -2.402 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.684 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 1 N--CA 1.377 -4.106 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.79 5.11 4.41 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 111.339 -2.664 . . . . 0.0 113.21 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.7 p -104.19 -31.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -55.75 -35.05 65.76 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.56 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.647 ' SG ' HD13 ' A' ' 29' ' ' ILE . 42.2 t -105.1 -2.82 23.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.007 0.432 . . . . 0.0 111.075 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 34.0 t80 -56.58 -56.24 23.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.226 0.536 . . . . 0.0 110.537 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -72.4 -27.68 26.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.1 mm-40 -65.21 -40.19 93.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.819 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.18 -37.91 75.24 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.821 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.58 -36.2 79.97 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.203 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -74.23 -55.55 5.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.28 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.54 95.75 0.89 Allowed Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.647 HD13 ' SG ' ' A' ' 21' ' ' CYS . 2.5 pp -139.49 125.25 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.07 89.34 1.08 Allowed Glycine 1 C--N 1.252 -4.106 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.457 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 42.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.666 1.986 . . . . 0.0 113.651 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -126.44 16.23 7.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.148 0.499 . . . . 0.0 111.691 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 65.0 m-85 -146.67 139.21 14.05 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.88 -42.33 59.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.802 3.002 . . . . 0.0 113.418 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -90.93 10.78 25.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 124.135 0.974 . . . . 0.0 111.966 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 45.5 t -94.68 95.02 8.47 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.727 0.775 . . . . 0.0 110.846 -176.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -82.34 50.45 1.62 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.35 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.841 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.216 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -102.36 109.4 21.05 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -96.94 144.57 26.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 m -88.96 106.87 18.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 10' ' ' LEU . 20.3 m -129.86 138.66 51.08 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 8' ' ' SER . 11.4 m-20 77.29 -43.03 0.41 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.415 1.486 . . . . 0.0 110.71 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.6 tt -57.07 -43.36 82.01 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.836 1.654 . . . . 0.0 111.324 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.0 t -110.57 -18.03 13.28 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.84 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 48.94 14.11 0.07 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 126.66 1.984 . . . . 0.0 115.385 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--N 1.304 -1.391 0 O-C-N 121.344 -0.848 . . . . 0.0 112.03 -177.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 19' ' ' VAL . 44.0 mt-10 . . . . . 0 N--CA 1.394 -3.252 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.37 4.0 0.87 Allowed 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 126.542 1.937 . . . . 0.0 112.401 -172.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.1 p -97.03 -31.91 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -67.95 -16.82 64.23 Favored 'General case' 0 C--O 1.19 -2.063 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.474 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 46.1 t -105.82 -18.04 14.18 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.0 110.326 174.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 40.2 t80 -62.21 -61.81 2.2 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.253 0.621 . . . . 0.0 112.101 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -71.0 -29.98 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.749 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.32 -41.99 80.0 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.82 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.69 -31.83 70.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.15 -33.17 72.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -78.62 -55.85 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 90.77 0.79 Allowed Glycine 0 CA--C 1.484 -1.865 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.561 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.524 HD11 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -136.28 127.17 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.504 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.13 113.67 4.34 Favored Glycine 1 C--N 1.235 -5.073 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.344 175.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m80 44.92 88.05 0.02 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.433 1.893 . . . . 0.0 114.495 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -129.29 -0.97 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.402 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 54.4 m-85 -145.9 143.43 19.55 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -48.17 -49.33 14.36 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 124.037 3.158 . . . . 0.0 113.189 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -88.59 17.92 5.04 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.532 1.133 . . . . 0.0 111.529 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 48.6 t -114.01 101.84 9.61 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.008 0.432 . . . . 0.0 110.768 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -114.28 -2.11 13.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.609 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.422 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 N-CA-C 113.653 0.221 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.4 t -110.51 113.03 25.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -117.19 131.23 56.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -131.13 107.19 8.85 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -153.08 111.68 3.71 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 67.97 14.2 9.31 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.559 1.171 . . . . 0.0 109.786 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.12 -43.19 22.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.509 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -90.48 -16.1 29.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttp 59.28 27.52 16.6 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--N 1.288 -2.067 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.946 -176.936 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 1 N--CA 1.379 -4.011 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.44 5.65 0.47 Allowed 'General case' 0 C--N 1.282 -2.347 0 C-N-CA 126.284 1.834 . . . . 0.0 112.267 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 17' ' ' GLU . 13.7 p -108.66 -21.92 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -64.33 -30.64 71.68 Favored 'General case' 0 C--O 1.203 -1.361 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.391 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 33' ' ' TYR . 36.6 t -105.6 -8.19 18.11 Favored 'General case' 0 C--O 1.189 -2.101 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -67.36 -53.66 27.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.8 -30.32 46.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.335 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.86 -38.08 58.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.111 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 11.7 t -64.41 -29.43 70.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.185 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -75.28 -5.77 46.37 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.346 0.0 OUTLIER -147.78 71.29 1.18 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.46 -25.68 26.77 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 25' ' ' CYS 0.287 1.9 pp -115.02 115.35 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 119.991 1.895 . . . . 0.0 112.071 -172.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.43 102.93 2.79 Favored Glycine 1 C--N 1.233 -5.156 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.403 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 67.65 88.13 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.693 1.197 . . . . 0.0 112.829 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -119.06 -2.8 10.71 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.049 0.928 . . . . 0.0 108.689 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 21' ' ' CYS . 61.3 m-85 -135.24 147.05 60.64 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.71 -36.21 98.52 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 123.532 2.821 . . . . 0.0 113.406 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.1 18.58 13.23 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.788 0.835 . . . . 0.0 111.01 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.09 96.3 10.53 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.891 0.853 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -94.43 -16.83 23.06 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.554 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.381 179.335 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 m -95.58 112.29 24.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -103.38 128.88 50.39 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 19.5 m -89.67 121.25 31.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.34 140.35 58.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.33 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 12' ' ' LYS . 24.0 t70 67.52 24.75 8.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.542 1.163 . . . . 0.0 110.637 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.9 tt -73.72 -44.65 55.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.133 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 p -107.57 -15.37 14.61 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 9' ' ' ASP . 32.3 tttp 68.3 14.01 9.13 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.798 1.639 . . . . 0.0 111.423 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.748 178.802 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 1 N--CA 1.377 -4.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 74.83 6.3 4.38 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 111.849 -2.432 . . . . 0.0 112.523 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.45 -34.68 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -62.4 -22.54 66.23 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.482 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -94.29 -38.04 11.21 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 28.3 t80 -56.83 -59.54 4.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.229 1.412 . . . . 0.0 111.204 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.6 mm -62.11 -35.59 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.854 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.48 -40.12 44.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.6 t -69.29 -28.44 66.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.418 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.45 -30.7 67.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.023 174.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -84.59 -57.37 3.16 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.02 97.46 0.26 Allowed Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.869 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -140.18 122.52 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.13 90.09 1.0 Allowed Glycine 1 C--N 1.241 -4.696 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.192 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 46.15 81.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.455 1.502 . . . . 0.0 112.554 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.43 -0.0 46.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.177 0.513 . . . . 0.0 111.791 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 57.8 m-85 -143.39 154.44 60.43 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 -42.52 67.41 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.459 2.773 . . . . 0.0 112.17 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -91.75 16.56 10.49 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 111.404 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -100.28 116.13 31.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -124.6 13.86 8.73 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.603 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.32 109.32 21.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.51 0.671 . . . . 0.0 112.799 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -90.64 127.48 36.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -100.66 139.04 36.9 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.273 0.559 . . . . 0.0 111.273 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -72.73 95.19 1.86 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.585 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.41 -0.82 2.08 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 173.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.34 -42.62 68.3 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 t -88.31 -13.45 40.76 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.346 21.0 pttp 43.94 57.81 3.95 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.929 1.692 . . . . 0.0 114.775 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--N 1.281 -2.378 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.903 177.298 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.383 -3.778 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.87 5.75 3.02 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.622 1.169 . . . . 0.0 113.137 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.9 t -108.42 -44.06 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -62.31 -13.3 27.28 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.724 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -105.61 -28.49 10.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.429 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 39.8 t80 -66.13 -66.63 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.892 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.7 mp -62.82 -31.67 53.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.903 0.859 . . . . 0.0 110.08 -175.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 mm-40 -68.49 -45.31 72.66 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.08 -33.12 75.28 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.15 -17.6 63.84 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.903 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -78.47 -33.06 48.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.399 0.618 . . . . 0.0 109.596 174.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.26 36.6 1.45 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.588 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 24' ' ' GLU . 1.9 pp -122.29 113.84 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.09 143.51 19.65 Favored Glycine 1 C--N 1.246 -4.445 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.499 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 36' ' ' CYS . 17.3 t-80 66.65 -99.76 0.06 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.213 1.005 . . . . 0.0 112.007 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 54.78 -62.41 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 126.69 1.996 . . . . 0.0 114.974 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -87.73 145.36 36.77 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 124.046 0.938 . . . . 0.0 109.878 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.94 -44.52 27.27 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 124.176 3.25 . . . . 0.0 113.313 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 17' ' ' GLU . 13.4 p90 -91.6 0.53 57.49 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.213 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.6 t -101.61 121.32 41.8 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.314 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -121.31 5.13 10.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.18 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.447 -0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.064 179.422 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.836 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.9 m -94.64 109.49 21.41 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -105.17 130.37 53.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -131.08 112.3 12.76 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.392 0.615 . . . . 0.0 109.758 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -162.11 -161.69 0.77 Allowed 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -70.84 5.5 1.93 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.325 0.65 . . . . 0.0 111.97 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.94 -45.51 92.39 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -112.28 -15.84 13.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.648 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 pttt 54.21 27.72 8.2 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.173 1.789 . . . . 0.0 111.712 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 C--N 1.294 -1.824 0 CA-C-N 112.317 -2.22 . . . . 0.0 107.245 -179.598 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 8.5 pt-20 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 122.516 1.15 . . . . 0.0 114.057 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.21 4.42 0.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.409 1.884 . . . . 0.0 114.468 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.58 -38.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.11 -29.3 68.52 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.624 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -104.76 -11.86 16.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.969 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 1.6 t80 -72.02 -66.52 0.63 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.749 0.785 . . . . 0.0 110.611 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -67.66 -24.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.314 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.45 -35.3 25.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.272 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.8 t -63.83 -33.64 76.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.77 -21.64 66.0 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.063 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -90.52 -47.49 7.67 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.35 90.19 0.93 Allowed Glycine 0 CA--C 1.475 -2.429 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.39 130.36 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.867 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.33 -132.64 0.15 Allowed Glycine 1 C--N 1.243 -4.628 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.117 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -82.04 80.21 8.35 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.668 -0.901 . . . . 0.0 109.146 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.01 -24.06 21.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.148 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -130.0 143.54 49.52 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.13 -21.57 28.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 124.01 3.14 . . . . 0.0 114.37 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -115.24 13.25 16.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.496 0.718 . . . . 0.0 111.162 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 39.6 t -99.04 121.68 41.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -115.34 33.84 5.22 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.98 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.7 t . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.343 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -95.52 110.77 22.8 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.976 0.511 . . . . 0.0 109.628 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.96 120.37 32.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.414 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 25.2 m -105.19 128.5 53.43 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.9 t -64.61 130.5 43.85 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 120.924 0.392 . . . . 0.0 110.835 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.17 24.27 14.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.449 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 3.1 tm? -63.95 -43.99 94.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -110.56 -17.08 13.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 57.7 13.82 2.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.171 1.789 . . . . 0.0 113.105 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 . . . . . 0 C--N 1.306 -1.324 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.193 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 1 N--CA 1.377 -4.097 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.88 5.45 0.97 Allowed 'General case' 0 C--N 1.25 -3.738 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.931 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.27 -49.26 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -72.91 -5.02 35.65 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 113.226 -1.807 . . . . 0.0 112.399 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 t -104.9 -31.16 9.39 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.601 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.1 t80 -66.34 -60.23 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.815 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.34 -32.4 56.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.5 0.667 . . . . 0.0 110.612 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.9 -37.2 62.15 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.197 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.3 t -66.08 -31.82 72.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.187 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.62 -25.12 68.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.598 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -79.23 -55.16 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.15 78.46 0.24 Allowed Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.857 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.596 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.7 pp -129.65 120.72 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.586 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.36 100.0 0.62 Allowed Glycine 1 C--N 1.244 -4.575 0 CA-C-N 113.396 -1.729 . . . . 0.0 111.562 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 64.8 m80 58.42 -83.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.758 1.623 . . . . 0.0 114.244 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 69.0 -67.82 0.2 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.379 1.472 . . . . 0.0 112.175 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 26.1 m-85 -83.01 142.37 44.47 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.76 -38.18 77.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 123.869 3.046 . . . . 0.0 112.809 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -94.5 3.61 54.91 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.145 0.978 . . . . 0.0 112.079 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -97.64 120.5 38.14 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.879 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -103.86 30.78 4.89 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.596 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.241 0.617 0 CA-C-O 121.093 0.473 . . . . 0.0 110.926 -179.871 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.1 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 m -101.53 108.46 20.04 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 121.629 0.728 . . . . 0.0 110.193 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.48 103.86 10.86 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -124.93 144.39 50.37 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 152.37 34.08 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 123.881 0.872 . . . . 0.0 109.797 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 78.61 -26.82 0.17 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.511 1.125 . . . . 0.0 111.453 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.97 -43.33 88.2 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -81.08 -15.92 54.65 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? 45.07 14.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 . . . . . 0 C--N 1.273 -2.739 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -175.258 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 44.9 mt-10 . . . . . 0 N--CA 1.397 -3.119 0 CA-C-O 122.569 1.175 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 73.87 5.36 4.8 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 111.437 -2.62 . . . . 0.0 111.737 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.01 -44.8 8.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -63.46 -12.0 28.06 Favored 'General case' 0 C--O 1.191 -1.989 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.616 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -105.03 -29.18 10.6 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.1 0.476 . . . . 0.0 110.019 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t80 -65.71 -59.28 4.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.918 -170.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mm -66.56 -29.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.526 0.679 . . . . 0.0 110.15 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -75.02 -32.9 61.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.631 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -65.43 -32.64 74.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.319 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.0 -7.91 54.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.43 -49.59 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.42 79.48 0.21 Allowed Glycine 0 CA--C 1.471 -2.667 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.659 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.0 134.51 50.67 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.019 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.17 -132.56 0.06 OUTLIER Glycine 1 C--N 1.234 -5.132 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.449 169.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -90.03 85.15 6.24 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.079 -1.248 . . . . 0.0 108.132 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -92.23 -34.39 14.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.78 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.4 m-85 -111.37 142.56 26.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -25.52 35.26 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 124.568 3.512 . . . . 0.0 114.187 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 33.4 p90 -115.09 18.92 16.06 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.739 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.3 t -85.96 114.68 23.05 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.935 0.874 . . . . 0.0 112.59 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -77.2 -4.44 44.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.959 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.378 0.609 . . . . 0.0 110.696 -175.605 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.726 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -112.05 109.49 19.26 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.143 0.497 . . . . 0.0 111.268 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -114.47 104.06 11.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -129.17 155.46 45.48 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.154 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 10' ' ' LEU . 38.8 m -48.98 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 126.413 1.885 . . . . 0.0 113.083 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 12' ' ' LYS . 11.7 m-20 -60.64 7.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.1 tt -63.31 -42.8 99.04 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.772 1.629 . . . . 0.0 107.853 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -102.83 -5.37 23.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.672 0.749 . . . . 0.0 109.426 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 25.6 pttm 55.2 19.42 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 127.388 2.275 . . . . 0.0 116.192 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.829 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 19' ' ' VAL . 1.9 mp0 . . . . . 0 N--CA 1.396 -3.151 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 61.35 5.58 1.18 Allowed 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.636 1.575 . . . . 0.0 111.83 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.448 ' H ' ' C ' ' A' ' 17' ' ' GLU . 42.7 t -108.15 -23.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -63.59 -34.29 77.5 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.912 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.5 t -106.08 -4.13 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.39 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -66.81 -51.45 55.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 26' ' ' LEU . 4.0 mp -79.88 -28.14 12.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.885 0.85 . . . . 0.0 109.076 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.58 -47.03 87.99 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.2 t -72.87 -18.02 61.47 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.058 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 61.3 tp -66.86 -26.68 67.02 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.5 -65.24 1.03 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.08 69.79 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.357 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.795 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 29' ' ' ILE . 2.9 pp -134.13 114.08 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 115.12 4.37 Favored Glycine 1 C--N 1.244 -4.533 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.836 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 52.62 72.91 0.38 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.013 0.925 . . . . 0.0 112.295 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -99.66 -20.42 16.31 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.751 0.786 . . . . 0.0 110.645 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 15.6 m-85 -119.2 151.76 51.35 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.35 -37.49 71.68 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.956 3.104 . . . . 0.0 113.34 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -100.55 11.81 38.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.601 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.4 t -89.24 109.56 20.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 0.0 110.231 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -100.2 6.41 44.78 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.937 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.912 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.7 -171.68 36.44 Favored Glycine 0 C--O 1.246 0.851 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 84.19 7.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.122 0.963 . . . . 0.0 112.366 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.43 81.08 0.84 Allowed Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -94.9 109.23 21.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.303 0.573 . . . . 0.0 111.541 -171.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.32 113.23 25.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -90.15 144.77 25.58 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.574 0.702 . . . . 0.0 112.283 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 10' ' ' LEU . 18.2 m -123.84 79.52 1.72 Allowed 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.571 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 79.1 -15.57 0.75 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.731 2.012 . . . . 0.0 111.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.8 tt -56.53 -44.68 81.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.303 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 50.9 m -112.91 -18.0 12.35 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.816 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HA ' ' CD ' ' A' ' 15' ' ' GLU . 61.4 tttm 41.37 59.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.313 1.054 . . . . 0.0 112.516 -174.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 11' ' ' SER . 96.3 mt-30 -135.22 -79.42 0.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.334 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -105.17 87.52 2.65 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.493 ' CD ' ' HA ' ' A' ' 12' ' ' LYS . 15.5 mm-40 -99.19 154.89 17.79 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.541 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.88 -45.66 3.6 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.416 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.43 153.88 29.35 Favored 'General case' 1 N--CA 1.37 -4.447 0 CA-C-O 122.739 1.257 . . . . 0.0 111.15 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 59.44 4.09 0.47 Allowed 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 127.994 2.518 . . . . 0.0 113.699 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.14 -40.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.955 0.884 . . . . 0.0 109.148 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -71.63 -10.53 59.91 Favored 'General case' 0 C--O 1.197 -1.663 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.995 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.84 -34.73 7.97 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.6 t80 -54.57 -58.0 9.2 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.99 1.316 . . . . 0.0 111.886 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -67.34 -21.51 27.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.962 0.887 . . . . 0.0 111.09 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.87 -36.24 15.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.795 0.807 . . . . 0.0 109.479 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.22 -28.68 66.57 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.028 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.9 -36.92 85.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.244 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -73.87 -54.86 7.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.63 66.18 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.379 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.82 132.77 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.932 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.6 -132.27 0.04 OUTLIER Glycine 1 C--N 1.238 -4.899 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.416 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -83.74 84.0 7.71 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.684 -0.892 . . . . 0.0 111.482 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -89.97 -36.74 14.8 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.58 0.705 . . . . 0.0 109.705 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.1 m-85 -108.83 151.93 42.06 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.33 -46.27 32.34 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.584 2.856 . . . . 0.0 112.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -89.26 3.83 50.74 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.238 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 46.6 t -87.94 108.67 19.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.046 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -109.97 75.95 0.96 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.988 0.899 . . . . 0.0 109.455 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.9 t -112.05 145.66 39.31 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.816 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 . . . . . 0 C--N 1.315 -0.906 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.302 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 C--O 1.244 0.773 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.72 174.37 38.23 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.051 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 67.79 119.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.488 1.515 . . . . 0.0 111.08 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.84 -58.23 4.33 Favored Glycine 0 C--N 1.307 -1.037 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -95.36 108.52 20.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -114.36 108.21 16.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -89.31 129.31 35.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.2 t -103.99 149.71 24.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 67.09 22.24 9.95 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.806 0.842 . . . . 0.0 111.532 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.71 -43.14 26.53 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 p -89.78 -15.73 31.75 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.885 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HE2' ' CE1' ' A' ' 35' ' ' PHE . 15.0 ttpp 56.9 30.58 18.2 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.421 1.488 . . . . 0.0 110.442 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -90.7 -16.06 29.19 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.863 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.3 tpt -64.04 -24.87 67.87 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -99.91 160.23 14.47 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.734 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 32.7 tt0 -99.01 134.36 41.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -93.02 163.58 13.6 Favored 'General case' 1 N--CA 1.373 -4.324 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.99 6.68 4.85 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.291 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.1 -43.94 7.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.4 mmm180 -61.18 -27.75 68.64 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.767 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.9 t -104.96 -4.63 21.86 Favored 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -66.61 -65.06 0.73 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.448 ' H ' HD13 ' A' ' 23' ' ' ILE . 3.9 mp -66.07 -28.99 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.27 1.033 . . . . 0.0 108.793 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 29' ' ' ILE . 13.8 mm-40 -66.69 -33.11 74.91 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -73.27 -31.12 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.33 -32.49 72.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.939 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.77 -52.37 21.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.941 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.67 92.57 2.27 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.684 HD13 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -135.25 121.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 122.509 1.147 . . . . 0.0 109.129 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.29 90.78 1.12 Allowed Glycine 1 C--N 1.236 -4.992 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.819 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 54.91 77.9 0.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.564 1.545 . . . . 0.0 113.759 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -90.89 -18.62 24.46 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.9 m-85 -135.79 147.84 62.87 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -58.01 -39.4 86.33 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 123.481 2.787 . . . . 0.0 111.855 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' A' ' 12' ' ' LYS . 24.7 p90 -98.82 16.76 21.26 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.387 -173.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.68 117.58 29.87 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -94.81 37.03 1.15 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.405 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 t -103.61 1.88 32.64 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.653 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 123.388 0.675 . . . . 0.0 111.679 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.1 m80 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.49 160.0 26.99 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.93 118.35 5.64 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.64 29.13 2.5 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.108 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -120.05 109.07 15.05 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.459 0.647 . . . . 0.0 111.533 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -116.49 120.81 39.95 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -115.16 113.97 24.66 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.969 0.414 . . . . 0.0 110.853 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 m -126.14 96.1 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.23 28.48 17.81 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.727 0.811 . . . . 0.0 110.576 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -69.17 -46.49 67.39 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -112.97 -14.15 13.04 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 62.75 21.38 12.73 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 125.701 1.6 . . . . 0.0 110.073 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -95.93 -38.6 10.18 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.251 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -68.09 -47.28 68.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.546 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.14 73.16 9.19 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.233 1.016 . . . . 0.0 113.635 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -91.49 -17.92 24.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.996 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.32 -178.62 4.16 Favored 'General case' 0 N--CA 1.388 -3.562 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 49.23 4.74 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 127.44 2.296 . . . . 0.0 116.294 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 16.9 m -107.95 -32.65 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 121.963 0.887 . . . . 0.0 108.716 173.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -68.18 -13.96 62.62 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.372 170.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -105.08 -32.16 8.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.514 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.601 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 42.7 t80 -57.11 -58.33 8.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.003 0.921 . . . . 0.0 112.013 -173.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 34.9 mm -66.02 -24.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.879 0.847 . . . . 0.0 110.654 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -86.19 -39.65 16.41 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.498 0.666 . . . . 0.0 109.981 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -68.8 -27.11 65.57 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.191 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.4 tp -62.92 -29.47 70.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.645 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 60.0 mttp -83.98 -54.14 5.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.73 69.66 0.05 OUTLIER Glycine 0 CA--C 1.482 -1.998 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.332 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.37 125.57 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.438 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.68 -132.42 0.04 OUTLIER Glycine 1 C--N 1.251 -4.141 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.951 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -79.25 93.22 5.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.924 -0.75 . . . . 0.0 110.463 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -98.83 -42.41 7.19 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.696 0.76 . . . . 0.0 109.565 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 35.3 m-85 -104.85 146.45 32.67 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.29 -30.63 73.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.934 3.089 . . . . 0.0 112.616 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.62 20.85 18.22 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.854 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 53.4 t -91.93 94.99 9.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.3 1.048 . . . . 0.0 108.306 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -98.45 17.85 17.95 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.615 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.0 146.22 29.01 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.99 0 C-N-CA 122.57 0.348 . . . . 0.0 110.72 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 53.2 m80 . . . . . 0 C--O 1.241 0.628 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.99 160.46 23.62 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.694 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -150.01 155.39 39.85 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.35 -9.28 5.91 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.494 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -100.25 107.25 19.03 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -118.03 123.65 46.21 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -130.75 106.92 8.78 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.194 0.521 . . . . 0.0 111.528 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.5 m -84.14 92.88 8.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.521 0.677 . . . . 0.0 110.769 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 70.81 -0.65 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.681 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.2 -42.52 65.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -88.95 -17.12 30.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 tttp 54.78 20.27 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -137.03 -53.16 0.69 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.767 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 ttm -86.93 76.99 9.31 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -165.29 147.91 7.95 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -113.28 159.29 19.51 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 19' ' ' VAL . 4.7 mp0 -91.98 -174.7 3.87 Favored 'General case' 0 N--CA 1.393 -3.279 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 51.43 3.93 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 126.919 2.087 . . . . 0.0 114.324 -173.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 17' ' ' GLU . 13.2 p -109.24 -32.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -64.57 -21.46 66.7 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.481 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 32.1 t -104.86 -24.26 12.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.664 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.3 t80 -61.36 -63.97 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.813 -173.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.51 -38.26 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.17 -44.9 82.71 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.472 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.24 -32.71 74.29 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.297 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.36 -20.56 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.319 0.58 . . . . 0.0 111.405 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -92.42 -54.6 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.77 98.45 0.47 Allowed Glycine 0 CA--C 1.484 -1.896 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.623 HD11 ' SG ' ' A' ' 36' ' ' CYS . 2.3 pp -137.84 126.07 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.65 107.67 3.55 Favored Glycine 1 C--N 1.238 -4.913 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.819 172.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.0 m80 50.91 89.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -126.9 -6.91 6.11 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 72.5 m-85 -145.78 147.49 32.83 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.53 -47.62 25.27 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 123.418 2.746 . . . . 0.0 111.992 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -92.01 12.9 20.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.818 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 29' ' ' ILE . 49.0 t -95.32 110.84 22.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.761 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.75 75.29 0.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.352 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.1 t -69.28 170.28 10.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 . . . . . 0 C--N 1.289 -2.035 0 O-C-N 121.695 -0.628 . . . . 0.0 109.864 -175.54 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.464 0.65 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.91 169.52 13.34 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.931 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 130.62 20.79 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.58 4.52 17.3 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -100.01 109.4 21.73 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.08 103.9 11.02 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 t -131.69 139.98 49.19 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -112.66 152.92 28.43 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.33 13.28 7.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.857 1.263 . . . . 0.0 110.099 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -84.85 -42.76 14.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -88.22 -15.42 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.9 tttp 55.66 60.34 3.36 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.024 1.73 . . . . 0.0 114.308 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -133.04 171.6 13.77 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -75.75 98.06 4.02 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.132 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.06 98.89 10.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.506 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 40.1 tt0 -141.4 -76.82 0.29 Allowed 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.265 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.6 145.81 27.17 Favored 'General case' 1 N--CA 1.374 -4.239 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 71.53 6.14 5.63 Favored 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 127.093 2.157 . . . . 0.0 111.134 -174.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.26 -53.54 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 34.7 mmt180 -58.85 -28.08 65.75 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.683 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -100.14 -19.41 16.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.021 0.528 . . . . 0.0 110.725 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 24.3 t80 -60.1 -60.17 4.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.951 0.405 . . . . 0.0 111.072 -171.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 23' ' ' ILE . 3.5 mp -67.71 -32.02 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -175.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -68.38 -39.21 81.83 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.914 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.5 t -64.97 -34.06 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.02 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.3 -19.0 63.11 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -80.53 -51.67 8.51 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.6 101.8 2.15 Favored Glycine 0 CA--C 1.468 -2.881 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.8 pp -137.23 129.15 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.657 0 CA-C-O 122.278 1.037 . . . . 0.0 109.829 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.12 111.1 3.21 Favored Glycine 1 C--N 1.235 -5.056 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.915 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.74 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.582 1.553 . . . . 0.0 113.867 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 63.23 -74.89 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.545 1.538 . . . . 0.0 113.389 -174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 39.6 m-85 -106.12 143.97 28.0 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.11 -33.04 95.05 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.808 3.005 . . . . 0.0 113.398 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -100.67 3.48 42.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.013 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' HD13 ' A' ' 29' ' ' ILE . 43.6 t -77.26 110.19 11.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.665 0.745 . . . . 0.0 110.683 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.37 75.22 4.53 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.409 1.099 . . . . 0.0 111.13 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 t -128.08 161.51 29.06 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.813 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 . . . . . 0 CA--C 1.501 -0.931 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.72 160.65 10.06 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.66 -45.43 17.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 123.632 0.773 . . . . 0.0 109.908 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.2 53.15 0.72 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -95.51 109.65 21.83 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.083 0.468 . . . . 0.0 110.558 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -105.45 111.22 23.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.013 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -131.06 114.83 15.65 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -72.02 143.81 49.02 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.391 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 76.56 2.61 3.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.217 1.007 . . . . 0.0 111.555 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -70.69 -44.01 67.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -111.23 -15.78 13.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.262 20.7 pttp 42.98 58.94 3.07 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.708 1.203 . . . . 0.0 114.118 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -80.35 -72.38 0.41 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.028 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 55.6 ttp -119.36 17.21 13.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' HA ' HG21 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -80.83 73.14 7.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.537 -172.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.34 -83.51 0.51 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.74 147.66 35.26 Favored 'General case' 0 N--CA 1.381 -3.903 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.27 6.05 1.27 Allowed 'General case' 0 C--N 1.261 -3.244 0 C-N-CA 127.181 2.193 . . . . 0.0 112.578 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.425 HG21 ' HA ' ' A' ' 15' ' ' GLU . 80.3 t -107.87 -38.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -66.11 -15.68 63.3 Favored 'General case' 0 C--O 1.188 -2.17 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.402 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -104.13 -23.28 13.3 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.666 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 48.0 t80 -69.07 -61.11 1.93 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.148 -173.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.73 -37.36 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.027 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' CB ' HG12 ' A' ' 29' ' ' ILE . 46.0 mm-40 -67.92 -41.01 83.29 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.867 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.3 -28.08 65.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.53 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.63 -12.59 60.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.51 -47.6 7.87 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 171.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.51 93.88 0.83 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.358 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.5 pp -138.25 123.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.698 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.97 90.68 1.67 Allowed Glycine 1 C--N 1.243 -4.625 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.556 172.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 56.72 90.93 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.25 1.42 . . . . 0.0 112.992 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -102.05 -26.7 13.29 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.242 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.9 m-85 -125.35 147.48 57.79 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.45 -28.36 63.52 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 123.7 2.934 . . . . 0.0 113.315 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -103.84 8.09 37.01 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.592 0.757 . . . . 0.0 111.535 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -88.12 112.87 23.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.47 35.43 4.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.685 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.7 t -87.84 -76.25 0.39 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.204 -179.484 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.33 -153.21 17.54 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -84.01 -17.97 38.68 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.007 0.432 . . . . 0.0 110.795 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.59 138.12 14.62 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.1 m -94.82 109.23 21.22 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -77.65 103.88 7.85 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.275 0.56 . . . . 0.0 110.633 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 15.3 t -129.94 151.53 50.4 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 p -68.49 138.34 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.296 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.451 ' OD2' ' HG3' ' A' ' 12' ' ' LYS . 8.8 m-20 61.78 29.91 18.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.964 0.906 . . . . 0.0 110.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.8 tt -60.11 -46.15 90.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 t -112.14 -18.3 12.6 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 45.1 tttp 51.36 23.97 1.95 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.623 1.569 . . . . 0.0 111.287 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -86.5 -45.21 11.32 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.056 0.943 . . . . 0.0 109.653 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 63.2 mtt -106.97 96.41 6.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.34 157.81 17.33 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.41 -31.88 5.78 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.115 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HA ' ' CE1' ' A' ' 35' ' ' PHE . 42.8 mt-10 -67.34 124.87 24.37 Favored 'General case' 0 N--CA 1.399 -2.975 0 CA-C-O 122.095 0.95 . . . . 0.0 109.007 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 75.59 6.12 3.98 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.88 -2.418 . . . . 0.0 112.033 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.54 -42.77 7.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.24 -35.21 62.23 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.668 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.7 -4.27 31.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.824 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -67.83 -65.1 0.73 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.702 0.287 . . . . 0.0 111.544 -171.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.78 -23.08 27.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.279 0.562 . . . . 0.0 110.083 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -68.45 -43.96 75.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.99 -13.82 62.27 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.787 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.31 -10.9 55.5 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.886 -0.508 . . . . 0.0 111.281 170.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -121.1 176.79 5.41 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.18 92.91 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 pp -130.33 115.26 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.616 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.78 90.74 0.97 Allowed Glycine 1 C--N 1.245 -4.501 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.758 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 62.92 88.82 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.856 0.836 . . . . 0.0 112.632 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.99 -37.31 12.91 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.702 -0.624 . . . . 0.0 110.802 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -118.88 154.1 52.86 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -51.9 -35.44 60.01 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.412 2.741 . . . . 0.0 113.298 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 17' ' ' GLU . 27.5 p90 -102.22 13.88 33.47 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.562 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.1 t -93.95 105.24 17.26 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -93.28 -1.68 55.82 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.537 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.54 122.11 16.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.73 162.35 10.44 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.373 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 74.71 172.6 0.27 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.744 1.218 . . . . 0.0 112.512 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.58 29.69 2.2 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.051 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 t -111.83 120.84 43.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -74.47 119.63 18.93 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.853 0.359 . . . . 0.0 110.512 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -117.19 123.65 47.2 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.462 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 10' ' ' LEU . 23.3 m -62.4 138.17 58.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.932 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 77.8 -30.04 0.16 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.227 1.811 . . . . 0.0 111.785 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 8' ' ' SER . 8.0 tt -71.34 -38.86 71.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -80.35 -15.45 56.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.105 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 47.75 58.77 4.68 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.845 1.658 . . . . 0.0 112.083 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -100.38 153.66 19.14 Favored 'General case' 0 C--N 1.27 -2.85 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.945 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.0 ttp -164.35 164.9 22.11 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . 9.8 pt-20 -73.27 84.74 1.4 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.621 1.201 . . . . 0.0 107.783 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.76 168.13 6.58 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 113.456 -1.702 . . . . 0.0 114.599 -169.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.1 162.32 23.76 Favored 'General case' 1 N--CA 1.379 -4.025 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.501 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.79 3.88 0.34 Allowed 'General case' 0 C--N 1.261 -3.262 0 C-N-CA 128.268 2.627 . . . . 0.0 114.298 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 14.6 p -108.62 -37.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HD2' ' HB2' ' A' ' 15' ' ' GLU . 1.4 mmp_? -62.81 -20.4 65.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.582 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 52.8 t -105.54 -4.84 20.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.429 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 27.7 t80 -64.66 -59.71 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.836 0.351 . . . . 0.0 111.476 -170.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 ' H ' ' A' ' 23' ' ' ILE . 4.0 mp -75.1 -25.95 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.011 0.91 . . . . 0.0 108.769 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.95 -38.52 82.93 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.717 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -76.48 -18.02 58.98 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.3 mt -78.85 -6.55 56.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.307 0.575 . . . . 0.0 109.898 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -102.52 -54.39 2.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.0 78.54 0.64 Allowed Glycine 0 CA--C 1.488 -1.614 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.375 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.739 HD11 ' O ' ' A' ' 29' ' ' ILE . 2.6 pp -136.1 121.16 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-O 123.078 1.418 . . . . 0.0 109.689 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.7 146.64 16.09 Favored Glycine 1 C--N 1.215 -6.142 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.437 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.496 ' H ' ' HA ' ' A' ' 37' ' ' HIS . 48.3 m-70 67.72 13.48 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.56 -39.12 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.207 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 43.8 m-85 -115.8 154.57 48.16 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.57 -21.39 18.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.878 3.052 . . . . 0.0 113.637 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -122.61 12.39 9.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.924 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 42.4 t -122.95 101.83 7.66 Favored 'General case' 0 CA--C 1.467 -2.222 0 C-N-CA 119.14 -1.024 . . . . 0.0 112.381 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.496 ' HA ' ' H ' ' A' ' 31' ' ' HIS . 9.1 m80 -128.96 75.69 1.67 Allowed 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -44.59 126.84 5.74 Favored 'General case' 0 C--N 1.368 1.408 0 CA-C-O 120.919 0.39 . . . . 0.0 110.092 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 . . . . . 0 N--CA 1.431 -1.383 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.264 -170.219 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.532 0.682 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.03 170.91 47.77 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.35 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.22 -19.59 18.49 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.271 -0.547 . . . . 0.0 110.139 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.28 116.39 4.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -95.15 109.06 21.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.106 0.479 . . . . 0.0 110.45 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -113.19 119.22 37.03 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m -132.0 143.33 50.0 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -57.98 123.23 15.14 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.539 0.524 . . . . 0.0 110.574 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t70 76.89 1.07 3.18 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.35 1.06 . . . . 0.0 112.429 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.6 -44.03 87.87 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.851 -0.531 . . . . 0.0 111.782 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 t -86.52 -17.06 35.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 42.91 59.91 2.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.314 1.445 . . . . 0.0 112.132 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -111.37 151.71 28.15 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.865 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -61.99 134.69 56.96 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.56 78.13 4.07 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -98.83 166.63 11.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.656 -164.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -59.97 149.02 33.17 Favored 'General case' 0 N--CA 1.384 -3.736 0 C-N-CA 125.591 1.556 . . . . 0.0 109.472 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.5 3.31 1.85 Allowed 'General case' 0 C--N 1.251 -3.698 0 C-N-CA 127.738 2.415 . . . . 0.0 113.015 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.31 -39.33 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.943 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 171.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 4.8 mmp_? -68.33 -4.43 14.44 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.694 172.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.5 t -106.37 -45.17 4.34 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.046 0.451 . . . . 0.0 110.121 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 18.1 t80 -51.31 -68.18 0.19 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.109 1.364 . . . . 0.0 113.772 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 22' ' ' PHE . 2.8 mp -66.26 -35.19 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 121.722 0.772 . . . . 0.0 110.345 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.9 mm-40 -58.81 -52.45 65.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.042 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.0 t -64.01 -29.45 70.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.874 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 84.1 mt -58.89 -22.92 60.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 65.4 pttt -94.0 -7.72 41.99 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.259 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.27 53.11 0.85 Allowed Glycine 0 N--CA 1.427 -1.9 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.442 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.91 123.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -132.57 0.1 Allowed Glycine 1 C--N 1.247 -4.393 0 CA-C-N 113.191 -1.822 . . . . 0.0 114.108 175.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -76.8 83.98 3.39 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.128 -0.63 . . . . 0.0 111.33 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -101.71 -14.79 17.21 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.557 0.694 . . . . 0.0 110.025 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 78.2 m-85 -128.85 146.84 62.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.99 -44.22 43.38 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 123.703 2.935 . . . . 0.0 112.995 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -90.75 9.65 29.17 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.35 1.06 . . . . 0.0 112.13 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 31.4 t -94.28 101.84 13.82 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.741 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -97.29 -2.99 41.43 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.395 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -76.52 145.74 38.91 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 . . . . . 0 C--N 1.31 -1.14 0 C-N-CA 122.926 0.49 . . . . 0.0 111.229 -176.021 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 120.891 0.377 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.21 160.37 27.03 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.73 111.05 22.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.789 0.794 . . . . 0.0 111.063 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 151.86 7.79 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.9 m -142.1 123.44 14.8 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -70.59 118.79 13.83 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -117.13 107.55 14.62 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.241 0.543 . . . . 0.0 110.981 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 10' ' ' LEU . 51.4 m -144.33 128.39 17.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 73.75 -31.68 0.22 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.065 1.346 . . . . 0.0 111.889 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.3 tt -55.32 -44.67 76.05 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.357 1.063 . . . . 0.0 110.014 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -111.56 -17.57 13.02 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.2 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 56.34 18.38 3.37 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.85 1.26 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -83.71 -10.07 58.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 17.1 ptp -56.69 -47.47 79.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 32.0 tt0 66.5 -51.43 0.44 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.769 1.627 . . . . 0.0 114.596 172.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -42.38 -51.05 5.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.506 1.922 . . . . 0.0 114.047 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' CD ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 tp10 -143.22 158.23 43.8 Favored 'General case' 0 N--CA 1.393 -3.283 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 63.53 5.27 2.07 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 128.41 2.684 . . . . 0.0 112.95 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 17' ' ' GLU . 74.4 t -110.07 -50.71 6.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 39.1 mmt180 -64.21 -28.89 70.05 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.368 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.6 t -105.41 -2.33 23.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.81 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 58.5 t80 -57.0 -62.87 1.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.601 0.964 . . . . 0.0 113.601 -169.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 3.2 mp -68.93 -34.67 65.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 2.9 mm-40 -56.31 -54.26 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.652 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.5 t -69.83 -29.79 67.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.54 1.136 . . . . 0.0 111.135 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.7 tp -66.04 -25.88 67.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.581 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 29.1 mmmt -97.71 -58.57 1.96 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.98 110.71 0.7 Allowed Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 pp -139.63 135.63 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.779 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.04 -131.69 0.03 OUTLIER Glycine 1 C--N 1.242 -4.689 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.036 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -96.79 88.92 4.73 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.77 -1.43 . . . . 0.0 109.599 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -107.05 -31.45 8.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.289 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 24' ' ' GLU . 71.1 m-85 -116.19 133.57 22.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.896 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 -16.99 57.4 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.468 3.445 . . . . 0.0 113.496 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -112.69 -10.61 13.62 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.099 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.425 ' HA ' ' CD ' ' A' ' 17' ' ' GLU . 47.3 t -76.89 111.55 12.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.169 -171.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -99.43 -5.56 29.23 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.93 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.5 t -68.42 -36.84 79.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.971 0.891 . . . . 0.0 108.925 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 113.3 -1.773 . . . . 0.0 111.195 178.838 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.41 160.17 33.93 Favored Glycine 0 N--CA 1.428 -1.862 0 O-C-N 123.891 0.745 . . . . 0.0 112.585 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 -38.65 2.27 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.03 21.84 10.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 174.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.4 m -134.1 114.01 12.69 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.39 117.64 19.8 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.37 0.419 . . . . 0.0 110.101 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -100.25 111.07 23.33 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -77.2 138.37 39.4 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.045 0.938 . . . . 0.0 111.113 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 66.49 13.2 9.16 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 124.119 0.968 . . . . 0.0 111.838 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.8 -43.62 53.74 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 t -94.05 -12.44 28.56 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt 58.02 35.48 25.26 Favored 'General case' 0 C--N 1.348 0.53 0 CA-C-O 123.411 1.577 . . . . 0.0 110.197 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -97.53 165.07 12.17 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.097 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.5 ptm -97.24 126.42 42.43 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -83.39 90.31 7.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 40.9 tt0 -116.87 -82.88 0.63 Allowed 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.72 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' ' HG2' ' A' ' 16' ' ' GLU . 51.2 mt-10 -122.34 165.9 15.54 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.04 4.21 2.96 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 126.432 1.893 . . . . 0.0 111.261 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 28.9 m -105.35 -6.24 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -82.93 -28.54 29.81 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.671 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.5 p -106.7 -4.14 19.79 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.257 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 41.0 t80 -56.72 -61.54 2.36 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.59 0.756 . . . . 0.0 112.582 -170.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.62 -28.31 27.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 7.3 mm-40 -59.1 -43.57 91.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.966 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -71.44 -32.86 68.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.733 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 85.4 mt -65.67 -27.28 68.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.432 0.634 . . . . 0.0 109.714 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' ' 24' ' ' GLU . 53.1 mtmt -83.39 -51.51 7.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.442 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.49 91.68 0.16 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.291 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.474 HD13 ' O ' ' A' ' 29' ' ' ILE . 2.2 pp -140.02 117.63 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.12 88.97 1.57 Allowed Glycine 1 C--N 1.252 -4.091 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.464 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 57.85 92.74 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.538 1.135 . . . . 0.0 112.505 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -111.64 -11.33 14.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.966 0.413 . . . . 0.0 111.426 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 77.7 m-85 -135.97 141.69 37.51 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -59.54 -37.58 87.99 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.434 2.756 . . . . 0.0 112.559 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 17' ' ' GLU . 17.2 p90 -93.23 14.8 17.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 124.172 0.989 . . . . 0.0 111.466 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.6 t -91.74 125.68 36.55 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -115.37 2.58 13.98 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.698 0.623 . . . . 0.0 112.295 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -81.0 86.65 6.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.318 -174.125 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.531 ' HB3' ' O ' ' A' ' 5' ' ' THR . 59.0 t-80 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.38 168.11 22.87 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 66.94 19.91 10.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 111.875 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.62 89.94 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 1' ' ' HIS . 20.9 m -95.57 121.62 37.46 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -106.84 144.53 33.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.7 m -128.43 108.18 10.35 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.73 0.776 . . . . 0.0 112.011 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 t -140.04 94.51 2.77 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.69 30.97 16.89 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.645 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.85 -44.35 61.49 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -110.7 -9.74 14.5 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.3 tttm 56.1 45.17 24.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.322 1.849 . . . . 0.0 110.977 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -138.48 149.23 45.21 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.684 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 2.0 mpt? -105.99 11.97 31.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' MET . 33.4 mt-10 71.46 -62.26 0.46 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.681 1.592 . . . . 0.0 109.833 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' HG13 ' A' ' 19' ' ' VAL . 33.1 tt0 -176.95 126.7 0.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 126.02 1.728 . . . . 0.0 106.825 174.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.46 142.22 36.06 Favored 'General case' 1 N--CA 1.377 -4.106 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.79 5.11 4.41 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 111.339 -2.664 . . . . 0.0 113.21 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 16' ' ' GLU . 7.7 p -104.19 -31.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -55.75 -35.05 65.76 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.56 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.647 ' SG ' HD13 ' A' ' 29' ' ' ILE . 42.2 t -105.1 -2.82 23.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.007 0.432 . . . . 0.0 111.075 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 34.0 t80 -56.58 -56.24 23.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.226 0.536 . . . . 0.0 110.537 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -72.4 -27.68 26.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.1 mm-40 -65.21 -40.19 93.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.819 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.18 -37.91 75.24 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.821 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.58 -36.2 79.97 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.203 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -74.23 -55.55 5.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.28 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.54 95.75 0.89 Allowed Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.647 HD13 ' SG ' ' A' ' 21' ' ' CYS . 2.5 pp -139.49 125.25 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.07 89.34 1.08 Allowed Glycine 1 C--N 1.252 -4.106 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.457 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 42.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.666 1.986 . . . . 0.0 113.651 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -126.44 16.23 7.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.148 0.499 . . . . 0.0 111.691 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 65.0 m-85 -146.67 139.21 14.05 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.88 -42.33 59.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.802 3.002 . . . . 0.0 113.418 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -90.93 10.78 25.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 124.135 0.974 . . . . 0.0 111.966 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 45.5 t -94.68 95.02 8.47 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.727 0.775 . . . . 0.0 110.846 -176.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -82.34 50.45 1.62 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.35 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -98.02 166.59 11.36 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 . . . . . 0 C--N 1.31 -1.115 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 -176.882 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.06 -171.28 21.06 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 62.65 82.77 0.17 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.111 0.964 . . . . 0.0 112.123 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.23 49.51 3.75 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.41 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -102.36 109.4 21.05 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -96.94 144.57 26.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 m -88.96 106.87 18.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 10' ' ' LEU . 20.3 m -129.86 138.66 51.08 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 11.4 m-20 77.29 -43.03 0.41 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.415 1.486 . . . . 0.0 110.71 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.6 tt -57.07 -43.36 82.01 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.836 1.654 . . . . 0.0 111.324 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.0 t -110.57 -18.03 13.28 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.84 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.526 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 49.6 tttp 48.94 14.11 0.07 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 126.66 1.984 . . . . 0.0 115.385 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -70.91 -57.41 4.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.344 -0.848 . . . . 0.0 112.03 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 28.1 ttt -94.06 -61.83 1.46 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.526 ' OE1' ' HG3' ' A' ' 12' ' ' LYS . 32.1 tt0 63.33 102.05 0.03 OUTLIER 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.689 1.195 . . . . 0.0 113.552 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 17' ' ' GLU . 40.6 tt0 -106.29 148.37 28.07 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.724 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 44.0 mt-10 -105.14 171.2 7.45 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.37 4.0 0.87 Allowed 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 126.542 1.937 . . . . 0.0 112.401 -172.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.1 p -97.03 -31.91 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -67.95 -16.82 64.23 Favored 'General case' 0 C--O 1.19 -2.063 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.474 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 46.1 t -105.82 -18.04 14.18 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.0 110.326 174.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 40.2 t80 -62.21 -61.81 2.2 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.253 0.621 . . . . 0.0 112.101 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -71.0 -29.98 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.749 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.32 -41.99 80.0 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.82 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.69 -31.83 70.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.15 -33.17 72.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -78.62 -55.85 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 90.77 0.79 Allowed Glycine 0 CA--C 1.484 -1.865 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.561 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.524 HD11 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -136.28 127.17 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.504 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.13 113.67 4.34 Favored Glycine 1 C--N 1.235 -5.073 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.344 175.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m80 44.92 88.05 0.02 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.433 1.893 . . . . 0.0 114.495 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -129.29 -0.97 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.402 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 54.4 m-85 -145.9 143.43 19.55 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -48.17 -49.33 14.36 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 124.037 3.158 . . . . 0.0 113.189 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -88.59 17.92 5.04 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.532 1.133 . . . . 0.0 111.529 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 48.6 t -114.01 101.84 9.61 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.008 0.432 . . . . 0.0 110.768 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -114.28 -2.11 13.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.609 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 t -79.6 102.72 9.05 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 . . . . . 0 C--N 1.288 -2.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.539 -174.336 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.84 -161.93 17.53 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.4 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -132.69 119.83 20.89 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.55 32.81 9.82 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.653 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.4 t -110.51 113.03 25.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -117.19 131.23 56.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -131.13 107.19 8.85 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -153.08 111.68 3.71 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 67.97 14.2 9.31 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.559 1.171 . . . . 0.0 109.786 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.12 -43.19 22.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.509 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -90.48 -16.1 29.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttp 59.28 27.52 16.6 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -84.43 142.3 30.2 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.946 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.6 tpp -146.51 87.27 1.71 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.65 97.86 0.48 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.698 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -114.76 -33.44 5.49 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.38 160.23 23.48 Favored 'General case' 1 N--CA 1.379 -4.011 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.828 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.44 5.65 0.47 Allowed 'General case' 0 C--N 1.282 -2.347 0 C-N-CA 126.284 1.834 . . . . 0.0 112.267 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 17' ' ' GLU . 13.7 p -108.66 -21.92 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -64.33 -30.64 71.68 Favored 'General case' 0 C--O 1.203 -1.361 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.391 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 33' ' ' TYR . 36.6 t -105.6 -8.19 18.11 Favored 'General case' 0 C--O 1.189 -2.101 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -67.36 -53.66 27.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.8 -30.32 46.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.335 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.86 -38.08 58.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.111 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 11.7 t -64.41 -29.43 70.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.185 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -75.28 -5.77 46.37 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.346 0.0 OUTLIER -147.78 71.29 1.18 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.46 -25.68 26.77 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 25' ' ' CYS 0.287 1.9 pp -115.02 115.35 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 119.991 1.895 . . . . 0.0 112.071 -172.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.43 102.93 2.79 Favored Glycine 1 C--N 1.233 -5.156 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.403 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 67.65 88.13 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.693 1.197 . . . . 0.0 112.829 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -119.06 -2.8 10.71 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.049 0.928 . . . . 0.0 108.689 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 21' ' ' CYS . 61.3 m-85 -135.24 147.05 60.64 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.71 -36.21 98.52 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 123.532 2.821 . . . . 0.0 113.406 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.1 18.58 13.23 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.788 0.835 . . . . 0.0 111.01 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.09 96.3 10.53 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.891 0.853 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -94.43 -16.83 23.06 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.554 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.46 105.03 0.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.381 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 . . . . . 0 C--N 1.299 -1.618 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.5 m80 . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 120.67 0.272 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.25 -149.6 37.56 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.114 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 73.11 142.26 0.06 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.66 1.184 . . . . 0.0 111.107 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.03 73.02 2.69 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 m -95.58 112.29 24.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -103.38 128.88 50.39 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 19.5 m -89.67 121.25 31.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.34 140.35 58.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.33 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 12' ' ' LYS . 24.0 t70 67.52 24.75 8.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.542 1.163 . . . . 0.0 110.637 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.9 tt -73.72 -44.65 55.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.133 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 p -107.57 -15.37 14.61 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 9' ' ' ASP . 32.3 tttp 68.3 14.01 9.13 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.798 1.639 . . . . 0.0 111.423 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -143.78 139.41 29.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.748 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.86 0.838 . . . . 0.0 108.977 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.45 125.06 23.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.996 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.58 -38.75 2.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.896 0.855 . . . . 0.0 108.847 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.96 133.11 35.28 Favored 'General case' 1 N--CA 1.377 -4.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 74.83 6.3 4.38 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 111.849 -2.432 . . . . 0.0 112.523 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.45 -34.68 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -62.4 -22.54 66.23 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.482 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -94.29 -38.04 11.21 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 28.3 t80 -56.83 -59.54 4.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.229 1.412 . . . . 0.0 111.204 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.6 mm -62.11 -35.59 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.854 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.48 -40.12 44.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.6 t -69.29 -28.44 66.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.418 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.45 -30.7 67.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.023 174.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -84.59 -57.37 3.16 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.02 97.46 0.26 Allowed Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.869 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -140.18 122.52 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.13 90.09 1.0 Allowed Glycine 1 C--N 1.241 -4.696 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.192 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 46.15 81.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.455 1.502 . . . . 0.0 112.554 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.43 -0.0 46.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.177 0.513 . . . . 0.0 111.791 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 57.8 m-85 -143.39 154.44 60.43 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 -42.52 67.41 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.459 2.773 . . . . 0.0 112.17 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -91.75 16.56 10.49 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 111.404 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -100.28 116.13 31.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -124.6 13.86 8.73 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.6 t -74.04 117.57 15.98 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.306 -1.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 -178.722 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.21 -170.22 13.39 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.09 -55.04 5.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.38 91.52 1.73 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.32 109.32 21.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.51 0.671 . . . . 0.0 112.799 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -90.64 127.48 36.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -100.66 139.04 36.9 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.273 0.559 . . . . 0.0 111.273 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -72.73 95.19 1.86 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.585 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.41 -0.82 2.08 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 173.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.34 -42.62 68.3 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 t -88.31 -13.45 40.76 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.346 21.0 pttp 43.94 57.81 3.95 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.929 1.692 . . . . 0.0 114.775 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -86.28 133.24 33.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.903 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtt -133.24 100.6 4.9 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -87.31 88.33 7.66 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.48 -23.8 34.51 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -124.85 -159.52 0.89 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 113.611 -1.632 . . . . 0.0 106.874 175.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.87 5.75 3.02 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.622 1.169 . . . . 0.0 113.137 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.9 t -108.42 -44.06 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -62.31 -13.3 27.28 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.724 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -105.61 -28.49 10.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.429 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 39.8 t80 -66.13 -66.63 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.892 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.7 mp -62.82 -31.67 53.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.903 0.859 . . . . 0.0 110.08 -175.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 mm-40 -68.49 -45.31 72.66 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.08 -33.12 75.28 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.15 -17.6 63.84 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.903 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -78.47 -33.06 48.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.399 0.618 . . . . 0.0 109.596 174.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.26 36.6 1.45 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.588 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 24' ' ' GLU . 1.9 pp -122.29 113.84 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.09 143.51 19.65 Favored Glycine 1 C--N 1.246 -4.445 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.499 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 36' ' ' CYS . 17.3 t-80 66.65 -99.76 0.06 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.213 1.005 . . . . 0.0 112.007 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 54.78 -62.41 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 126.69 1.996 . . . . 0.0 114.974 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -87.73 145.36 36.77 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 124.046 0.938 . . . . 0.0 109.878 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.94 -44.52 27.27 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 124.176 3.25 . . . . 0.0 113.313 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 17' ' ' GLU . 13.4 p90 -91.6 0.53 57.49 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.213 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.6 t -101.61 121.32 41.8 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.314 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -121.31 5.13 10.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.18 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 35.4 t -75.67 146.3 40.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.064 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 . . . . . 0 C--N 1.306 -1.29 0 C-N-CA 123.476 0.711 . . . . 0.0 109.446 -177.525 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 34.3 t60 . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.28 -158.45 21.1 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -85.64 169.62 13.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.897 0.349 . . . . 0.0 110.281 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.1 -179.38 17.03 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.9 m -94.64 109.49 21.41 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -105.17 130.37 53.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -131.08 112.3 12.76 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.392 0.615 . . . . 0.0 109.758 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -162.11 -161.69 0.77 Allowed 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -70.84 5.5 1.93 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.325 0.65 . . . . 0.0 111.97 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.94 -45.51 92.39 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -112.28 -15.84 13.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.648 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 pttt 54.21 27.72 8.2 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.173 1.789 . . . . 0.0 111.712 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -140.95 166.65 24.21 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.317 -2.22 . . . . 0.0 107.245 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -127.82 164.75 21.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.94 -36.24 65.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.164 0.985 . . . . 0.0 111.677 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 23.6 tt0 -121.24 -177.71 3.59 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' H ' ' HG2' ' A' ' 16' ' ' GLU 0.267 8.5 pt-20 58.49 129.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.491 2.316 . . . . 0.0 114.057 -174.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.21 4.42 0.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.409 1.884 . . . . 0.0 114.468 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.58 -38.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.11 -29.3 68.52 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.624 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -104.76 -11.86 16.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.969 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 1.6 t80 -72.02 -66.52 0.63 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.749 0.785 . . . . 0.0 110.611 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -67.66 -24.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.314 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.45 -35.3 25.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.272 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.8 t -63.83 -33.64 76.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.77 -21.64 66.0 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.063 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -90.52 -47.49 7.67 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.35 90.19 0.93 Allowed Glycine 0 CA--C 1.475 -2.429 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.39 130.36 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.867 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.33 -132.64 0.15 Allowed Glycine 1 C--N 1.243 -4.628 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.117 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -82.04 80.21 8.35 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.668 -0.901 . . . . 0.0 109.146 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.01 -24.06 21.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.148 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -130.0 143.54 49.52 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.13 -21.57 28.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 124.01 3.14 . . . . 0.0 114.37 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -115.24 13.25 16.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.496 0.718 . . . . 0.0 111.162 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 39.6 t -99.04 121.68 41.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -115.34 33.84 5.22 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.98 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.7 t -65.68 161.23 21.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.4 mtt-85 . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.725 -0.609 . . . . 0.0 110.398 -175.406 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.053 0.454 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.83 160.63 10.03 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -88.58 106.83 18.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.51 83.96 0.88 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -95.52 110.77 22.8 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.976 0.511 . . . . 0.0 109.628 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.96 120.37 32.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.414 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 25.2 m -105.19 128.5 53.43 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.9 t -64.61 130.5 43.85 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 120.924 0.392 . . . . 0.0 110.835 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.17 24.27 14.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.449 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 3.1 tm? -63.95 -43.99 94.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -110.56 -17.08 13.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 57.7 13.82 2.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.171 1.789 . . . . 0.0 113.105 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -139.18 154.8 48.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -82.7 72.01 9.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.179 0.99 . . . . 0.0 111.636 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -147.96 91.93 1.99 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.33 153.36 23.37 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 122.219 1.009 . . . . 0.0 113.013 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.04 154.19 40.18 Favored 'General case' 1 N--CA 1.377 -4.097 0 CA-C-N 113.974 -1.467 . . . . 0.0 107.866 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.88 5.45 0.97 Allowed 'General case' 0 C--N 1.25 -3.738 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.931 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.27 -49.26 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -72.91 -5.02 35.65 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 113.226 -1.807 . . . . 0.0 112.399 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 t -104.9 -31.16 9.39 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.601 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.1 t80 -66.34 -60.23 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.815 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.34 -32.4 56.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.5 0.667 . . . . 0.0 110.612 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.9 -37.2 62.15 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.197 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.3 t -66.08 -31.82 72.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.187 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.62 -25.12 68.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.598 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -79.23 -55.16 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.15 78.46 0.24 Allowed Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.857 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.596 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.7 pp -129.65 120.72 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.586 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.36 100.0 0.62 Allowed Glycine 1 C--N 1.244 -4.575 0 CA-C-N 113.396 -1.729 . . . . 0.0 111.562 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 64.8 m80 58.42 -83.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.758 1.623 . . . . 0.0 114.244 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 69.0 -67.82 0.2 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.379 1.472 . . . . 0.0 112.175 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 26.1 m-85 -83.01 142.37 44.47 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.76 -38.18 77.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 123.869 3.046 . . . . 0.0 112.809 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -94.5 3.61 54.91 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.145 0.978 . . . . 0.0 112.079 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -97.64 120.5 38.14 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.879 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -103.86 30.78 4.89 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.596 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.0 t -70.98 106.57 3.71 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.093 0.473 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 C--N 1.31 -1.14 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.263 -176.483 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 . . . . . 0 C--O 1.243 0.713 0 CA-C-O 122.046 0.927 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.13 162.56 24.68 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -84.0 -42.95 15.67 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.35 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.49 1.05 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 m -101.53 108.46 20.04 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 121.629 0.728 . . . . 0.0 110.193 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.48 103.86 10.86 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -124.93 144.39 50.37 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 152.37 34.08 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 123.881 0.872 . . . . 0.0 109.797 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 78.61 -26.82 0.17 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.511 1.125 . . . . 0.0 111.453 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.97 -43.33 88.2 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -81.08 -15.92 54.65 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? 45.07 14.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -141.3 -34.83 0.48 Allowed 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 mmt 52.79 73.42 0.35 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.783 0.802 . . . . 0.0 110.727 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.04 118.23 27.46 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.668 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -103.62 -24.79 13.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.551 0.691 . . . . 0.0 109.891 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 44.9 mt-10 -68.14 132.11 46.62 Favored 'General case' 0 N--CA 1.397 -3.119 0 CA-C-O 122.569 1.175 . . . . 0.0 109.572 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 73.87 5.36 4.8 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 111.437 -2.62 . . . . 0.0 111.737 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.01 -44.8 8.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -63.46 -12.0 28.06 Favored 'General case' 0 C--O 1.191 -1.989 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.616 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -105.03 -29.18 10.6 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.1 0.476 . . . . 0.0 110.019 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t80 -65.71 -59.28 4.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.918 -170.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mm -66.56 -29.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.526 0.679 . . . . 0.0 110.15 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -75.02 -32.9 61.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.631 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -65.43 -32.64 74.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.319 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.0 -7.91 54.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.43 -49.59 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.42 79.48 0.21 Allowed Glycine 0 CA--C 1.471 -2.667 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.659 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.0 134.51 50.67 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.019 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.17 -132.56 0.06 OUTLIER Glycine 1 C--N 1.234 -5.132 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.449 169.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -90.03 85.15 6.24 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.079 -1.248 . . . . 0.0 108.132 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -92.23 -34.39 14.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.78 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.4 m-85 -111.37 142.56 26.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -25.52 35.26 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 124.568 3.512 . . . . 0.0 114.187 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 33.4 p90 -115.09 18.92 16.06 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.739 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.3 t -85.96 114.68 23.05 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.935 0.874 . . . . 0.0 112.59 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -77.2 -4.44 44.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.959 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 t -69.13 140.39 54.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.378 0.609 . . . . 0.0 110.696 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 . . . . . 0 C--O 1.254 1.334 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.485 -175.635 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 C--O 1.241 0.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.96 159.47 11.95 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.754 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' H ' HG21 ' A' ' 23' ' ' ILE . 44.5 tt0 -86.97 87.02 7.36 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.035 0.921 . . . . 0.0 109.161 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.08 156.65 7.25 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -112.05 109.49 19.26 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.143 0.497 . . . . 0.0 111.268 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -114.47 104.06 11.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -129.17 155.46 45.48 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.154 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 10' ' ' LEU . 38.8 m -48.98 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 126.413 1.885 . . . . 0.0 113.083 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 12' ' ' LYS . 11.7 m-20 -60.64 7.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.1 tt -63.31 -42.8 99.04 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.772 1.629 . . . . 0.0 107.853 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -102.83 -5.37 23.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.672 0.749 . . . . 0.0 109.426 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 25.6 pttm 55.2 19.42 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 127.388 2.275 . . . . 0.0 116.192 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -86.53 -173.62 4.6 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.6 tpt -84.13 123.04 29.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -90.29 94.78 9.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.64 179.95 5.91 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.682 0.753 . . . . 0.0 112.403 -171.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 19' ' ' VAL . 1.9 mp0 -83.47 -172.25 4.04 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.767 177.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 61.35 5.58 1.18 Allowed 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.636 1.575 . . . . 0.0 111.83 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.448 ' H ' ' C ' ' A' ' 17' ' ' GLU . 42.7 t -108.15 -23.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -63.59 -34.29 77.5 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.912 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.5 t -106.08 -4.13 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.39 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -66.81 -51.45 55.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.439 HG21 ' H ' ' A' ' 3' ' ' GLU . 4.0 mp -79.88 -28.14 12.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.885 0.85 . . . . 0.0 109.076 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.58 -47.03 87.99 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.2 t -72.87 -18.02 61.47 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.058 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 61.3 tp -66.86 -26.68 67.02 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.5 -65.24 1.03 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.08 69.79 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.357 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.795 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 29' ' ' ILE . 2.9 pp -134.13 114.08 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 115.12 4.37 Favored Glycine 1 C--N 1.244 -4.533 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.836 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 52.62 72.91 0.38 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.013 0.925 . . . . 0.0 112.295 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -99.66 -20.42 16.31 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.751 0.786 . . . . 0.0 110.645 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 15.6 m-85 -119.2 151.76 51.35 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.35 -37.49 71.68 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.956 3.104 . . . . 0.0 113.34 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -100.55 11.81 38.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.601 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.4 t -89.24 109.56 20.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 0.0 110.231 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -100.2 6.41 44.78 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.937 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.8 t -89.99 126.54 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 123.306 0.642 . . . . 0.0 109.388 177.826 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.957 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -94.9 109.23 21.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.303 0.573 . . . . 0.0 111.541 -171.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.32 113.23 25.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -90.15 144.77 25.58 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.574 0.702 . . . . 0.0 112.283 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m -123.84 79.52 1.72 Allowed 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.571 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 79.1 -15.57 0.75 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.731 2.012 . . . . 0.0 111.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.53 -44.68 81.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.303 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 50.9 m -112.91 -18.0 12.35 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.816 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.4 tttm 41.37 59.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.313 1.054 . . . . 0.0 112.516 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 11' ' ' SER . 96.3 mt-30 . . . . . 0 C--N 1.297 -1.69 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.334 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.37 -4.447 0 CA-C-O 122.739 1.257 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 59.44 4.09 0.47 Allowed 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 127.994 2.518 . . . . 0.0 113.699 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.14 -40.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.955 0.884 . . . . 0.0 109.148 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -71.63 -10.53 59.91 Favored 'General case' 0 C--O 1.197 -1.663 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.995 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.84 -34.73 7.97 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.6 t80 -54.57 -58.0 9.2 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.99 1.316 . . . . 0.0 111.886 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -67.34 -21.51 27.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.962 0.887 . . . . 0.0 111.09 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.87 -36.24 15.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.795 0.807 . . . . 0.0 109.479 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.22 -28.68 66.57 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.028 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.9 -36.92 85.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.244 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -73.87 -54.86 7.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.63 66.18 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.379 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.82 132.77 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.932 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.6 -132.27 0.04 OUTLIER Glycine 1 C--N 1.238 -4.899 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.416 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -83.74 84.0 7.71 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.684 -0.892 . . . . 0.0 111.482 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -89.97 -36.74 14.8 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.58 0.705 . . . . 0.0 109.705 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.1 m-85 -108.83 151.93 42.06 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.33 -46.27 32.34 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.584 2.856 . . . . 0.0 112.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -89.26 3.83 50.74 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.238 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 46.6 t -87.94 108.67 19.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.046 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -109.97 75.95 0.96 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.988 0.899 . . . . 0.0 109.455 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 C--N 1.293 -1.865 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.816 176.901 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.838 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -95.36 108.52 20.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -114.36 108.21 16.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -89.31 129.31 35.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.2 t -103.99 149.71 24.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 67.09 22.24 9.95 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.806 0.842 . . . . 0.0 111.532 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.71 -43.14 26.53 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 p -89.78 -15.73 31.75 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.885 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE2' ' CE1' ' A' ' 35' ' ' PHE . 15.0 ttpp 56.9 30.58 18.2 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.421 1.488 . . . . 0.0 110.442 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.863 -178.823 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 1 N--CA 1.373 -4.324 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.99 6.68 4.85 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.291 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.1 -43.94 7.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -61.18 -27.75 68.64 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.767 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.9 t -104.96 -4.63 21.86 Favored 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -66.61 -65.06 0.73 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.54 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.9 mp -66.07 -28.99 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.27 1.033 . . . . 0.0 108.793 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB3' HG12 ' A' ' 29' ' ' ILE . 13.8 mm-40 -66.69 -33.11 74.91 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -73.27 -31.12 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.33 -32.49 72.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.939 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.77 -52.37 21.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.941 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.67 92.57 2.27 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -135.25 121.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 122.509 1.147 . . . . 0.0 109.129 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.29 90.78 1.12 Allowed Glycine 1 C--N 1.236 -4.992 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.819 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 54.91 77.9 0.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.564 1.545 . . . . 0.0 113.759 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -90.89 -18.62 24.46 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.9 m-85 -135.79 147.84 62.87 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -58.01 -39.4 86.33 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 123.481 2.787 . . . . 0.0 111.855 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.439 ' CE1' ' HE2' ' A' ' 12' ' ' LYS . 24.7 p90 -98.82 16.76 21.26 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.387 -173.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.68 117.58 29.87 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -94.81 37.03 1.15 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.405 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 t . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.653 -178.548 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.528 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -120.05 109.07 15.05 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.459 0.647 . . . . 0.0 111.533 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -116.49 120.81 39.95 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -115.16 113.97 24.66 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.969 0.414 . . . . 0.0 110.853 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 m -126.14 96.1 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.23 28.48 17.81 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.727 0.811 . . . . 0.0 110.576 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -69.17 -46.49 67.39 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -112.97 -14.15 13.04 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 62.75 21.38 12.73 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 125.701 1.6 . . . . 0.0 110.073 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.251 -178.91 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.388 -3.562 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 49.23 4.74 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 127.44 2.296 . . . . 0.0 116.294 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 16.9 m -107.95 -32.65 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 121.963 0.887 . . . . 0.0 108.716 173.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.598 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -68.18 -13.96 62.62 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.372 170.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -105.08 -32.16 8.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.514 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 42.7 t80 -57.11 -58.33 8.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.003 0.921 . . . . 0.0 112.013 -173.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.471 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 34.9 mm -66.02 -24.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.879 0.847 . . . . 0.0 110.654 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -86.19 -39.65 16.41 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.498 0.666 . . . . 0.0 109.981 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -68.8 -27.11 65.57 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.191 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.4 tp -62.92 -29.47 70.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.645 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.471 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 60.0 mttp -83.98 -54.14 5.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.73 69.66 0.05 OUTLIER Glycine 0 CA--C 1.482 -1.998 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.332 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.37 125.57 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.438 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.68 -132.42 0.04 OUTLIER Glycine 1 C--N 1.251 -4.141 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.951 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -79.25 93.22 5.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.924 -0.75 . . . . 0.0 110.463 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -98.83 -42.41 7.19 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.696 0.76 . . . . 0.0 109.565 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.599 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 35.3 m-85 -104.85 146.45 32.67 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.29 -30.63 73.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.934 3.089 . . . . 0.0 112.616 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.62 20.85 18.22 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.854 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 53.4 t -91.93 94.99 9.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.3 1.048 . . . . 0.0 108.306 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -98.45 17.85 17.95 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.615 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.651 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.433 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -100.25 107.25 19.03 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -118.03 123.65 46.21 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -130.75 106.92 8.78 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.194 0.521 . . . . 0.0 111.528 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.5 m -84.14 92.88 8.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.521 0.677 . . . . 0.0 110.769 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 70.81 -0.65 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.681 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.2 -42.52 65.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -88.95 -17.12 30.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 tttp 54.78 20.27 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 C--N 1.299 -1.611 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.767 -179.395 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 . . . . . 0 N--CA 1.393 -3.279 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 51.43 3.93 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 126.919 2.087 . . . . 0.0 114.324 -173.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.24 -32.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -64.57 -21.46 66.7 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.481 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 32.1 t -104.86 -24.26 12.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.664 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.3 t80 -61.36 -63.97 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.813 -173.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.51 -38.26 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.0 mm-40 -66.17 -44.9 82.71 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.472 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.24 -32.71 74.29 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.297 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.36 -20.56 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.319 0.58 . . . . 0.0 111.405 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -92.42 -54.6 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.77 98.45 0.47 Allowed Glycine 0 CA--C 1.484 -1.896 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.629 HD11 ' SG ' ' A' ' 36' ' ' CYS . 2.3 pp -137.84 126.07 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.65 107.67 3.55 Favored Glycine 1 C--N 1.238 -4.913 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.819 172.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.0 m80 50.91 89.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -126.9 -6.91 6.11 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.632 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 72.5 m-85 -145.78 147.49 32.83 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.53 -47.62 25.27 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 123.418 2.746 . . . . 0.0 111.992 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -92.01 12.9 20.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.818 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 49.0 t -95.32 110.84 22.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.761 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.75 75.29 0.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.352 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.124 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -100.01 109.4 21.73 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.08 103.9 11.02 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 t -131.69 139.98 49.19 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -112.66 152.92 28.43 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.33 13.28 7.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.857 1.263 . . . . 0.0 110.099 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -84.85 -42.76 14.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -88.22 -15.42 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.9 tttp 55.66 60.34 3.36 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.024 1.73 . . . . 0.0 114.308 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 . . . . . 0 C--N 1.267 -3.011 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 1 N--CA 1.374 -4.239 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 71.53 6.14 5.63 Favored 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 127.093 2.157 . . . . 0.0 111.134 -174.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.26 -53.54 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -58.85 -28.08 65.75 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.683 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -100.14 -19.41 16.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.021 0.528 . . . . 0.0 110.725 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 24.3 t80 -60.1 -60.17 4.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.951 0.405 . . . . 0.0 111.072 -171.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.5 mp -67.71 -32.02 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -175.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' HG12 ' A' ' 29' ' ' ILE . 40.0 mm-40 -68.38 -39.21 81.83 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.914 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.5 t -64.97 -34.06 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.02 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -70.3 -19.0 63.11 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -80.53 -51.67 8.51 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.6 101.8 2.15 Favored Glycine 0 CA--C 1.468 -2.881 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.8 pp -137.23 129.15 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.657 0 CA-C-O 122.278 1.037 . . . . 0.0 109.829 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.12 111.1 3.21 Favored Glycine 1 C--N 1.235 -5.056 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.915 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.74 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.582 1.553 . . . . 0.0 113.867 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 63.23 -74.89 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.545 1.538 . . . . 0.0 113.389 -174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.551 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 39.6 m-85 -106.12 143.97 28.0 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.11 -33.04 95.05 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.808 3.005 . . . . 0.0 113.398 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -100.67 3.48 42.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.013 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.6 t -77.26 110.19 11.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.665 0.745 . . . . 0.0 110.683 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.37 75.22 4.53 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.409 1.099 . . . . 0.0 111.13 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.295 -1.795 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.813 176.091 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.076 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -95.51 109.65 21.83 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.083 0.468 . . . . 0.0 110.558 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -105.45 111.22 23.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.013 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -131.06 114.83 15.65 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -72.02 143.81 49.02 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.391 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 76.56 2.61 3.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.217 1.007 . . . . 0.0 111.555 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -70.69 -44.01 67.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -111.23 -15.78 13.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.262 20.7 pttp 42.98 58.94 3.07 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.708 1.203 . . . . 0.0 114.118 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 . . . . . 0 C--N 1.287 -2.109 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.028 -176.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.381 -3.903 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.27 6.05 1.27 Allowed 'General case' 0 C--N 1.261 -3.244 0 C-N-CA 127.181 2.193 . . . . 0.0 112.578 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.3 t -107.87 -38.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -66.11 -15.68 63.3 Favored 'General case' 0 C--O 1.188 -2.17 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.402 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -104.13 -23.28 13.3 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 48.0 t80 -69.07 -61.11 1.93 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.148 -173.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.73 -37.36 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.027 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB3' HG12 ' A' ' 29' ' ' ILE . 46.0 mm-40 -67.92 -41.01 83.29 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.867 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.3 -28.08 65.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.53 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.63 -12.59 60.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.51 -47.6 7.87 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 171.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.51 93.88 0.83 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.358 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.484 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.5 pp -138.25 123.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.698 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.97 90.68 1.67 Allowed Glycine 1 C--N 1.243 -4.625 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.556 172.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 56.72 90.93 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.25 1.42 . . . . 0.0 112.992 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -102.05 -26.7 13.29 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.242 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.9 m-85 -125.35 147.48 57.79 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.45 -28.36 63.52 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 123.7 2.934 . . . . 0.0 113.315 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -103.84 8.09 37.01 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.592 0.757 . . . . 0.0 111.535 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -88.12 112.87 23.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.47 35.43 4.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.685 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.7 t . . . . . 0 C--N 1.31 -1.132 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.192 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.243 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.1 m -94.82 109.23 21.22 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -77.65 103.88 7.85 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.275 0.56 . . . . 0.0 110.633 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 15.3 t -129.94 151.53 50.4 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 p -68.49 138.34 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.296 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 12' ' ' LYS . 8.8 m-20 61.78 29.91 18.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.964 0.906 . . . . 0.0 110.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.8 tt -60.11 -46.15 90.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 t -112.14 -18.3 12.6 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 45.1 tttp 51.36 23.97 1.95 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.623 1.569 . . . . 0.0 111.287 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 . . . . . 0 C--N 1.298 -1.635 0 C-N-CA 124.056 0.943 . . . . 0.0 109.653 -179.216 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' ' CE1' ' A' ' 35' ' ' PHE . 42.8 mt-10 . . . . . 0 N--CA 1.399 -2.975 0 CA-C-O 122.095 0.95 . . . . 0.0 109.007 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 75.59 6.12 3.98 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.88 -2.418 . . . . 0.0 112.033 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.54 -42.77 7.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.24 -35.21 62.23 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.668 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.7 -4.27 31.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.824 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -67.83 -65.1 0.73 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.702 0.287 . . . . 0.0 111.544 -171.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.78 -23.08 27.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.279 0.562 . . . . 0.0 110.083 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -68.45 -43.96 75.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.99 -13.82 62.27 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.787 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.31 -10.9 55.5 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.886 -0.508 . . . . 0.0 111.281 170.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -121.1 176.79 5.41 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.18 92.91 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 pp -130.33 115.26 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.616 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.78 90.74 0.97 Allowed Glycine 1 C--N 1.245 -4.501 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.758 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 62.92 88.82 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.856 0.836 . . . . 0.0 112.632 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.99 -37.31 12.91 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.702 -0.624 . . . . 0.0 110.802 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 20.3 m-85 -118.88 154.1 52.86 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -51.9 -35.44 60.01 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.412 2.741 . . . . 0.0 113.298 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 17' ' ' GLU . 27.5 p90 -102.22 13.88 33.47 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.562 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.1 t -93.95 105.24 17.26 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -93.28 -1.68 55.82 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.537 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.441 -0.923 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.758 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.244 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 t -111.83 120.84 43.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -74.47 119.63 18.93 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.853 0.359 . . . . 0.0 110.512 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -117.19 123.65 47.2 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.462 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 m -62.4 138.17 58.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.932 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 77.8 -30.04 0.16 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.227 1.811 . . . . 0.0 111.785 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tt -71.34 -38.86 71.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -80.35 -15.45 56.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.105 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 47.75 58.77 4.68 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.845 1.658 . . . . 0.0 112.083 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 . . . . . 0 C--N 1.27 -2.85 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.945 178.872 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 1 N--CA 1.379 -4.025 0 CA-C-O 122.442 1.115 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.79 3.88 0.34 Allowed 'General case' 0 C--N 1.261 -3.262 0 C-N-CA 128.268 2.627 . . . . 0.0 114.298 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 14.6 p -108.62 -37.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -62.81 -20.4 65.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.582 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 52.8 t -105.54 -4.84 20.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.419 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 27.7 t80 -64.66 -59.71 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.836 0.351 . . . . 0.0 111.476 -170.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.581 ' H ' HD12 ' A' ' 23' ' ' ILE . 4.0 mp -75.1 -25.95 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.011 0.91 . . . . 0.0 108.769 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB3' HD11 ' A' ' 29' ' ' ILE . 7.0 mm-40 -67.95 -38.52 82.93 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.717 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -76.48 -18.02 58.98 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 94.3 mt -78.85 -6.55 56.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.307 0.575 . . . . 0.0 109.898 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -102.52 -54.39 2.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.0 78.54 0.64 Allowed Glycine 0 CA--C 1.488 -1.614 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.375 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.6 pp -136.1 121.16 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-O 123.078 1.418 . . . . 0.0 109.689 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.7 146.64 16.09 Favored Glycine 1 C--N 1.215 -6.142 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.437 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.545 ' H ' ' HA ' ' A' ' 37' ' ' HIS . 48.3 m-70 67.72 13.48 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HB2' HD13 ' A' ' 29' ' ' ILE . 75.5 mmtt -76.56 -39.12 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.207 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 43.8 m-85 -115.8 154.57 48.16 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.57 -21.39 18.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.878 3.052 . . . . 0.0 113.637 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -122.61 12.39 9.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.924 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.432 ' CB ' ' HB2' ' A' ' 33' ' ' TYR . 42.4 t -122.95 101.83 7.66 Favored 'General case' 0 CA--C 1.467 -2.222 0 C-N-CA 119.14 -1.024 . . . . 0.0 112.381 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.545 ' HA ' ' H ' ' A' ' 31' ' ' HIS . 9.1 m80 -128.96 75.69 1.67 Allowed 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.368 1.408 0 CA-C-O 120.919 0.39 . . . . 0.0 110.092 -178.87 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.768 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -95.15 109.06 21.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.106 0.479 . . . . 0.0 110.45 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -113.19 119.22 37.03 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 21.6 m -132.0 143.33 50.0 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -57.98 123.23 15.14 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.539 0.524 . . . . 0.0 110.574 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t70 76.89 1.07 3.18 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.35 1.06 . . . . 0.0 112.429 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 20.0 tp -65.6 -44.03 87.87 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.851 -0.531 . . . . 0.0 111.782 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 t -86.52 -17.06 35.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 42.91 59.91 2.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.314 1.445 . . . . 0.0 112.132 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 . . . . . 0 C--N 1.271 -2.811 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.865 178.183 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.384 -3.736 0 CA-C-O 122.655 1.217 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.5 3.31 1.85 Allowed 'General case' 0 C--N 1.251 -3.698 0 C-N-CA 127.738 2.415 . . . . 0.0 113.015 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.31 -39.33 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.943 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 171.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.8 mmp_? -68.33 -4.43 14.44 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.694 172.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.5 t -106.37 -45.17 4.34 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.046 0.451 . . . . 0.0 110.121 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HB3' HD12 ' A' ' 23' ' ' ILE . 18.1 t80 -51.31 -68.18 0.19 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.109 1.364 . . . . 0.0 113.772 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 22' ' ' PHE . 2.8 mp -66.26 -35.19 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 121.722 0.772 . . . . 0.0 110.345 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.9 mm-40 -58.81 -52.45 65.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.042 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.0 t -64.01 -29.45 70.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.874 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 84.1 mt -58.89 -22.92 60.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 65.4 pttt -94.0 -7.72 41.99 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.259 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.27 53.11 0.85 Allowed Glycine 0 N--CA 1.427 -1.9 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.442 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.91 123.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -132.57 0.1 Allowed Glycine 1 C--N 1.247 -4.393 0 CA-C-N 113.191 -1.822 . . . . 0.0 114.108 175.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -76.8 83.98 3.39 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.128 -0.63 . . . . 0.0 111.33 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -101.71 -14.79 17.21 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.557 0.694 . . . . 0.0 110.025 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 78.2 m-85 -128.85 146.84 62.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.99 -44.22 43.38 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 123.703 2.935 . . . . 0.0 112.995 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -90.75 9.65 29.17 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.35 1.06 . . . . 0.0 112.13 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 31.4 t -94.28 101.84 13.82 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.741 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -97.29 -2.99 41.43 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.395 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.313 -0.981 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.615 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.203 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.9 m -142.1 123.44 14.8 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -70.59 118.79 13.83 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -117.13 107.55 14.62 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.241 0.543 . . . . 0.0 110.981 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 10' ' ' LEU . 51.4 m -144.33 128.39 17.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 73.75 -31.68 0.22 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.065 1.346 . . . . 0.0 111.889 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.3 tt -55.32 -44.67 76.05 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.357 1.063 . . . . 0.0 110.014 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -111.56 -17.57 13.02 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.2 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 56.34 18.38 3.37 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.85 1.26 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -174.358 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' CD ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 tp10 . . . . . 0 N--CA 1.393 -3.283 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 63.53 5.27 2.07 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 128.41 2.684 . . . . 0.0 112.95 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -110.07 -50.71 6.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -64.21 -28.89 70.05 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.368 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.6 t -105.41 -2.33 23.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.81 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 58.5 t80 -57.0 -62.87 1.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.601 0.964 . . . . 0.0 113.601 -169.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 3.2 mp -68.93 -34.67 65.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 2.9 mm-40 -56.31 -54.26 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.652 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.5 t -69.83 -29.79 67.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.54 1.136 . . . . 0.0 111.135 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.7 tp -66.04 -25.88 67.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.581 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 29.1 mmmt -97.71 -58.57 1.96 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.98 110.71 0.7 Allowed Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.9 pp -139.63 135.63 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.779 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.04 -131.69 0.03 OUTLIER Glycine 1 C--N 1.242 -4.689 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.036 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -96.79 88.92 4.73 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.77 -1.43 . . . . 0.0 109.599 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -107.05 -31.45 8.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.289 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 71.1 m-85 -116.19 133.57 22.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.896 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 -16.99 57.4 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.468 3.445 . . . . 0.0 113.496 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -112.69 -10.61 13.62 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.099 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 47.3 t -76.89 111.55 12.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.169 -171.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -99.43 -5.56 29.23 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.93 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.234 0.283 0 CA-C-O 121.971 0.891 . . . . 0.0 108.925 176.485 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.028 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.4 m -134.1 114.01 12.69 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.39 117.64 19.8 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.37 0.419 . . . . 0.0 110.101 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -100.25 111.07 23.33 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -77.2 138.37 39.4 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.045 0.938 . . . . 0.0 111.113 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 66.49 13.2 9.16 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 124.119 0.968 . . . . 0.0 111.838 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.8 -43.62 53.74 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 t -94.05 -12.44 28.56 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt 58.02 35.48 25.26 Favored 'General case' 0 C--N 1.348 0.53 0 CA-C-O 123.411 1.577 . . . . 0.0 110.197 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--N 1.284 -2.253 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.097 177.958 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 51.2 mt-10 . . . . . 0 N--CA 1.392 -3.329 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.04 4.21 2.96 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 126.432 1.893 . . . . 0.0 111.261 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 28.9 m -105.35 -6.24 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -82.93 -28.54 29.81 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.671 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.5 p -106.7 -4.14 19.79 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.257 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 41.0 t80 -56.72 -61.54 2.36 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.59 0.756 . . . . 0.0 112.582 -170.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.9 mp -72.62 -28.31 27.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 7.3 mm-40 -59.1 -43.57 91.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.966 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -71.44 -32.86 68.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.733 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 85.4 mt -65.67 -27.28 68.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.432 0.634 . . . . 0.0 109.714 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 24' ' ' GLU . 53.1 mtmt -83.39 -51.51 7.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.442 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.49 91.68 0.16 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.291 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.491 ' HB ' ' HG2' ' A' ' 32' ' ' LYS . 2.2 pp -140.02 117.63 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.12 88.97 1.57 Allowed Glycine 1 C--N 1.252 -4.091 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.464 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 57.85 92.74 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.538 1.135 . . . . 0.0 112.505 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HG2' ' HB ' ' A' ' 29' ' ' ILE . 75.4 mmtt -111.64 -11.33 14.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.966 0.413 . . . . 0.0 111.426 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 77.7 m-85 -135.97 141.69 37.51 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -59.54 -37.58 87.99 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.434 2.756 . . . . 0.0 112.559 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 17' ' ' GLU . 17.2 p90 -93.23 14.8 17.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 124.172 0.989 . . . . 0.0 111.466 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.6 t -91.74 125.68 36.55 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -115.37 2.58 13.98 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.698 0.623 . . . . 0.0 112.295 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.067 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.829 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -95.57 121.62 37.46 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -106.84 144.53 33.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.7 m -128.43 108.18 10.35 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.73 0.776 . . . . 0.0 112.011 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 t -140.04 94.51 2.77 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.69 30.97 16.89 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.645 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.85 -44.35 61.49 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -110.7 -9.74 14.5 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.3 tttm 56.1 45.17 24.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.322 1.849 . . . . 0.0 110.977 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 . . . . . 0 C--N 1.281 -2.402 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.684 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 1 N--CA 1.377 -4.106 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.79 5.11 4.41 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 111.339 -2.664 . . . . 0.0 113.21 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.7 p -104.19 -31.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 20.7 mmm180 -55.75 -35.05 65.76 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.56 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 29' ' ' ILE . 42.2 t -105.1 -2.82 23.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.007 0.432 . . . . 0.0 111.075 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 34.0 t80 -56.58 -56.24 23.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.226 0.536 . . . . 0.0 110.537 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -72.4 -27.68 26.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.1 mm-40 -65.21 -40.19 93.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.819 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.18 -37.91 75.24 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.821 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.58 -36.2 79.97 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.203 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -74.23 -55.55 5.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.28 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.54 95.75 0.89 Allowed Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.658 HD11 ' SG ' ' A' ' 21' ' ' CYS . 2.5 pp -139.49 125.25 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.07 89.34 1.08 Allowed Glycine 1 C--N 1.252 -4.106 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.457 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 42.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.666 1.986 . . . . 0.0 113.651 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -126.44 16.23 7.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.148 0.499 . . . . 0.0 111.691 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 65.0 m-85 -146.67 139.21 14.05 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.88 -42.33 59.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.802 3.002 . . . . 0.0 113.418 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 20' ' ' ARG . 4.6 p90 -90.93 10.78 25.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 124.135 0.974 . . . . 0.0 111.966 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 45.5 t -94.68 95.02 8.47 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.727 0.775 . . . . 0.0 110.846 -176.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -82.34 50.45 1.62 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.35 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.841 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.216 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -102.36 109.4 21.05 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -96.94 144.57 26.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 m -88.96 106.87 18.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 10' ' ' LEU . 20.3 m -129.86 138.66 51.08 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 77.29 -43.03 0.41 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.415 1.486 . . . . 0.0 110.71 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.6 tt -57.07 -43.36 82.01 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.836 1.654 . . . . 0.0 111.324 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.0 t -110.57 -18.03 13.28 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.84 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 48.94 14.11 0.07 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 126.66 1.984 . . . . 0.0 115.385 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--N 1.304 -1.391 0 O-C-N 121.344 -0.848 . . . . 0.0 112.03 -177.968 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.394 -3.252 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.37 4.0 0.87 Allowed 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 126.542 1.937 . . . . 0.0 112.401 -172.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.1 p -97.03 -31.91 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -67.95 -16.82 64.23 Favored 'General case' 0 C--O 1.19 -2.063 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.474 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.1 t -105.82 -18.04 14.18 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.0 110.326 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 40.2 t80 -62.21 -61.81 2.2 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.253 0.621 . . . . 0.0 112.101 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 47.3 mm -71.0 -29.98 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.749 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.5 mm-40 -68.32 -41.99 80.0 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.82 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.69 -31.83 70.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.15 -33.17 72.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 35.8 mmtp -78.62 -55.85 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 90.77 0.79 Allowed Glycine 0 CA--C 1.484 -1.865 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.561 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -136.28 127.17 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.504 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.13 113.67 4.34 Favored Glycine 1 C--N 1.235 -5.073 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.344 175.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m80 44.92 88.05 0.02 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.433 1.893 . . . . 0.0 114.495 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -129.29 -0.97 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.402 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 54.4 m-85 -145.9 143.43 19.55 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -48.17 -49.33 14.36 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 124.037 3.158 . . . . 0.0 113.189 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -88.59 17.92 5.04 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.532 1.133 . . . . 0.0 111.529 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 48.6 t -114.01 101.84 9.61 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.008 0.432 . . . . 0.0 110.768 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -114.28 -2.11 13.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.609 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.422 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 N-CA-C 113.653 0.221 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.4 t -110.51 113.03 25.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -117.19 131.23 56.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -131.13 107.19 8.85 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -153.08 111.68 3.71 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 67.97 14.2 9.31 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.559 1.171 . . . . 0.0 109.786 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.12 -43.19 22.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.509 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -90.48 -16.1 29.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttp 59.28 27.52 16.6 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--N 1.288 -2.067 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.946 -176.936 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.379 -4.011 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.44 5.65 0.47 Allowed 'General case' 0 C--N 1.282 -2.347 0 C-N-CA 126.284 1.834 . . . . 0.0 112.267 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -108.66 -21.92 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -64.33 -30.64 71.68 Favored 'General case' 0 C--O 1.203 -1.361 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.391 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' HB2' ' CD1' ' A' ' 33' ' ' TYR . 36.6 t -105.6 -8.19 18.11 Favored 'General case' 0 C--O 1.189 -2.101 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -67.36 -53.66 27.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.8 -30.32 46.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.335 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.86 -38.08 58.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.111 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 11.7 t -64.41 -29.43 70.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.185 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -75.28 -5.77 46.37 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.346 0.0 OUTLIER -147.78 71.29 1.18 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.46 -25.68 26.77 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 25' ' ' CYS 0.287 1.9 pp -115.02 115.35 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 119.991 1.895 . . . . 0.0 112.071 -172.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.43 102.93 2.79 Favored Glycine 1 C--N 1.233 -5.156 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.403 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 67.65 88.13 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.693 1.197 . . . . 0.0 112.829 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -119.06 -2.8 10.71 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.049 0.928 . . . . 0.0 108.689 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 61.3 m-85 -135.24 147.05 60.64 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.71 -36.21 98.52 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 123.532 2.821 . . . . 0.0 113.406 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.1 18.58 13.23 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.788 0.835 . . . . 0.0 111.01 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.09 96.3 10.53 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.891 0.853 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -94.43 -16.83 23.06 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.554 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.381 179.335 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 m -95.58 112.29 24.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -103.38 128.88 50.39 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.428 ' HB ' HD12 ' A' ' 10' ' ' LEU . 19.5 m -89.67 121.25 31.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.34 140.35 58.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.33 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 12' ' ' LYS . 24.0 t70 67.52 24.75 8.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.542 1.163 . . . . 0.0 110.637 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 7' ' ' THR . 4.9 tt -73.72 -44.65 55.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.133 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 p -107.57 -15.37 14.61 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 9' ' ' ASP . 32.3 tttp 68.3 14.01 9.13 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.798 1.639 . . . . 0.0 111.423 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.748 178.802 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 1 N--CA 1.377 -4.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 74.83 6.3 4.38 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 111.849 -2.432 . . . . 0.0 112.523 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.45 -34.68 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -62.4 -22.54 66.23 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.482 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -94.29 -38.04 11.21 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 28.3 t80 -56.83 -59.54 4.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.229 1.412 . . . . 0.0 111.204 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.6 mm -62.11 -35.59 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.854 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.48 -40.12 44.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.6 t -69.29 -28.44 66.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.418 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.45 -30.7 67.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.023 174.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -84.59 -57.37 3.16 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.02 97.46 0.26 Allowed Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.869 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -140.18 122.52 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.13 90.09 1.0 Allowed Glycine 1 C--N 1.241 -4.696 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.192 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 46.15 81.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.455 1.502 . . . . 0.0 112.554 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.43 -0.0 46.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.177 0.513 . . . . 0.0 111.791 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.607 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 57.8 m-85 -143.39 154.44 60.43 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 -42.52 67.41 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.459 2.773 . . . . 0.0 112.17 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -91.75 16.56 10.49 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 111.404 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -100.28 116.13 31.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -124.6 13.86 8.73 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.889 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.603 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.32 109.32 21.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.51 0.671 . . . . 0.0 112.799 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -90.64 127.48 36.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -100.66 139.04 36.9 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.273 0.559 . . . . 0.0 111.273 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -72.73 95.19 1.86 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.585 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.41 -0.82 2.08 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 173.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.34 -42.62 68.3 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 t -88.31 -13.45 40.76 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.346 21.0 pttp 43.94 57.81 3.95 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.929 1.692 . . . . 0.0 114.775 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--N 1.281 -2.378 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.903 177.298 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.383 -3.778 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.87 5.75 3.02 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.622 1.169 . . . . 0.0 113.137 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.9 t -108.42 -44.06 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -62.31 -13.3 27.28 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.724 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -105.61 -28.49 10.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.429 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 39.8 t80 -66.13 -66.63 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.892 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.7 mp -62.82 -31.67 53.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.903 0.859 . . . . 0.0 110.08 -175.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 mm-40 -68.49 -45.31 72.66 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.08 -33.12 75.28 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.15 -17.6 63.84 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.903 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -78.47 -33.06 48.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.399 0.618 . . . . 0.0 109.596 174.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.26 36.6 1.45 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.588 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 24' ' ' GLU . 1.9 pp -122.29 113.84 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.09 143.51 19.65 Favored Glycine 1 C--N 1.246 -4.445 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.499 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' CYS . 17.3 t-80 66.65 -99.76 0.06 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.213 1.005 . . . . 0.0 112.007 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 54.78 -62.41 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 126.69 1.996 . . . . 0.0 114.974 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -87.73 145.36 36.77 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 124.046 0.938 . . . . 0.0 109.878 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.94 -44.52 27.27 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 124.176 3.25 . . . . 0.0 113.313 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 17' ' ' GLU . 13.4 p90 -91.6 0.53 57.49 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.213 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.6 t -101.61 121.32 41.8 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.314 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -121.31 5.13 10.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.18 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.447 -0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.064 179.422 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.836 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.9 m -94.64 109.49 21.41 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -105.17 130.37 53.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -131.08 112.3 12.76 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.392 0.615 . . . . 0.0 109.758 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -162.11 -161.69 0.77 Allowed 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -70.84 5.5 1.93 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.325 0.65 . . . . 0.0 111.97 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.94 -45.51 92.39 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -112.28 -15.84 13.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.648 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 pttt 54.21 27.72 8.2 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.173 1.789 . . . . 0.0 111.712 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 . . . . . 0 C--N 1.294 -1.824 0 CA-C-N 112.317 -2.22 . . . . 0.0 107.245 -179.598 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 8.5 pt-20 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 122.516 1.15 . . . . 0.0 114.057 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.21 4.42 0.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.409 1.884 . . . . 0.0 114.468 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.58 -38.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.11 -29.3 68.52 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.624 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 53.1 t -104.76 -11.86 16.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.969 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 1.6 t80 -72.02 -66.52 0.63 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.749 0.785 . . . . 0.0 110.611 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -67.66 -24.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.314 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.45 -35.3 25.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.272 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 38.8 t -63.83 -33.64 76.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.77 -21.64 66.0 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.063 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -90.52 -47.49 7.67 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.35 90.19 0.93 Allowed Glycine 0 CA--C 1.475 -2.429 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.7 pp -139.39 130.36 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.867 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.33 -132.64 0.15 Allowed Glycine 1 C--N 1.243 -4.628 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.117 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -82.04 80.21 8.35 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.668 -0.901 . . . . 0.0 109.146 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.01 -24.06 21.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.148 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 50.9 m-85 -130.0 143.54 49.52 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.13 -21.57 28.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 124.01 3.14 . . . . 0.0 114.37 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -115.24 13.25 16.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.496 0.718 . . . . 0.0 111.162 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 39.6 t -99.04 121.68 41.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -115.34 33.84 5.22 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.98 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.7 t . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.343 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -95.52 110.77 22.8 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.976 0.511 . . . . 0.0 109.628 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.96 120.37 32.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.414 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 25.2 m -105.19 128.5 53.43 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.9 t -64.61 130.5 43.85 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 120.924 0.392 . . . . 0.0 110.835 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.17 24.27 14.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.449 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 3.1 tm? -63.95 -43.99 94.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -110.56 -17.08 13.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 57.7 13.82 2.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.171 1.789 . . . . 0.0 113.105 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 . . . . . 0 C--N 1.306 -1.324 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.193 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 1 N--CA 1.377 -4.097 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.88 5.45 0.97 Allowed 'General case' 0 C--N 1.25 -3.738 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.931 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.27 -49.26 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -72.91 -5.02 35.65 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 113.226 -1.807 . . . . 0.0 112.399 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 t -104.9 -31.16 9.39 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.1 t80 -66.34 -60.23 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.815 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.34 -32.4 56.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.5 0.667 . . . . 0.0 110.612 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.9 -37.2 62.15 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.197 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.3 t -66.08 -31.82 72.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.187 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 96.7 mt -63.62 -25.12 68.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.598 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -79.23 -55.16 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.15 78.46 0.24 Allowed Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.857 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -129.65 120.72 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.586 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.36 100.0 0.62 Allowed Glycine 1 C--N 1.244 -4.575 0 CA-C-N 113.396 -1.729 . . . . 0.0 111.562 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 58.42 -83.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.758 1.623 . . . . 0.0 114.244 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 69.0 -67.82 0.2 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.379 1.472 . . . . 0.0 112.175 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 26.1 m-85 -83.01 142.37 44.47 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.76 -38.18 77.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 123.869 3.046 . . . . 0.0 112.809 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -94.5 3.61 54.91 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.145 0.978 . . . . 0.0 112.079 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -97.64 120.5 38.14 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.879 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -103.86 30.78 4.89 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.596 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.241 0.617 0 CA-C-O 121.093 0.473 . . . . 0.0 110.926 -179.871 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.1 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 m -101.53 108.46 20.04 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 121.629 0.728 . . . . 0.0 110.193 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.48 103.86 10.86 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.41 HG23 ' HB2' ' A' ' 10' ' ' LEU . 12.8 t -124.93 144.39 50.37 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 152.37 34.08 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 123.881 0.872 . . . . 0.0 109.797 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 78.61 -26.82 0.17 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.511 1.125 . . . . 0.0 111.453 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HB2' HG23 ' A' ' 7' ' ' THR . 2.7 tm? -65.97 -43.33 88.2 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -81.08 -15.92 54.65 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? 45.07 14.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 . . . . . 0 C--N 1.273 -2.739 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -175.258 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 44.9 mt-10 . . . . . 0 N--CA 1.397 -3.119 0 CA-C-O 122.569 1.175 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 73.87 5.36 4.8 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 111.437 -2.62 . . . . 0.0 111.737 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.01 -44.8 8.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -63.46 -12.0 28.06 Favored 'General case' 0 C--O 1.191 -1.989 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.616 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -105.03 -29.18 10.6 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.1 0.476 . . . . 0.0 110.019 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t80 -65.71 -59.28 4.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.918 -170.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mm -66.56 -29.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.526 0.679 . . . . 0.0 110.15 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HB3' HG12 ' A' ' 29' ' ' ILE . 7.3 mm-40 -75.02 -32.9 61.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.631 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -65.43 -32.64 74.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.319 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.0 -7.91 54.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.43 -49.59 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.42 79.48 0.21 Allowed Glycine 0 CA--C 1.471 -2.667 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.659 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.8 pp -136.0 134.51 50.67 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.019 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.17 -132.56 0.06 OUTLIER Glycine 1 C--N 1.234 -5.132 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.449 169.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -90.03 85.15 6.24 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.079 -1.248 . . . . 0.0 108.132 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -92.23 -34.39 14.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.78 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.693 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.4 m-85 -111.37 142.56 26.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -25.52 35.26 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 124.568 3.512 . . . . 0.0 114.187 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 33.4 p90 -115.09 18.92 16.06 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.739 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.693 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.3 t -85.96 114.68 23.05 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.935 0.874 . . . . 0.0 112.59 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -77.2 -4.44 44.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.959 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.378 0.609 . . . . 0.0 110.696 -175.605 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.726 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -112.05 109.49 19.26 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.143 0.497 . . . . 0.0 111.268 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -114.47 104.06 11.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -129.17 155.46 45.48 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.154 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' LEU . 38.8 m -48.98 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 126.413 1.885 . . . . 0.0 113.083 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 12' ' ' LYS . 11.7 m-20 -60.64 7.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.1 tt -63.31 -42.8 99.04 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.772 1.629 . . . . 0.0 107.853 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -102.83 -5.37 23.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.672 0.749 . . . . 0.0 109.426 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 25.6 pttm 55.2 19.42 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 127.388 2.275 . . . . 0.0 116.192 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.829 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 1.9 mp0 . . . . . 0 N--CA 1.396 -3.151 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 61.35 5.58 1.18 Allowed 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.636 1.575 . . . . 0.0 111.83 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.15 -23.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 17' ' ' GLU . 27.6 mmt180 -63.59 -34.29 77.5 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.912 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.5 t -106.08 -4.13 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.39 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -66.81 -51.45 55.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 26' ' ' LEU . 4.0 mp -79.88 -28.14 12.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.885 0.85 . . . . 0.0 109.076 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.58 -47.03 87.99 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.2 t -72.87 -18.02 61.47 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.058 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 61.3 tp -66.86 -26.68 67.02 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.5 -65.24 1.03 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.08 69.79 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.357 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.795 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.9 pp -134.13 114.08 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 115.12 4.37 Favored Glycine 1 C--N 1.244 -4.533 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.836 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 52.62 72.91 0.38 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.013 0.925 . . . . 0.0 112.295 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' CB ' HD13 ' A' ' 29' ' ' ILE . 62.8 tttp -99.66 -20.42 16.31 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.751 0.786 . . . . 0.0 110.645 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 15.6 m-85 -119.2 151.76 51.35 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.35 -37.49 71.68 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.956 3.104 . . . . 0.0 113.34 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -100.55 11.81 38.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.601 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.4 t -89.24 109.56 20.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 0.0 110.231 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -100.2 6.41 44.78 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.937 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.912 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.7 -171.68 36.44 Favored Glycine 0 C--O 1.246 0.851 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 84.19 7.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.122 0.963 . . . . 0.0 112.366 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.43 81.08 0.84 Allowed Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -94.9 109.23 21.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.303 0.573 . . . . 0.0 111.541 -171.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.32 113.23 25.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -90.15 144.77 25.58 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.574 0.702 . . . . 0.0 112.283 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m -123.84 79.52 1.72 Allowed 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.571 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 79.1 -15.57 0.75 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.731 2.012 . . . . 0.0 111.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.53 -44.68 81.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.303 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 50.9 m -112.91 -18.0 12.35 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.816 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HA ' ' CD ' ' A' ' 15' ' ' GLU . 61.4 tttm 41.37 59.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.313 1.054 . . . . 0.0 112.516 -174.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 11' ' ' SER . 96.3 mt-30 -135.22 -79.42 0.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.334 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -105.17 87.52 2.65 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' CD ' ' HA ' ' A' ' 12' ' ' LYS . 15.5 mm-40 -99.19 154.89 17.79 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.541 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.88 -45.66 3.6 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.416 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.43 153.88 29.35 Favored 'General case' 1 N--CA 1.37 -4.447 0 CA-C-O 122.739 1.257 . . . . 0.0 111.15 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 59.44 4.09 0.47 Allowed 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 127.994 2.518 . . . . 0.0 113.699 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.14 -40.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.955 0.884 . . . . 0.0 109.148 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -71.63 -10.53 59.91 Favored 'General case' 0 C--O 1.197 -1.663 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.995 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.84 -34.73 7.97 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.6 t80 -54.57 -58.0 9.2 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.99 1.316 . . . . 0.0 111.886 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -67.34 -21.51 27.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.962 0.887 . . . . 0.0 111.09 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.87 -36.24 15.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.795 0.807 . . . . 0.0 109.479 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.22 -28.68 66.57 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.028 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.9 -36.92 85.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.244 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -73.87 -54.86 7.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.63 66.18 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.379 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.82 132.77 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.932 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.6 -132.27 0.04 OUTLIER Glycine 1 C--N 1.238 -4.899 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.416 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -83.74 84.0 7.71 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.684 -0.892 . . . . 0.0 111.482 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -89.97 -36.74 14.8 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.58 0.705 . . . . 0.0 109.705 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.1 m-85 -108.83 151.93 42.06 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.33 -46.27 32.34 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.584 2.856 . . . . 0.0 112.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -89.26 3.83 50.74 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.238 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 46.6 t -87.94 108.67 19.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.046 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -109.97 75.95 0.96 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.988 0.899 . . . . 0.0 109.455 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.9 t -112.05 145.66 39.31 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.816 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 . . . . . 0 C--N 1.315 -0.906 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.302 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 C--O 1.244 0.773 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.72 174.37 38.23 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.051 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 67.79 119.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.488 1.515 . . . . 0.0 111.08 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.84 -58.23 4.33 Favored Glycine 0 C--N 1.307 -1.037 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -95.36 108.52 20.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -114.36 108.21 16.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -89.31 129.31 35.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.2 t -103.99 149.71 24.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 67.09 22.24 9.95 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.806 0.842 . . . . 0.0 111.532 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.71 -43.14 26.53 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 p -89.78 -15.73 31.75 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.885 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE2' ' CE1' ' A' ' 35' ' ' PHE . 15.0 ttpp 56.9 30.58 18.2 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.421 1.488 . . . . 0.0 110.442 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -90.7 -16.06 29.19 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.863 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.3 tpt -64.04 -24.87 67.87 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -99.91 160.23 14.47 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.734 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 32.7 tt0 -99.01 134.36 41.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -93.02 163.58 13.6 Favored 'General case' 1 N--CA 1.373 -4.324 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.99 6.68 4.85 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.291 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.1 -43.94 7.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.4 mmm180 -61.18 -27.75 68.64 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.767 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.9 t -104.96 -4.63 21.86 Favored 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -66.61 -65.06 0.73 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.54 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.9 mp -66.07 -28.99 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.27 1.033 . . . . 0.0 108.793 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB3' HG12 ' A' ' 29' ' ' ILE . 13.8 mm-40 -66.69 -33.11 74.91 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -73.27 -31.12 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.33 -32.49 72.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.939 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.77 -52.37 21.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.941 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.67 92.57 2.27 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -135.25 121.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 122.509 1.147 . . . . 0.0 109.129 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.29 90.78 1.12 Allowed Glycine 1 C--N 1.236 -4.992 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.819 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 54.91 77.9 0.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.564 1.545 . . . . 0.0 113.759 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -90.89 -18.62 24.46 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.9 m-85 -135.79 147.84 62.87 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -58.01 -39.4 86.33 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 123.481 2.787 . . . . 0.0 111.855 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.439 ' CE1' ' HE2' ' A' ' 12' ' ' LYS . 24.7 p90 -98.82 16.76 21.26 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.387 -173.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.68 117.58 29.87 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -94.81 37.03 1.15 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.405 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 t -103.61 1.88 32.64 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.653 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 123.388 0.675 . . . . 0.0 111.679 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.1 m80 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.49 160.0 26.99 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.93 118.35 5.64 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.64 29.13 2.5 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.108 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -120.05 109.07 15.05 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.459 0.647 . . . . 0.0 111.533 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -116.49 120.81 39.95 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -115.16 113.97 24.66 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.969 0.414 . . . . 0.0 110.853 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 m -126.14 96.1 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.23 28.48 17.81 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.727 0.811 . . . . 0.0 110.576 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -69.17 -46.49 67.39 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -112.97 -14.15 13.04 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 62.75 21.38 12.73 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 125.701 1.6 . . . . 0.0 110.073 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -95.93 -38.6 10.18 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.251 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -68.09 -47.28 68.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.546 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 1.2 pm0 -82.14 73.16 9.19 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.233 1.016 . . . . 0.0 113.635 -177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -91.49 -17.92 24.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.996 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.32 -178.62 4.16 Favored 'General case' 0 N--CA 1.388 -3.562 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 49.23 4.74 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 127.44 2.296 . . . . 0.0 116.294 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 16.9 m -107.95 -32.65 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 121.963 0.887 . . . . 0.0 108.716 173.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.598 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -68.18 -13.96 62.62 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.372 170.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -105.08 -32.16 8.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.514 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 42.7 t80 -57.11 -58.33 8.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.003 0.921 . . . . 0.0 112.013 -173.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.471 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 34.9 mm -66.02 -24.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.879 0.847 . . . . 0.0 110.654 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -86.19 -39.65 16.41 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.498 0.666 . . . . 0.0 109.981 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -68.8 -27.11 65.57 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.191 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.4 tp -62.92 -29.47 70.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.645 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 60.0 mttp -83.98 -54.14 5.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.73 69.66 0.05 OUTLIER Glycine 0 CA--C 1.482 -1.998 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.332 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.37 125.57 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.438 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.68 -132.42 0.04 OUTLIER Glycine 1 C--N 1.251 -4.141 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.951 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -79.25 93.22 5.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.924 -0.75 . . . . 0.0 110.463 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -98.83 -42.41 7.19 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.696 0.76 . . . . 0.0 109.565 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.599 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 35.3 m-85 -104.85 146.45 32.67 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.29 -30.63 73.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.934 3.089 . . . . 0.0 112.616 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.62 20.85 18.22 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.854 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 53.4 t -91.93 94.99 9.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.3 1.048 . . . . 0.0 108.306 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -98.45 17.85 17.95 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.615 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.0 146.22 29.01 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.99 0 C-N-CA 122.57 0.348 . . . . 0.0 110.72 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 53.2 m80 . . . . . 0 C--O 1.241 0.628 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.99 160.46 23.62 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.694 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -150.01 155.39 39.85 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.35 -9.28 5.91 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.494 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -100.25 107.25 19.03 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -118.03 123.65 46.21 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -130.75 106.92 8.78 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.194 0.521 . . . . 0.0 111.528 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.5 m -84.14 92.88 8.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.521 0.677 . . . . 0.0 110.769 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 70.81 -0.65 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.681 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.2 -42.52 65.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -88.95 -17.12 30.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 tttp 54.78 20.27 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -137.03 -53.16 0.69 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.767 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 ttm -86.93 76.99 9.31 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -165.29 147.91 7.95 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -113.28 159.29 19.51 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.98 -174.7 3.87 Favored 'General case' 0 N--CA 1.393 -3.279 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 51.43 3.93 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 126.919 2.087 . . . . 0.0 114.324 -173.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.24 -32.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -64.57 -21.46 66.7 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.481 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 32.1 t -104.86 -24.26 12.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.664 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.3 t80 -61.36 -63.97 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.813 -173.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.51 -38.26 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.0 mm-40 -66.17 -44.9 82.71 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.472 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.24 -32.71 74.29 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.297 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.36 -20.56 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.319 0.58 . . . . 0.0 111.405 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -92.42 -54.6 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.77 98.45 0.47 Allowed Glycine 0 CA--C 1.484 -1.896 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.629 HD11 ' SG ' ' A' ' 36' ' ' CYS . 2.3 pp -137.84 126.07 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.65 107.67 3.55 Favored Glycine 1 C--N 1.238 -4.913 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.819 172.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.0 m80 50.91 89.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -126.9 -6.91 6.11 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.632 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 72.5 m-85 -145.78 147.49 32.83 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.53 -47.62 25.27 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 123.418 2.746 . . . . 0.0 111.992 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -92.01 12.9 20.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.818 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 49.0 t -95.32 110.84 22.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.761 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.75 75.29 0.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.352 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.1 t -69.28 170.28 10.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 . . . . . 0 C--N 1.289 -2.035 0 O-C-N 121.695 -0.628 . . . . 0.0 109.864 -175.54 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.464 0.65 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.91 169.52 13.34 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.931 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 130.62 20.79 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.58 4.52 17.3 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -100.01 109.4 21.73 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.08 103.9 11.02 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 t -131.69 139.98 49.19 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -112.66 152.92 28.43 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.33 13.28 7.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.857 1.263 . . . . 0.0 110.099 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -84.85 -42.76 14.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -88.22 -15.42 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.9 tttp 55.66 60.34 3.36 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.024 1.73 . . . . 0.0 114.308 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -133.04 171.6 13.77 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -75.75 98.06 4.02 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.132 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.06 98.89 10.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.506 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 40.1 tt0 -141.4 -76.82 0.29 Allowed 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.265 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.6 145.81 27.17 Favored 'General case' 1 N--CA 1.374 -4.239 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 71.53 6.14 5.63 Favored 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 127.093 2.157 . . . . 0.0 111.134 -174.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.26 -53.54 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 34.7 mmt180 -58.85 -28.08 65.75 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.683 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -100.14 -19.41 16.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.021 0.528 . . . . 0.0 110.725 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 24.3 t80 -60.1 -60.17 4.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.951 0.405 . . . . 0.0 111.072 -171.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.5 mp -67.71 -32.02 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -175.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' HG12 ' A' ' 29' ' ' ILE . 40.0 mm-40 -68.38 -39.21 81.83 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.914 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.5 t -64.97 -34.06 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.02 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -70.3 -19.0 63.11 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -80.53 -51.67 8.51 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.6 101.8 2.15 Favored Glycine 0 CA--C 1.468 -2.881 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.8 pp -137.23 129.15 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.657 0 CA-C-O 122.278 1.037 . . . . 0.0 109.829 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.12 111.1 3.21 Favored Glycine 1 C--N 1.235 -5.056 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.915 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.74 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.582 1.553 . . . . 0.0 113.867 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 63.23 -74.89 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.545 1.538 . . . . 0.0 113.389 -174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.551 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 39.6 m-85 -106.12 143.97 28.0 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.11 -33.04 95.05 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.808 3.005 . . . . 0.0 113.398 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -100.67 3.48 42.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.013 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.6 t -77.26 110.19 11.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.665 0.745 . . . . 0.0 110.683 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.37 75.22 4.53 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.409 1.099 . . . . 0.0 111.13 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 t -128.08 161.51 29.06 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.813 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 . . . . . 0 CA--C 1.501 -0.931 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.72 160.65 10.06 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.66 -45.43 17.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 123.632 0.773 . . . . 0.0 109.908 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.2 53.15 0.72 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -95.51 109.65 21.83 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.083 0.468 . . . . 0.0 110.558 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -105.45 111.22 23.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.013 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -131.06 114.83 15.65 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -72.02 143.81 49.02 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.391 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 76.56 2.61 3.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.217 1.007 . . . . 0.0 111.555 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -70.69 -44.01 67.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -111.23 -15.78 13.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.262 20.7 pttp 42.98 58.94 3.07 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.708 1.203 . . . . 0.0 114.118 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.405 ' HB2' ' H ' ' A' ' 14' ' ' MET . 29.5 mt-30 -80.35 -72.38 0.41 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.028 -176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.405 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 55.6 ttp -119.36 17.21 13.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.578 ' HA ' HG21 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -80.83 73.14 7.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.537 -172.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.34 -83.51 0.51 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.74 147.66 35.26 Favored 'General case' 0 N--CA 1.381 -3.903 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.27 6.05 1.27 Allowed 'General case' 0 C--N 1.261 -3.244 0 C-N-CA 127.181 2.193 . . . . 0.0 112.578 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 15' ' ' GLU . 80.3 t -107.87 -38.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -66.11 -15.68 63.3 Favored 'General case' 0 C--O 1.188 -2.17 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.402 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -104.13 -23.28 13.3 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 48.0 t80 -69.07 -61.11 1.93 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.148 -173.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.73 -37.36 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.027 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB3' HG12 ' A' ' 29' ' ' ILE . 46.0 mm-40 -67.92 -41.01 83.29 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.867 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.3 -28.08 65.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.53 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.63 -12.59 60.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.51 -47.6 7.87 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 171.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.51 93.88 0.83 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.358 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.484 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.5 pp -138.25 123.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.698 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.97 90.68 1.67 Allowed Glycine 1 C--N 1.243 -4.625 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.556 172.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 56.72 90.93 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.25 1.42 . . . . 0.0 112.992 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -102.05 -26.7 13.29 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.242 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.9 m-85 -125.35 147.48 57.79 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.45 -28.36 63.52 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 123.7 2.934 . . . . 0.0 113.315 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -103.84 8.09 37.01 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.592 0.757 . . . . 0.0 111.535 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -88.12 112.87 23.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.47 35.43 4.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.685 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.7 t -87.84 -76.25 0.39 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.204 -179.484 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.33 -153.21 17.54 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -84.01 -17.97 38.68 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.007 0.432 . . . . 0.0 110.795 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.59 138.12 14.62 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.1 m -94.82 109.23 21.22 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -77.65 103.88 7.85 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.275 0.56 . . . . 0.0 110.633 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 15.3 t -129.94 151.53 50.4 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 p -68.49 138.34 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.296 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 12' ' ' LYS . 8.8 m-20 61.78 29.91 18.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.964 0.906 . . . . 0.0 110.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.8 tt -60.11 -46.15 90.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 t -112.14 -18.3 12.6 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 45.1 tttp 51.36 23.97 1.95 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.623 1.569 . . . . 0.0 111.287 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -86.5 -45.21 11.32 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.056 0.943 . . . . 0.0 109.653 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 63.2 mtt -106.97 96.41 6.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.34 157.81 17.33 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.41 -31.88 5.78 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.115 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' ' CE1' ' A' ' 35' ' ' PHE . 42.8 mt-10 -67.34 124.87 24.37 Favored 'General case' 0 N--CA 1.399 -2.975 0 CA-C-O 122.095 0.95 . . . . 0.0 109.007 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 75.59 6.12 3.98 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.88 -2.418 . . . . 0.0 112.033 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.54 -42.77 7.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.24 -35.21 62.23 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.668 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.7 -4.27 31.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.824 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -67.83 -65.1 0.73 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.702 0.287 . . . . 0.0 111.544 -171.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.78 -23.08 27.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.279 0.562 . . . . 0.0 110.083 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -68.45 -43.96 75.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.99 -13.82 62.27 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.787 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.31 -10.9 55.5 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.886 -0.508 . . . . 0.0 111.281 170.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -121.1 176.79 5.41 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.18 92.91 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 pp -130.33 115.26 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.616 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.78 90.74 0.97 Allowed Glycine 1 C--N 1.245 -4.501 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.758 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 62.92 88.82 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.856 0.836 . . . . 0.0 112.632 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.99 -37.31 12.91 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.702 -0.624 . . . . 0.0 110.802 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 20.3 m-85 -118.88 154.1 52.86 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -51.9 -35.44 60.01 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.412 2.741 . . . . 0.0 113.298 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 17' ' ' GLU . 27.5 p90 -102.22 13.88 33.47 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.562 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.1 t -93.95 105.24 17.26 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -93.28 -1.68 55.82 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.537 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.54 122.11 16.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.73 162.35 10.44 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.373 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 74.71 172.6 0.27 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.744 1.218 . . . . 0.0 112.512 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.58 29.69 2.2 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.051 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 t -111.83 120.84 43.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -74.47 119.63 18.93 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.853 0.359 . . . . 0.0 110.512 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -117.19 123.65 47.2 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.462 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 m -62.4 138.17 58.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.932 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 77.8 -30.04 0.16 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.227 1.811 . . . . 0.0 111.785 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tt -71.34 -38.86 71.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -80.35 -15.45 56.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.105 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 47.75 58.77 4.68 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.845 1.658 . . . . 0.0 112.083 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -100.38 153.66 19.14 Favored 'General case' 0 C--N 1.27 -2.85 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.945 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.0 ttp -164.35 164.9 22.11 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . 9.8 pt-20 -73.27 84.74 1.4 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.621 1.201 . . . . 0.0 107.783 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.76 168.13 6.58 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 113.456 -1.702 . . . . 0.0 114.599 -169.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.1 162.32 23.76 Favored 'General case' 1 N--CA 1.379 -4.025 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.501 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.79 3.88 0.34 Allowed 'General case' 0 C--N 1.261 -3.262 0 C-N-CA 128.268 2.627 . . . . 0.0 114.298 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 14.6 p -108.62 -37.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' HD2' ' HB2' ' A' ' 15' ' ' GLU . 1.4 mmp_? -62.81 -20.4 65.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.582 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 52.8 t -105.54 -4.84 20.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.419 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 27.7 t80 -64.66 -59.71 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.836 0.351 . . . . 0.0 111.476 -170.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.581 ' H ' HD12 ' A' ' 23' ' ' ILE . 4.0 mp -75.1 -25.95 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.011 0.91 . . . . 0.0 108.769 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB3' HD11 ' A' ' 29' ' ' ILE . 7.0 mm-40 -67.95 -38.52 82.93 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.717 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -76.48 -18.02 58.98 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 94.3 mt -78.85 -6.55 56.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.307 0.575 . . . . 0.0 109.898 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -102.52 -54.39 2.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.0 78.54 0.64 Allowed Glycine 0 CA--C 1.488 -1.614 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.375 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.6 pp -136.1 121.16 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-O 123.078 1.418 . . . . 0.0 109.689 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.7 146.64 16.09 Favored Glycine 1 C--N 1.215 -6.142 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.437 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.545 ' H ' ' HA ' ' A' ' 37' ' ' HIS . 48.3 m-70 67.72 13.48 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HB2' HD13 ' A' ' 29' ' ' ILE . 75.5 mmtt -76.56 -39.12 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.207 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 43.8 m-85 -115.8 154.57 48.16 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.57 -21.39 18.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.878 3.052 . . . . 0.0 113.637 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -122.61 12.39 9.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.924 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.432 ' CB ' ' HB2' ' A' ' 33' ' ' TYR . 42.4 t -122.95 101.83 7.66 Favored 'General case' 0 CA--C 1.467 -2.222 0 C-N-CA 119.14 -1.024 . . . . 0.0 112.381 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.545 ' HA ' ' H ' ' A' ' 31' ' ' HIS . 9.1 m80 -128.96 75.69 1.67 Allowed 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -44.59 126.84 5.74 Favored 'General case' 0 C--N 1.368 1.408 0 CA-C-O 120.919 0.39 . . . . 0.0 110.092 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 . . . . . 0 N--CA 1.431 -1.383 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.264 -170.219 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.532 0.682 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.03 170.91 47.77 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.35 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.22 -19.59 18.49 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.271 -0.547 . . . . 0.0 110.139 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.28 116.39 4.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -95.15 109.06 21.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.106 0.479 . . . . 0.0 110.45 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -113.19 119.22 37.03 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 21.6 m -132.0 143.33 50.0 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -57.98 123.23 15.14 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.539 0.524 . . . . 0.0 110.574 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t70 76.89 1.07 3.18 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.35 1.06 . . . . 0.0 112.429 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 20.0 tp -65.6 -44.03 87.87 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.851 -0.531 . . . . 0.0 111.782 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 t -86.52 -17.06 35.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 42.91 59.91 2.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.314 1.445 . . . . 0.0 112.132 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -111.37 151.71 28.15 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.865 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -61.99 134.69 56.96 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.56 78.13 4.07 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -98.83 166.63 11.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.656 -164.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -59.97 149.02 33.17 Favored 'General case' 0 N--CA 1.384 -3.736 0 C-N-CA 125.591 1.556 . . . . 0.0 109.472 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.5 3.31 1.85 Allowed 'General case' 0 C--N 1.251 -3.698 0 C-N-CA 127.738 2.415 . . . . 0.0 113.015 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.31 -39.33 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.943 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 171.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.8 mmp_? -68.33 -4.43 14.44 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.694 172.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.5 t -106.37 -45.17 4.34 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.046 0.451 . . . . 0.0 110.121 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HB3' HD12 ' A' ' 23' ' ' ILE . 18.1 t80 -51.31 -68.18 0.19 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.109 1.364 . . . . 0.0 113.772 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 22' ' ' PHE . 2.8 mp -66.26 -35.19 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 121.722 0.772 . . . . 0.0 110.345 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.9 mm-40 -58.81 -52.45 65.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.042 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.0 t -64.01 -29.45 70.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.874 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 84.1 mt -58.89 -22.92 60.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 65.4 pttt -94.0 -7.72 41.99 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.259 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.27 53.11 0.85 Allowed Glycine 0 N--CA 1.427 -1.9 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.442 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.91 123.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -132.57 0.1 Allowed Glycine 1 C--N 1.247 -4.393 0 CA-C-N 113.191 -1.822 . . . . 0.0 114.108 175.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -76.8 83.98 3.39 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.128 -0.63 . . . . 0.0 111.33 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -101.71 -14.79 17.21 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.557 0.694 . . . . 0.0 110.025 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 78.2 m-85 -128.85 146.84 62.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.99 -44.22 43.38 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 123.703 2.935 . . . . 0.0 112.995 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -90.75 9.65 29.17 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.35 1.06 . . . . 0.0 112.13 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 31.4 t -94.28 101.84 13.82 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.741 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -97.29 -2.99 41.43 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.395 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -76.52 145.74 38.91 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 . . . . . 0 C--N 1.31 -1.14 0 C-N-CA 122.926 0.49 . . . . 0.0 111.229 -176.021 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 120.891 0.377 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.21 160.37 27.03 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.73 111.05 22.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.789 0.794 . . . . 0.0 111.063 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 151.86 7.79 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.9 m -142.1 123.44 14.8 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -70.59 118.79 13.83 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -117.13 107.55 14.62 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.241 0.543 . . . . 0.0 110.981 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 10' ' ' LEU . 51.4 m -144.33 128.39 17.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 73.75 -31.68 0.22 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.065 1.346 . . . . 0.0 111.889 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.3 tt -55.32 -44.67 76.05 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.357 1.063 . . . . 0.0 110.014 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -111.56 -17.57 13.02 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.2 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 56.34 18.38 3.37 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.85 1.26 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -83.71 -10.07 58.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 17.1 ptp -56.69 -47.47 79.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 32.0 tt0 66.5 -51.43 0.44 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.769 1.627 . . . . 0.0 114.596 172.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -42.38 -51.05 5.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.506 1.922 . . . . 0.0 114.047 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' CD ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 tp10 -143.22 158.23 43.8 Favored 'General case' 0 N--CA 1.393 -3.283 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 63.53 5.27 2.07 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 128.41 2.684 . . . . 0.0 112.95 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -110.07 -50.71 6.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 39.1 mmt180 -64.21 -28.89 70.05 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.368 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.6 t -105.41 -2.33 23.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.81 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 58.5 t80 -57.0 -62.87 1.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.601 0.964 . . . . 0.0 113.601 -169.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 3.2 mp -68.93 -34.67 65.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 2.9 mm-40 -56.31 -54.26 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.652 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.5 t -69.83 -29.79 67.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.54 1.136 . . . . 0.0 111.135 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.7 tp -66.04 -25.88 67.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.581 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 29.1 mmmt -97.71 -58.57 1.96 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.98 110.71 0.7 Allowed Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.9 pp -139.63 135.63 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.779 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.04 -131.69 0.03 OUTLIER Glycine 1 C--N 1.242 -4.689 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.036 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -96.79 88.92 4.73 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.77 -1.43 . . . . 0.0 109.599 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -107.05 -31.45 8.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.289 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 71.1 m-85 -116.19 133.57 22.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.896 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 -16.99 57.4 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.468 3.445 . . . . 0.0 113.496 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -112.69 -10.61 13.62 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.099 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 47.3 t -76.89 111.55 12.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.169 -171.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -99.43 -5.56 29.23 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.93 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.5 t -68.42 -36.84 79.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.971 0.891 . . . . 0.0 108.925 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 113.3 -1.773 . . . . 0.0 111.195 178.838 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.2 m80 . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.41 160.17 33.93 Favored Glycine 0 N--CA 1.428 -1.862 0 O-C-N 123.891 0.745 . . . . 0.0 112.585 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 -38.65 2.27 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.03 21.84 10.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 174.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.4 m -134.1 114.01 12.69 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.39 117.64 19.8 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.37 0.419 . . . . 0.0 110.101 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -100.25 111.07 23.33 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -77.2 138.37 39.4 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.045 0.938 . . . . 0.0 111.113 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 66.49 13.2 9.16 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 124.119 0.968 . . . . 0.0 111.838 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.8 -43.62 53.74 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 t -94.05 -12.44 28.56 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt 58.02 35.48 25.26 Favored 'General case' 0 C--N 1.348 0.53 0 CA-C-O 123.411 1.577 . . . . 0.0 110.197 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -97.53 165.07 12.17 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.097 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.5 ptm -97.24 126.42 42.43 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -83.39 90.31 7.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.58 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 40.9 tt0 -116.87 -82.88 0.63 Allowed 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.72 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.58 ' HG3' ' HG2' ' A' ' 16' ' ' GLU . 51.2 mt-10 -122.34 165.9 15.54 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.04 4.21 2.96 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 126.432 1.893 . . . . 0.0 111.261 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 28.9 m -105.35 -6.24 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -82.93 -28.54 29.81 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.671 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.5 p -106.7 -4.14 19.79 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.257 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 41.0 t80 -56.72 -61.54 2.36 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.59 0.756 . . . . 0.0 112.582 -170.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.9 mp -72.62 -28.31 27.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 7.3 mm-40 -59.1 -43.57 91.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.966 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -71.44 -32.86 68.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.733 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 85.4 mt -65.67 -27.28 68.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.432 0.634 . . . . 0.0 109.714 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 24' ' ' GLU . 53.1 mtmt -83.39 -51.51 7.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.442 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.49 91.68 0.16 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.291 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.491 ' HB ' ' HG2' ' A' ' 32' ' ' LYS . 2.2 pp -140.02 117.63 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.12 88.97 1.57 Allowed Glycine 1 C--N 1.252 -4.091 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.464 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 57.85 92.74 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.538 1.135 . . . . 0.0 112.505 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HG2' ' HB ' ' A' ' 29' ' ' ILE . 75.4 mmtt -111.64 -11.33 14.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.966 0.413 . . . . 0.0 111.426 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 77.7 m-85 -135.97 141.69 37.51 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -59.54 -37.58 87.99 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.434 2.756 . . . . 0.0 112.559 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 17' ' ' GLU . 17.2 p90 -93.23 14.8 17.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 124.172 0.989 . . . . 0.0 111.466 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.6 t -91.74 125.68 36.55 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -115.37 2.58 13.98 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.698 0.623 . . . . 0.0 112.295 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -81.0 86.65 6.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.318 -174.125 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.542 ' HB3' ' O ' ' A' ' 5' ' ' THR . 59.0 t-80 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.38 168.11 22.87 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 66.94 19.91 10.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 111.875 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.62 89.94 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 1' ' ' HIS . 20.9 m -95.57 121.62 37.46 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -106.84 144.53 33.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.7 m -128.43 108.18 10.35 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.73 0.776 . . . . 0.0 112.011 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 t -140.04 94.51 2.77 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.69 30.97 16.89 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.645 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.85 -44.35 61.49 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -110.7 -9.74 14.5 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.3 tttm 56.1 45.17 24.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.322 1.849 . . . . 0.0 110.977 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -138.48 149.23 45.21 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.684 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -105.99 11.97 31.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 71.46 -62.26 0.46 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.681 1.592 . . . . 0.0 109.833 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 19' ' ' VAL . 33.1 tt0 -176.95 126.7 0.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 126.02 1.728 . . . . 0.0 106.825 174.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.46 142.22 36.06 Favored 'General case' 1 N--CA 1.377 -4.106 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.79 5.11 4.41 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 111.339 -2.664 . . . . 0.0 113.21 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 16' ' ' GLU . 7.7 p -104.19 -31.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 20.7 mmm180 -55.75 -35.05 65.76 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.56 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 29' ' ' ILE . 42.2 t -105.1 -2.82 23.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.007 0.432 . . . . 0.0 111.075 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 34.0 t80 -56.58 -56.24 23.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.226 0.536 . . . . 0.0 110.537 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -72.4 -27.68 26.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.1 mm-40 -65.21 -40.19 93.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.819 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.18 -37.91 75.24 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.821 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.58 -36.2 79.97 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.203 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -74.23 -55.55 5.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.28 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.54 95.75 0.89 Allowed Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.658 HD11 ' SG ' ' A' ' 21' ' ' CYS . 2.5 pp -139.49 125.25 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.07 89.34 1.08 Allowed Glycine 1 C--N 1.252 -4.106 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.457 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 42.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.666 1.986 . . . . 0.0 113.651 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -126.44 16.23 7.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.148 0.499 . . . . 0.0 111.691 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 65.0 m-85 -146.67 139.21 14.05 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.88 -42.33 59.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.802 3.002 . . . . 0.0 113.418 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 20' ' ' ARG . 4.6 p90 -90.93 10.78 25.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 124.135 0.974 . . . . 0.0 111.966 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 45.5 t -94.68 95.02 8.47 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.727 0.775 . . . . 0.0 110.846 -176.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -82.34 50.45 1.62 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.35 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -98.02 166.59 11.36 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 . . . . . 0 C--N 1.31 -1.115 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 -176.882 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.06 -171.28 21.06 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 62.65 82.77 0.17 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.111 0.964 . . . . 0.0 112.123 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.23 49.51 3.75 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.41 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -102.36 109.4 21.05 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -96.94 144.57 26.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 m -88.96 106.87 18.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 10' ' ' LEU . 20.3 m -129.86 138.66 51.08 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 11.4 m-20 77.29 -43.03 0.41 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.415 1.486 . . . . 0.0 110.71 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.6 tt -57.07 -43.36 82.01 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.836 1.654 . . . . 0.0 111.324 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.0 t -110.57 -18.03 13.28 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.84 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.524 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 49.6 tttp 48.94 14.11 0.07 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 126.66 1.984 . . . . 0.0 115.385 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -70.91 -57.41 4.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.344 -0.848 . . . . 0.0 112.03 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 28.1 ttt -94.06 -61.83 1.46 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.526 ' OE1' ' HA ' ' A' ' 9' ' ' ASP . 32.1 tt0 63.33 102.05 0.03 OUTLIER 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.689 1.195 . . . . 0.0 113.552 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 17' ' ' GLU . 40.6 tt0 -106.29 148.37 28.07 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.724 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 44.0 mt-10 -105.14 171.2 7.45 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.37 4.0 0.87 Allowed 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 126.542 1.937 . . . . 0.0 112.401 -172.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.1 p -97.03 -31.91 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -67.95 -16.82 64.23 Favored 'General case' 0 C--O 1.19 -2.063 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.474 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.1 t -105.82 -18.04 14.18 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.0 110.326 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 40.2 t80 -62.21 -61.81 2.2 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.253 0.621 . . . . 0.0 112.101 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 47.3 mm -71.0 -29.98 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.749 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.5 mm-40 -68.32 -41.99 80.0 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.82 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.69 -31.83 70.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.15 -33.17 72.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 35.8 mmtp -78.62 -55.85 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 90.77 0.79 Allowed Glycine 0 CA--C 1.484 -1.865 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.561 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -136.28 127.17 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.504 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.13 113.67 4.34 Favored Glycine 1 C--N 1.235 -5.073 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.344 175.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 44.92 88.05 0.02 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.433 1.893 . . . . 0.0 114.495 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -129.29 -0.97 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.402 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 54.4 m-85 -145.9 143.43 19.55 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -48.17 -49.33 14.36 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 124.037 3.158 . . . . 0.0 113.189 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -88.59 17.92 5.04 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.532 1.133 . . . . 0.0 111.529 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 48.6 t -114.01 101.84 9.61 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.008 0.432 . . . . 0.0 110.768 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -114.28 -2.11 13.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.609 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 t -79.6 102.72 9.05 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 . . . . . 0 C--N 1.288 -2.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.539 -174.336 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.84 -161.93 17.53 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.4 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -132.69 119.83 20.89 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.55 32.81 9.82 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.653 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.4 t -110.51 113.03 25.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -117.19 131.23 56.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -131.13 107.19 8.85 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -153.08 111.68 3.71 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 67.97 14.2 9.31 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.559 1.171 . . . . 0.0 109.786 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.12 -43.19 22.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.509 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -90.48 -16.1 29.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttp 59.28 27.52 16.6 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -84.43 142.3 30.2 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.946 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.6 tpp -146.51 87.27 1.71 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.65 97.86 0.48 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.698 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -114.76 -33.44 5.49 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.38 160.23 23.48 Favored 'General case' 1 N--CA 1.379 -4.011 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.44 5.65 0.47 Allowed 'General case' 0 C--N 1.282 -2.347 0 C-N-CA 126.284 1.834 . . . . 0.0 112.267 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -108.66 -21.92 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -64.33 -30.64 71.68 Favored 'General case' 0 C--O 1.203 -1.361 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.391 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' HB2' ' CD1' ' A' ' 33' ' ' TYR . 36.6 t -105.6 -8.19 18.11 Favored 'General case' 0 C--O 1.189 -2.101 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -67.36 -53.66 27.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.8 -30.32 46.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.335 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.86 -38.08 58.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.111 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 11.7 t -64.41 -29.43 70.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.185 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -75.28 -5.77 46.37 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.346 0.0 OUTLIER -147.78 71.29 1.18 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.46 -25.68 26.77 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 25' ' ' CYS 0.287 1.9 pp -115.02 115.35 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 119.991 1.895 . . . . 0.0 112.071 -172.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.43 102.93 2.79 Favored Glycine 1 C--N 1.233 -5.156 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.403 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 67.65 88.13 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.693 1.197 . . . . 0.0 112.829 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -119.06 -2.8 10.71 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.049 0.928 . . . . 0.0 108.689 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 61.3 m-85 -135.24 147.05 60.64 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.71 -36.21 98.52 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 123.532 2.821 . . . . 0.0 113.406 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.1 18.58 13.23 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.788 0.835 . . . . 0.0 111.01 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.09 96.3 10.53 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.891 0.853 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -94.43 -16.83 23.06 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.554 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.46 105.03 0.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.381 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 . . . . . 0 C--N 1.299 -1.618 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.5 m80 . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 120.67 0.272 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.25 -149.6 37.56 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.114 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 73.11 142.26 0.06 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.66 1.184 . . . . 0.0 111.107 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.03 73.02 2.69 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 m -95.58 112.29 24.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -103.38 128.88 50.39 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.428 ' HB ' HD12 ' A' ' 10' ' ' LEU . 19.5 m -89.67 121.25 31.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.34 140.35 58.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.33 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 12' ' ' LYS . 24.0 t70 67.52 24.75 8.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.542 1.163 . . . . 0.0 110.637 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 7' ' ' THR . 4.9 tt -73.72 -44.65 55.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.133 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 p -107.57 -15.37 14.61 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 9' ' ' ASP . 32.3 tttp 68.3 14.01 9.13 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.798 1.639 . . . . 0.0 111.423 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -143.78 139.41 29.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.748 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.86 0.838 . . . . 0.0 108.977 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.45 125.06 23.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.996 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.58 -38.75 2.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.896 0.855 . . . . 0.0 108.847 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.96 133.11 35.28 Favored 'General case' 1 N--CA 1.377 -4.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 74.83 6.3 4.38 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 111.849 -2.432 . . . . 0.0 112.523 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.45 -34.68 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -62.4 -22.54 66.23 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.482 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -94.29 -38.04 11.21 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 28.3 t80 -56.83 -59.54 4.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.229 1.412 . . . . 0.0 111.204 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.6 mm -62.11 -35.59 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.854 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.48 -40.12 44.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.6 t -69.29 -28.44 66.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.418 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.45 -30.7 67.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.023 174.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -84.59 -57.37 3.16 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.02 97.46 0.26 Allowed Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.869 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -140.18 122.52 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.13 90.09 1.0 Allowed Glycine 1 C--N 1.241 -4.696 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.192 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 46.15 81.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.455 1.502 . . . . 0.0 112.554 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.43 -0.0 46.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.177 0.513 . . . . 0.0 111.791 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.607 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 57.8 m-85 -143.39 154.44 60.43 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 -42.52 67.41 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.459 2.773 . . . . 0.0 112.17 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -91.75 16.56 10.49 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 111.404 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -100.28 116.13 31.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -124.6 13.86 8.73 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.6 t -74.04 117.57 15.98 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.306 -1.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 -178.722 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.21 -170.22 13.39 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.09 -55.04 5.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.38 91.52 1.73 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.32 109.32 21.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.51 0.671 . . . . 0.0 112.799 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -90.64 127.48 36.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -100.66 139.04 36.9 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.273 0.559 . . . . 0.0 111.273 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -72.73 95.19 1.86 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.585 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.41 -0.82 2.08 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 173.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.34 -42.62 68.3 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 t -88.31 -13.45 40.76 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.346 21.0 pttp 43.94 57.81 3.95 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.929 1.692 . . . . 0.0 114.775 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -86.28 133.24 33.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.903 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtt -133.24 100.6 4.9 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -87.31 88.33 7.66 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.48 -23.8 34.51 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -124.85 -159.52 0.89 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 113.611 -1.632 . . . . 0.0 106.874 175.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.87 5.75 3.02 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.622 1.169 . . . . 0.0 113.137 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.9 t -108.42 -44.06 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -62.31 -13.3 27.28 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.724 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -105.61 -28.49 10.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.429 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 39.8 t80 -66.13 -66.63 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.892 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.7 mp -62.82 -31.67 53.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.903 0.859 . . . . 0.0 110.08 -175.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 mm-40 -68.49 -45.31 72.66 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.08 -33.12 75.28 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.15 -17.6 63.84 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.903 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -78.47 -33.06 48.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.399 0.618 . . . . 0.0 109.596 174.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.26 36.6 1.45 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.588 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 24' ' ' GLU . 1.9 pp -122.29 113.84 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.09 143.51 19.65 Favored Glycine 1 C--N 1.246 -4.445 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.499 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' CYS . 17.3 t-80 66.65 -99.76 0.06 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.213 1.005 . . . . 0.0 112.007 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 54.78 -62.41 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 126.69 1.996 . . . . 0.0 114.974 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -87.73 145.36 36.77 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 124.046 0.938 . . . . 0.0 109.878 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.94 -44.52 27.27 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 124.176 3.25 . . . . 0.0 113.313 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 17' ' ' GLU . 13.4 p90 -91.6 0.53 57.49 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.213 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.6 t -101.61 121.32 41.8 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.314 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -121.31 5.13 10.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.18 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 35.4 t -75.67 146.3 40.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.064 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 . . . . . 0 C--N 1.306 -1.29 0 C-N-CA 123.476 0.711 . . . . 0.0 109.446 -177.525 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 34.3 t60 . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.28 -158.45 21.1 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -85.64 169.62 13.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.897 0.349 . . . . 0.0 110.281 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.1 -179.38 17.03 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.9 m -94.64 109.49 21.41 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -105.17 130.37 53.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -131.08 112.3 12.76 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.392 0.615 . . . . 0.0 109.758 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -162.11 -161.69 0.77 Allowed 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -70.84 5.5 1.93 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.325 0.65 . . . . 0.0 111.97 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.94 -45.51 92.39 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -112.28 -15.84 13.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.648 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 pttt 54.21 27.72 8.2 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.173 1.789 . . . . 0.0 111.712 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -140.95 166.65 24.21 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.317 -2.22 . . . . 0.0 107.245 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -127.82 164.75 21.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.94 -36.24 65.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.164 0.985 . . . . 0.0 111.677 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 23.6 tt0 -121.24 -177.71 3.59 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 16' ' ' GLU 0.267 8.5 pt-20 58.49 129.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.491 2.316 . . . . 0.0 114.057 -174.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.21 4.42 0.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.409 1.884 . . . . 0.0 114.468 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.58 -38.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.11 -29.3 68.52 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.624 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 53.1 t -104.76 -11.86 16.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.969 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 1.6 t80 -72.02 -66.52 0.63 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.749 0.785 . . . . 0.0 110.611 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -67.66 -24.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.314 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.45 -35.3 25.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.272 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 38.8 t -63.83 -33.64 76.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.77 -21.64 66.0 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.063 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -90.52 -47.49 7.67 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.35 90.19 0.93 Allowed Glycine 0 CA--C 1.475 -2.429 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.7 pp -139.39 130.36 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.867 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.33 -132.64 0.15 Allowed Glycine 1 C--N 1.243 -4.628 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.117 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -82.04 80.21 8.35 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.668 -0.901 . . . . 0.0 109.146 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.01 -24.06 21.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.148 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 50.9 m-85 -130.0 143.54 49.52 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.13 -21.57 28.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 124.01 3.14 . . . . 0.0 114.37 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -115.24 13.25 16.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.496 0.718 . . . . 0.0 111.162 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 39.6 t -99.04 121.68 41.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -115.34 33.84 5.22 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.98 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.7 t -65.68 161.23 21.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.4 mtt-85 . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.725 -0.609 . . . . 0.0 110.398 -175.406 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.053 0.454 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.83 160.63 10.03 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -88.58 106.83 18.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.51 83.96 0.88 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -95.52 110.77 22.8 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.976 0.511 . . . . 0.0 109.628 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.96 120.37 32.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.414 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 25.2 m -105.19 128.5 53.43 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.9 t -64.61 130.5 43.85 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 120.924 0.392 . . . . 0.0 110.835 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.17 24.27 14.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.449 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 3.1 tm? -63.95 -43.99 94.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -110.56 -17.08 13.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 57.7 13.82 2.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.171 1.789 . . . . 0.0 113.105 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -139.18 154.8 48.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -82.7 72.01 9.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.179 0.99 . . . . 0.0 111.636 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -147.96 91.93 1.99 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.33 153.36 23.37 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 122.219 1.009 . . . . 0.0 113.013 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.04 154.19 40.18 Favored 'General case' 1 N--CA 1.377 -4.097 0 CA-C-N 113.974 -1.467 . . . . 0.0 107.866 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.88 5.45 0.97 Allowed 'General case' 0 C--N 1.25 -3.738 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.931 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.27 -49.26 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -72.91 -5.02 35.65 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 113.226 -1.807 . . . . 0.0 112.399 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 t -104.9 -31.16 9.39 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.1 t80 -66.34 -60.23 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.815 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.34 -32.4 56.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.5 0.667 . . . . 0.0 110.612 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.9 -37.2 62.15 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.197 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.3 t -66.08 -31.82 72.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.187 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 96.7 mt -63.62 -25.12 68.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.598 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -79.23 -55.16 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.15 78.46 0.24 Allowed Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.857 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -129.65 120.72 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.586 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.36 100.0 0.62 Allowed Glycine 1 C--N 1.244 -4.575 0 CA-C-N 113.396 -1.729 . . . . 0.0 111.562 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 64.8 m80 58.42 -83.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.758 1.623 . . . . 0.0 114.244 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 69.0 -67.82 0.2 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.379 1.472 . . . . 0.0 112.175 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 26.1 m-85 -83.01 142.37 44.47 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.76 -38.18 77.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 123.869 3.046 . . . . 0.0 112.809 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -94.5 3.61 54.91 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.145 0.978 . . . . 0.0 112.079 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -97.64 120.5 38.14 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.879 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -103.86 30.78 4.89 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.596 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.0 t -70.98 106.57 3.71 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.093 0.473 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 C--N 1.31 -1.14 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.263 -176.483 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 . . . . . 0 C--O 1.243 0.713 0 CA-C-O 122.046 0.927 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.13 162.56 24.68 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -84.0 -42.95 15.67 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.35 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.49 1.05 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 m -101.53 108.46 20.04 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 121.629 0.728 . . . . 0.0 110.193 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.48 103.86 10.86 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.41 HG23 ' HB2' ' A' ' 10' ' ' LEU . 12.8 t -124.93 144.39 50.37 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 152.37 34.08 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 123.881 0.872 . . . . 0.0 109.797 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 78.61 -26.82 0.17 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.511 1.125 . . . . 0.0 111.453 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HB2' HG23 ' A' ' 7' ' ' THR . 2.7 tm? -65.97 -43.33 88.2 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -81.08 -15.92 54.65 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? 45.07 14.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -141.3 -34.83 0.48 Allowed 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 mmt 52.79 73.42 0.35 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.783 0.802 . . . . 0.0 110.727 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.04 118.23 27.46 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.668 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -103.62 -24.79 13.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.551 0.691 . . . . 0.0 109.891 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 44.9 mt-10 -68.14 132.11 46.62 Favored 'General case' 0 N--CA 1.397 -3.119 0 CA-C-O 122.569 1.175 . . . . 0.0 109.572 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 73.87 5.36 4.8 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 111.437 -2.62 . . . . 0.0 111.737 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.01 -44.8 8.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -63.46 -12.0 28.06 Favored 'General case' 0 C--O 1.191 -1.989 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.616 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -105.03 -29.18 10.6 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.1 0.476 . . . . 0.0 110.019 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t80 -65.71 -59.28 4.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.918 -170.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mm -66.56 -29.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.526 0.679 . . . . 0.0 110.15 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HB3' HG12 ' A' ' 29' ' ' ILE . 7.3 mm-40 -75.02 -32.9 61.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.631 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -65.43 -32.64 74.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.319 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.0 -7.91 54.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.43 -49.59 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.42 79.48 0.21 Allowed Glycine 0 CA--C 1.471 -2.667 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.659 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.8 pp -136.0 134.51 50.67 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.019 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.17 -132.56 0.06 OUTLIER Glycine 1 C--N 1.234 -5.132 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.449 169.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -90.03 85.15 6.24 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.079 -1.248 . . . . 0.0 108.132 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -92.23 -34.39 14.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.78 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.693 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.4 m-85 -111.37 142.56 26.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -25.52 35.26 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 124.568 3.512 . . . . 0.0 114.187 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 33.4 p90 -115.09 18.92 16.06 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.739 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.693 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.3 t -85.96 114.68 23.05 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.935 0.874 . . . . 0.0 112.59 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -77.2 -4.44 44.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.959 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 t -69.13 140.39 54.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.378 0.609 . . . . 0.0 110.696 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 . . . . . 0 C--O 1.254 1.334 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.485 -175.635 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 C--O 1.241 0.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.96 159.47 11.95 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.754 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.548 ' H ' HG21 ' A' ' 23' ' ' ILE . 44.5 tt0 -86.97 87.02 7.36 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.035 0.921 . . . . 0.0 109.161 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.08 156.65 7.25 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -112.05 109.49 19.26 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.143 0.497 . . . . 0.0 111.268 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -114.47 104.06 11.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -129.17 155.46 45.48 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.154 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' LEU . 38.8 m -48.98 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 126.413 1.885 . . . . 0.0 113.083 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 12' ' ' LYS . 11.7 m-20 -60.64 7.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.1 tt -63.31 -42.8 99.04 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.772 1.629 . . . . 0.0 107.853 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -102.83 -5.37 23.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.672 0.749 . . . . 0.0 109.426 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 25.6 pttm 55.2 19.42 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 127.388 2.275 . . . . 0.0 116.192 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -86.53 -173.62 4.6 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.6 tpt -84.13 123.04 29.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -90.29 94.78 9.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.64 179.95 5.91 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.682 0.753 . . . . 0.0 112.403 -171.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 1.9 mp0 -83.47 -172.25 4.04 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.767 177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 61.35 5.58 1.18 Allowed 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.636 1.575 . . . . 0.0 111.83 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.15 -23.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 17' ' ' GLU . 27.6 mmt180 -63.59 -34.29 77.5 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.912 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.5 t -106.08 -4.13 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.39 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -66.81 -51.45 55.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.548 HG21 ' H ' ' A' ' 3' ' ' GLU . 4.0 mp -79.88 -28.14 12.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.885 0.85 . . . . 0.0 109.076 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.58 -47.03 87.99 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.2 t -72.87 -18.02 61.47 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.058 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 61.3 tp -66.86 -26.68 67.02 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.5 -65.24 1.03 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.08 69.79 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.357 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.795 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.9 pp -134.13 114.08 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 115.12 4.37 Favored Glycine 1 C--N 1.244 -4.533 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.836 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 52.62 72.91 0.38 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.013 0.925 . . . . 0.0 112.295 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' CB ' HD13 ' A' ' 29' ' ' ILE . 62.8 tttp -99.66 -20.42 16.31 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.751 0.786 . . . . 0.0 110.645 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 15.6 m-85 -119.2 151.76 51.35 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.35 -37.49 71.68 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.956 3.104 . . . . 0.0 113.34 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -100.55 11.81 38.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.601 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.4 t -89.24 109.56 20.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 0.0 110.231 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -100.2 6.41 44.78 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.937 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.8 t -89.99 126.54 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 123.306 0.642 . . . . 0.0 109.388 177.826 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.957 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -94.9 109.23 21.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.303 0.573 . . . . 0.0 111.541 -171.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.32 113.23 25.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -90.15 144.77 25.58 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.574 0.702 . . . . 0.0 112.283 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m -123.84 79.52 1.72 Allowed 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.571 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 79.1 -15.57 0.75 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.731 2.012 . . . . 0.0 111.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.53 -44.68 81.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.303 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 50.9 m -112.91 -18.0 12.35 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.816 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.4 tttm 41.37 59.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.313 1.054 . . . . 0.0 112.516 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 11' ' ' SER . 96.3 mt-30 . . . . . 0 C--N 1.297 -1.69 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.334 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.37 -4.447 0 CA-C-O 122.739 1.257 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 59.44 4.09 0.47 Allowed 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 127.994 2.518 . . . . 0.0 113.699 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.14 -40.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.955 0.884 . . . . 0.0 109.148 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -71.63 -10.53 59.91 Favored 'General case' 0 C--O 1.197 -1.663 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.995 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.84 -34.73 7.97 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.6 t80 -54.57 -58.0 9.2 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.99 1.316 . . . . 0.0 111.886 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -67.34 -21.51 27.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.962 0.887 . . . . 0.0 111.09 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.87 -36.24 15.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.795 0.807 . . . . 0.0 109.479 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.22 -28.68 66.57 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.028 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.9 -36.92 85.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.244 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -73.87 -54.86 7.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.63 66.18 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.379 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.82 132.77 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.932 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.6 -132.27 0.04 OUTLIER Glycine 1 C--N 1.238 -4.899 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.416 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -83.74 84.0 7.71 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.684 -0.892 . . . . 0.0 111.482 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -89.97 -36.74 14.8 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.58 0.705 . . . . 0.0 109.705 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.1 m-85 -108.83 151.93 42.06 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.33 -46.27 32.34 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.584 2.856 . . . . 0.0 112.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -89.26 3.83 50.74 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.238 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 46.6 t -87.94 108.67 19.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.046 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -109.97 75.95 0.96 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.988 0.899 . . . . 0.0 109.455 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 C--N 1.293 -1.865 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.816 176.901 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.838 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -95.36 108.52 20.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -114.36 108.21 16.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -89.31 129.31 35.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.2 t -103.99 149.71 24.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 67.09 22.24 9.95 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.806 0.842 . . . . 0.0 111.532 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.71 -43.14 26.53 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 p -89.78 -15.73 31.75 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.885 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE2' ' CE1' ' A' ' 35' ' ' PHE . 15.0 ttpp 56.9 30.58 18.2 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.421 1.488 . . . . 0.0 110.442 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.863 -178.823 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 1 N--CA 1.373 -4.324 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.99 6.68 4.85 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.291 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.1 -43.94 7.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -61.18 -27.75 68.64 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.767 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.9 t -104.96 -4.63 21.86 Favored 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -66.61 -65.06 0.73 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.54 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.9 mp -66.07 -28.99 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.27 1.033 . . . . 0.0 108.793 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB3' HG12 ' A' ' 29' ' ' ILE . 13.8 mm-40 -66.69 -33.11 74.91 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -73.27 -31.12 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.33 -32.49 72.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.939 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.77 -52.37 21.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.941 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.67 92.57 2.27 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -135.25 121.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 122.509 1.147 . . . . 0.0 109.129 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.29 90.78 1.12 Allowed Glycine 1 C--N 1.236 -4.992 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.819 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 54.91 77.9 0.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.564 1.545 . . . . 0.0 113.759 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -90.89 -18.62 24.46 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.9 m-85 -135.79 147.84 62.87 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -58.01 -39.4 86.33 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 123.481 2.787 . . . . 0.0 111.855 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.439 ' CE1' ' HE2' ' A' ' 12' ' ' LYS . 24.7 p90 -98.82 16.76 21.26 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.387 -173.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.68 117.58 29.87 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -94.81 37.03 1.15 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.405 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 t . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.653 -178.548 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.528 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -120.05 109.07 15.05 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.459 0.647 . . . . 0.0 111.533 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -116.49 120.81 39.95 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -115.16 113.97 24.66 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.969 0.414 . . . . 0.0 110.853 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 m -126.14 96.1 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.23 28.48 17.81 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.727 0.811 . . . . 0.0 110.576 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -69.17 -46.49 67.39 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -112.97 -14.15 13.04 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 62.75 21.38 12.73 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 125.701 1.6 . . . . 0.0 110.073 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.251 -178.91 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.388 -3.562 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 49.23 4.74 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 127.44 2.296 . . . . 0.0 116.294 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 16.9 m -107.95 -32.65 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 121.963 0.887 . . . . 0.0 108.716 173.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.598 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -68.18 -13.96 62.62 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.372 170.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -105.08 -32.16 8.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.514 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 42.7 t80 -57.11 -58.33 8.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.003 0.921 . . . . 0.0 112.013 -173.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.471 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 34.9 mm -66.02 -24.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.879 0.847 . . . . 0.0 110.654 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -86.19 -39.65 16.41 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.498 0.666 . . . . 0.0 109.981 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -68.8 -27.11 65.57 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.191 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.4 tp -62.92 -29.47 70.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.645 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.471 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 60.0 mttp -83.98 -54.14 5.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.73 69.66 0.05 OUTLIER Glycine 0 CA--C 1.482 -1.998 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.332 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.37 125.57 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.438 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.68 -132.42 0.04 OUTLIER Glycine 1 C--N 1.251 -4.141 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.951 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -79.25 93.22 5.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.924 -0.75 . . . . 0.0 110.463 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -98.83 -42.41 7.19 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.696 0.76 . . . . 0.0 109.565 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.599 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 35.3 m-85 -104.85 146.45 32.67 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.29 -30.63 73.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.934 3.089 . . . . 0.0 112.616 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.62 20.85 18.22 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.854 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 53.4 t -91.93 94.99 9.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.3 1.048 . . . . 0.0 108.306 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -98.45 17.85 17.95 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.615 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.651 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.433 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -100.25 107.25 19.03 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -118.03 123.65 46.21 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -130.75 106.92 8.78 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.194 0.521 . . . . 0.0 111.528 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.5 m -84.14 92.88 8.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.521 0.677 . . . . 0.0 110.769 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 70.81 -0.65 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.681 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.2 -42.52 65.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -88.95 -17.12 30.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 tttp 54.78 20.27 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 C--N 1.299 -1.611 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.767 -179.395 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 . . . . . 0 N--CA 1.393 -3.279 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 51.43 3.93 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 126.919 2.087 . . . . 0.0 114.324 -173.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.24 -32.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -64.57 -21.46 66.7 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.481 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 32.1 t -104.86 -24.26 12.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.664 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.3 t80 -61.36 -63.97 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.813 -173.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.51 -38.26 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.0 mm-40 -66.17 -44.9 82.71 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.472 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.24 -32.71 74.29 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.297 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.36 -20.56 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.319 0.58 . . . . 0.0 111.405 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -92.42 -54.6 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.77 98.45 0.47 Allowed Glycine 0 CA--C 1.484 -1.896 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.629 HD11 ' SG ' ' A' ' 36' ' ' CYS . 2.3 pp -137.84 126.07 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.65 107.67 3.55 Favored Glycine 1 C--N 1.238 -4.913 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.819 172.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.0 m80 50.91 89.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -126.9 -6.91 6.11 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.632 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 72.5 m-85 -145.78 147.49 32.83 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.53 -47.62 25.27 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 123.418 2.746 . . . . 0.0 111.992 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -92.01 12.9 20.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.818 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 49.0 t -95.32 110.84 22.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.761 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.75 75.29 0.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.352 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.124 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -100.01 109.4 21.73 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.08 103.9 11.02 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 t -131.69 139.98 49.19 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -112.66 152.92 28.43 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.33 13.28 7.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.857 1.263 . . . . 0.0 110.099 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -84.85 -42.76 14.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -88.22 -15.42 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.9 tttp 55.66 60.34 3.36 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.024 1.73 . . . . 0.0 114.308 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 . . . . . 0 C--N 1.267 -3.011 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 1 N--CA 1.374 -4.239 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 71.53 6.14 5.63 Favored 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 127.093 2.157 . . . . 0.0 111.134 -174.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.26 -53.54 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -58.85 -28.08 65.75 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.683 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -100.14 -19.41 16.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.021 0.528 . . . . 0.0 110.725 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 24.3 t80 -60.1 -60.17 4.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.951 0.405 . . . . 0.0 111.072 -171.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.5 mp -67.71 -32.02 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -175.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' HG12 ' A' ' 29' ' ' ILE . 40.0 mm-40 -68.38 -39.21 81.83 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.914 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.5 t -64.97 -34.06 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.02 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -70.3 -19.0 63.11 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -80.53 -51.67 8.51 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.6 101.8 2.15 Favored Glycine 0 CA--C 1.468 -2.881 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.8 pp -137.23 129.15 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.657 0 CA-C-O 122.278 1.037 . . . . 0.0 109.829 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.12 111.1 3.21 Favored Glycine 1 C--N 1.235 -5.056 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.915 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.74 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.582 1.553 . . . . 0.0 113.867 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 63.23 -74.89 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.545 1.538 . . . . 0.0 113.389 -174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.551 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 39.6 m-85 -106.12 143.97 28.0 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.11 -33.04 95.05 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.808 3.005 . . . . 0.0 113.398 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -100.67 3.48 42.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.013 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.6 t -77.26 110.19 11.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.665 0.745 . . . . 0.0 110.683 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.37 75.22 4.53 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.409 1.099 . . . . 0.0 111.13 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.295 -1.795 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.813 176.091 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.076 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -95.51 109.65 21.83 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.083 0.468 . . . . 0.0 110.558 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -105.45 111.22 23.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.013 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -131.06 114.83 15.65 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -72.02 143.81 49.02 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.391 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 76.56 2.61 3.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.217 1.007 . . . . 0.0 111.555 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -70.69 -44.01 67.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -111.23 -15.78 13.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.262 20.7 pttp 42.98 58.94 3.07 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.708 1.203 . . . . 0.0 114.118 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 . . . . . 0 C--N 1.287 -2.109 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.028 -176.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.381 -3.903 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.27 6.05 1.27 Allowed 'General case' 0 C--N 1.261 -3.244 0 C-N-CA 127.181 2.193 . . . . 0.0 112.578 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.3 t -107.87 -38.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -66.11 -15.68 63.3 Favored 'General case' 0 C--O 1.188 -2.17 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.402 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -104.13 -23.28 13.3 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 48.0 t80 -69.07 -61.11 1.93 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.148 -173.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.73 -37.36 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.027 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB3' HG12 ' A' ' 29' ' ' ILE . 46.0 mm-40 -67.92 -41.01 83.29 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.867 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.3 -28.08 65.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.53 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.63 -12.59 60.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.51 -47.6 7.87 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 171.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.51 93.88 0.83 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.358 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.484 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.5 pp -138.25 123.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.698 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.97 90.68 1.67 Allowed Glycine 1 C--N 1.243 -4.625 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.556 172.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 56.72 90.93 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.25 1.42 . . . . 0.0 112.992 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -102.05 -26.7 13.29 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.242 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.9 m-85 -125.35 147.48 57.79 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.45 -28.36 63.52 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 123.7 2.934 . . . . 0.0 113.315 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -103.84 8.09 37.01 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.592 0.757 . . . . 0.0 111.535 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -88.12 112.87 23.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.47 35.43 4.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.685 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.7 t . . . . . 0 C--N 1.31 -1.132 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.192 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.243 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.1 m -94.82 109.23 21.22 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -77.65 103.88 7.85 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.275 0.56 . . . . 0.0 110.633 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 15.3 t -129.94 151.53 50.4 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 p -68.49 138.34 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.296 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 12' ' ' LYS . 8.8 m-20 61.78 29.91 18.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.964 0.906 . . . . 0.0 110.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.8 tt -60.11 -46.15 90.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 t -112.14 -18.3 12.6 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 45.1 tttp 51.36 23.97 1.95 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.623 1.569 . . . . 0.0 111.287 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--N 1.298 -1.635 0 C-N-CA 124.056 0.943 . . . . 0.0 109.653 -179.216 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' ' CE1' ' A' ' 35' ' ' PHE . 42.8 mt-10 . . . . . 0 N--CA 1.399 -2.975 0 CA-C-O 122.095 0.95 . . . . 0.0 109.007 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 75.59 6.12 3.98 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.88 -2.418 . . . . 0.0 112.033 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.54 -42.77 7.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.24 -35.21 62.23 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.668 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.7 -4.27 31.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.824 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -67.83 -65.1 0.73 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.702 0.287 . . . . 0.0 111.544 -171.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.78 -23.08 27.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.279 0.562 . . . . 0.0 110.083 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -68.45 -43.96 75.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.99 -13.82 62.27 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.787 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.31 -10.9 55.5 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.886 -0.508 . . . . 0.0 111.281 170.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -121.1 176.79 5.41 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.18 92.91 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 pp -130.33 115.26 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.616 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.78 90.74 0.97 Allowed Glycine 1 C--N 1.245 -4.501 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.758 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 62.92 88.82 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.856 0.836 . . . . 0.0 112.632 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.99 -37.31 12.91 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.702 -0.624 . . . . 0.0 110.802 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 20.3 m-85 -118.88 154.1 52.86 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -51.9 -35.44 60.01 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.412 2.741 . . . . 0.0 113.298 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 17' ' ' GLU . 27.5 p90 -102.22 13.88 33.47 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.562 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.1 t -93.95 105.24 17.26 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -93.28 -1.68 55.82 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.537 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.441 -0.923 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.758 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.244 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 t -111.83 120.84 43.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -74.47 119.63 18.93 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.853 0.359 . . . . 0.0 110.512 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -117.19 123.65 47.2 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.462 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 m -62.4 138.17 58.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.932 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 77.8 -30.04 0.16 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.227 1.811 . . . . 0.0 111.785 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tt -71.34 -38.86 71.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -80.35 -15.45 56.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.105 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 47.75 58.77 4.68 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.845 1.658 . . . . 0.0 112.083 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 . . . . . 0 C--N 1.27 -2.85 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.945 178.872 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 1 N--CA 1.379 -4.025 0 CA-C-O 122.442 1.115 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.79 3.88 0.34 Allowed 'General case' 0 C--N 1.261 -3.262 0 C-N-CA 128.268 2.627 . . . . 0.0 114.298 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 14.6 p -108.62 -37.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -62.81 -20.4 65.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.582 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 52.8 t -105.54 -4.84 20.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.419 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 27.7 t80 -64.66 -59.71 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.836 0.351 . . . . 0.0 111.476 -170.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.581 ' H ' HD12 ' A' ' 23' ' ' ILE . 4.0 mp -75.1 -25.95 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.011 0.91 . . . . 0.0 108.769 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB3' HD11 ' A' ' 29' ' ' ILE . 7.0 mm-40 -67.95 -38.52 82.93 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.717 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -76.48 -18.02 58.98 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 94.3 mt -78.85 -6.55 56.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.307 0.575 . . . . 0.0 109.898 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -102.52 -54.39 2.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.0 78.54 0.64 Allowed Glycine 0 CA--C 1.488 -1.614 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.375 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.6 pp -136.1 121.16 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-O 123.078 1.418 . . . . 0.0 109.689 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.7 146.64 16.09 Favored Glycine 1 C--N 1.215 -6.142 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.437 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.545 ' H ' ' HA ' ' A' ' 37' ' ' HIS . 48.3 m-70 67.72 13.48 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HB2' HD13 ' A' ' 29' ' ' ILE . 75.5 mmtt -76.56 -39.12 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.207 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 43.8 m-85 -115.8 154.57 48.16 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.57 -21.39 18.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.878 3.052 . . . . 0.0 113.637 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -122.61 12.39 9.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.924 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.432 ' CB ' ' HB2' ' A' ' 33' ' ' TYR . 42.4 t -122.95 101.83 7.66 Favored 'General case' 0 CA--C 1.467 -2.222 0 C-N-CA 119.14 -1.024 . . . . 0.0 112.381 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.545 ' HA ' ' H ' ' A' ' 31' ' ' HIS . 9.1 m80 -128.96 75.69 1.67 Allowed 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.368 1.408 0 CA-C-O 120.919 0.39 . . . . 0.0 110.092 -178.87 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.768 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -95.15 109.06 21.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.106 0.479 . . . . 0.0 110.45 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -113.19 119.22 37.03 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 21.6 m -132.0 143.33 50.0 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -57.98 123.23 15.14 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.539 0.524 . . . . 0.0 110.574 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t70 76.89 1.07 3.18 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.35 1.06 . . . . 0.0 112.429 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 20.0 tp -65.6 -44.03 87.87 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.851 -0.531 . . . . 0.0 111.782 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 t -86.52 -17.06 35.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 42.91 59.91 2.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.314 1.445 . . . . 0.0 112.132 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 . . . . . 0 C--N 1.271 -2.811 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.865 178.183 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.384 -3.736 0 CA-C-O 122.655 1.217 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.5 3.31 1.85 Allowed 'General case' 0 C--N 1.251 -3.698 0 C-N-CA 127.738 2.415 . . . . 0.0 113.015 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.31 -39.33 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.943 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 171.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.8 mmp_? -68.33 -4.43 14.44 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.694 172.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.5 t -106.37 -45.17 4.34 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.046 0.451 . . . . 0.0 110.121 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HB3' HD12 ' A' ' 23' ' ' ILE . 18.1 t80 -51.31 -68.18 0.19 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.109 1.364 . . . . 0.0 113.772 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 22' ' ' PHE . 2.8 mp -66.26 -35.19 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 121.722 0.772 . . . . 0.0 110.345 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.9 mm-40 -58.81 -52.45 65.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.042 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.0 t -64.01 -29.45 70.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.874 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 84.1 mt -58.89 -22.92 60.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 65.4 pttt -94.0 -7.72 41.99 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.259 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.27 53.11 0.85 Allowed Glycine 0 N--CA 1.427 -1.9 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.442 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.91 123.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -132.57 0.1 Allowed Glycine 1 C--N 1.247 -4.393 0 CA-C-N 113.191 -1.822 . . . . 0.0 114.108 175.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -76.8 83.98 3.39 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.128 -0.63 . . . . 0.0 111.33 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -101.71 -14.79 17.21 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.557 0.694 . . . . 0.0 110.025 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 78.2 m-85 -128.85 146.84 62.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.99 -44.22 43.38 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 123.703 2.935 . . . . 0.0 112.995 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -90.75 9.65 29.17 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.35 1.06 . . . . 0.0 112.13 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 31.4 t -94.28 101.84 13.82 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.741 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -97.29 -2.99 41.43 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.395 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.313 -0.981 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.615 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.203 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.9 m -142.1 123.44 14.8 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -70.59 118.79 13.83 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -117.13 107.55 14.62 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.241 0.543 . . . . 0.0 110.981 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 10' ' ' LEU . 51.4 m -144.33 128.39 17.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 73.75 -31.68 0.22 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.065 1.346 . . . . 0.0 111.889 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.3 tt -55.32 -44.67 76.05 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.357 1.063 . . . . 0.0 110.014 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -111.56 -17.57 13.02 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.2 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 56.34 18.38 3.37 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.85 1.26 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -174.358 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' CD ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 tp10 . . . . . 0 N--CA 1.393 -3.283 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 63.53 5.27 2.07 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 128.41 2.684 . . . . 0.0 112.95 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -110.07 -50.71 6.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -64.21 -28.89 70.05 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.368 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.6 t -105.41 -2.33 23.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.81 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 58.5 t80 -57.0 -62.87 1.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.601 0.964 . . . . 0.0 113.601 -169.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 3.2 mp -68.93 -34.67 65.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 2.9 mm-40 -56.31 -54.26 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.652 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.5 t -69.83 -29.79 67.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.54 1.136 . . . . 0.0 111.135 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.7 tp -66.04 -25.88 67.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.581 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 29.1 mmmt -97.71 -58.57 1.96 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.98 110.71 0.7 Allowed Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.9 pp -139.63 135.63 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.779 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.04 -131.69 0.03 OUTLIER Glycine 1 C--N 1.242 -4.689 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.036 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -96.79 88.92 4.73 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.77 -1.43 . . . . 0.0 109.599 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -107.05 -31.45 8.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.289 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 71.1 m-85 -116.19 133.57 22.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.896 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 -16.99 57.4 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.468 3.445 . . . . 0.0 113.496 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -112.69 -10.61 13.62 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.099 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 47.3 t -76.89 111.55 12.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.169 -171.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -99.43 -5.56 29.23 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.93 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.234 0.283 0 CA-C-O 121.971 0.891 . . . . 0.0 108.925 176.485 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.028 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.4 m -134.1 114.01 12.69 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.39 117.64 19.8 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.37 0.419 . . . . 0.0 110.101 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -100.25 111.07 23.33 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -77.2 138.37 39.4 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.045 0.938 . . . . 0.0 111.113 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 66.49 13.2 9.16 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 124.119 0.968 . . . . 0.0 111.838 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.8 -43.62 53.74 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 t -94.05 -12.44 28.56 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt 58.02 35.48 25.26 Favored 'General case' 0 C--N 1.348 0.53 0 CA-C-O 123.411 1.577 . . . . 0.0 110.197 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--N 1.284 -2.253 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.097 177.958 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 51.2 mt-10 . . . . . 0 N--CA 1.392 -3.329 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.04 4.21 2.96 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 126.432 1.893 . . . . 0.0 111.261 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 28.9 m -105.35 -6.24 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -82.93 -28.54 29.81 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.671 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.5 p -106.7 -4.14 19.79 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.257 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 41.0 t80 -56.72 -61.54 2.36 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.59 0.756 . . . . 0.0 112.582 -170.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.9 mp -72.62 -28.31 27.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 7.3 mm-40 -59.1 -43.57 91.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.966 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -71.44 -32.86 68.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.733 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 85.4 mt -65.67 -27.28 68.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.432 0.634 . . . . 0.0 109.714 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 24' ' ' GLU . 53.1 mtmt -83.39 -51.51 7.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.442 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.49 91.68 0.16 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.291 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.491 ' HB ' ' HG2' ' A' ' 32' ' ' LYS . 2.2 pp -140.02 117.63 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.12 88.97 1.57 Allowed Glycine 1 C--N 1.252 -4.091 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.464 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 57.85 92.74 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.538 1.135 . . . . 0.0 112.505 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HG2' ' HB ' ' A' ' 29' ' ' ILE . 75.4 mmtt -111.64 -11.33 14.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.966 0.413 . . . . 0.0 111.426 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 77.7 m-85 -135.97 141.69 37.51 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -59.54 -37.58 87.99 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.434 2.756 . . . . 0.0 112.559 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 17' ' ' GLU . 17.2 p90 -93.23 14.8 17.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 124.172 0.989 . . . . 0.0 111.466 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.6 t -91.74 125.68 36.55 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -115.37 2.58 13.98 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.698 0.623 . . . . 0.0 112.295 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.067 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.829 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -95.57 121.62 37.46 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -106.84 144.53 33.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.7 m -128.43 108.18 10.35 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.73 0.776 . . . . 0.0 112.011 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 t -140.04 94.51 2.77 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.69 30.97 16.89 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.645 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.85 -44.35 61.49 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -110.7 -9.74 14.5 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.3 tttm 56.1 45.17 24.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.322 1.849 . . . . 0.0 110.977 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 . . . . . 0 C--N 1.281 -2.402 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.684 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 1 N--CA 1.377 -4.106 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.79 5.11 4.41 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 111.339 -2.664 . . . . 0.0 113.21 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.7 p -104.19 -31.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 20.7 mmm180 -55.75 -35.05 65.76 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.56 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 29' ' ' ILE . 42.2 t -105.1 -2.82 23.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.007 0.432 . . . . 0.0 111.075 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 34.0 t80 -56.58 -56.24 23.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.226 0.536 . . . . 0.0 110.537 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -72.4 -27.68 26.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.1 mm-40 -65.21 -40.19 93.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.819 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.18 -37.91 75.24 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.821 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.58 -36.2 79.97 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.203 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -74.23 -55.55 5.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.28 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.54 95.75 0.89 Allowed Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.658 HD11 ' SG ' ' A' ' 21' ' ' CYS . 2.5 pp -139.49 125.25 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.07 89.34 1.08 Allowed Glycine 1 C--N 1.252 -4.106 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.457 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 42.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.666 1.986 . . . . 0.0 113.651 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -126.44 16.23 7.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.148 0.499 . . . . 0.0 111.691 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 65.0 m-85 -146.67 139.21 14.05 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.88 -42.33 59.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.802 3.002 . . . . 0.0 113.418 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 20' ' ' ARG . 4.6 p90 -90.93 10.78 25.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 124.135 0.974 . . . . 0.0 111.966 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 45.5 t -94.68 95.02 8.47 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.727 0.775 . . . . 0.0 110.846 -176.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 37' ' ' HIS . 6.8 p80 -82.34 50.45 1.62 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.35 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.841 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.216 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -102.36 109.4 21.05 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -96.94 144.57 26.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 m -88.96 106.87 18.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 10' ' ' LEU . 20.3 m -129.86 138.66 51.08 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 77.29 -43.03 0.41 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.415 1.486 . . . . 0.0 110.71 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.6 tt -57.07 -43.36 82.01 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.836 1.654 . . . . 0.0 111.324 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.0 t -110.57 -18.03 13.28 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.84 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 48.94 14.11 0.07 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 126.66 1.984 . . . . 0.0 115.385 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--N 1.304 -1.391 0 O-C-N 121.344 -0.848 . . . . 0.0 112.03 -177.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.394 -3.252 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.37 4.0 0.87 Allowed 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 126.542 1.937 . . . . 0.0 112.401 -172.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.1 p -97.03 -31.91 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -67.95 -16.82 64.23 Favored 'General case' 0 C--O 1.19 -2.063 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.474 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.1 t -105.82 -18.04 14.18 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.0 110.326 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 40.2 t80 -62.21 -61.81 2.2 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.253 0.621 . . . . 0.0 112.101 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 47.3 mm -71.0 -29.98 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.749 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.5 mm-40 -68.32 -41.99 80.0 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.82 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.69 -31.83 70.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.15 -33.17 72.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 35.8 mmtp -78.62 -55.85 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 90.77 0.79 Allowed Glycine 0 CA--C 1.484 -1.865 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.561 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -136.28 127.17 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.504 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.13 113.67 4.34 Favored Glycine 1 C--N 1.235 -5.073 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.344 175.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m80 44.92 88.05 0.02 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.433 1.893 . . . . 0.0 114.495 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -129.29 -0.97 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.402 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 54.4 m-85 -145.9 143.43 19.55 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -48.17 -49.33 14.36 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 124.037 3.158 . . . . 0.0 113.189 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -88.59 17.92 5.04 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.532 1.133 . . . . 0.0 111.529 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 48.6 t -114.01 101.84 9.61 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.008 0.432 . . . . 0.0 110.768 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -114.28 -2.11 13.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.609 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.422 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 N-CA-C 113.653 0.221 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.4 t -110.51 113.03 25.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -117.19 131.23 56.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -131.13 107.19 8.85 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -153.08 111.68 3.71 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 67.97 14.2 9.31 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.559 1.171 . . . . 0.0 109.786 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.12 -43.19 22.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.509 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -90.48 -16.1 29.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttp 59.28 27.52 16.6 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 C--N 1.288 -2.067 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.946 -176.936 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.379 -4.011 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.44 5.65 0.47 Allowed 'General case' 0 C--N 1.282 -2.347 0 C-N-CA 126.284 1.834 . . . . 0.0 112.267 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -108.66 -21.92 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -64.33 -30.64 71.68 Favored 'General case' 0 C--O 1.203 -1.361 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.391 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' HB2' ' CD1' ' A' ' 33' ' ' TYR . 36.6 t -105.6 -8.19 18.11 Favored 'General case' 0 C--O 1.189 -2.101 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -67.36 -53.66 27.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.8 -30.32 46.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.335 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.86 -38.08 58.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.111 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 11.7 t -64.41 -29.43 70.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.185 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -75.28 -5.77 46.37 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.346 0.0 OUTLIER -147.78 71.29 1.18 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.46 -25.68 26.77 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 25' ' ' CYS 0.287 1.9 pp -115.02 115.35 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 119.991 1.895 . . . . 0.0 112.071 -172.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.43 102.93 2.79 Favored Glycine 1 C--N 1.233 -5.156 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.403 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 67.65 88.13 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.693 1.197 . . . . 0.0 112.829 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -119.06 -2.8 10.71 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.049 0.928 . . . . 0.0 108.689 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 61.3 m-85 -135.24 147.05 60.64 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.71 -36.21 98.52 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 123.532 2.821 . . . . 0.0 113.406 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.1 18.58 13.23 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.788 0.835 . . . . 0.0 111.01 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.09 96.3 10.53 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.891 0.853 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -94.43 -16.83 23.06 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.554 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.381 179.335 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 m -95.58 112.29 24.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -103.38 128.88 50.39 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.428 ' HB ' HD12 ' A' ' 10' ' ' LEU . 19.5 m -89.67 121.25 31.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.34 140.35 58.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.33 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 12' ' ' LYS . 24.0 t70 67.52 24.75 8.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.542 1.163 . . . . 0.0 110.637 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 7' ' ' THR . 4.9 tt -73.72 -44.65 55.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.133 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 p -107.57 -15.37 14.61 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 9' ' ' ASP . 32.3 tttp 68.3 14.01 9.13 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.798 1.639 . . . . 0.0 111.423 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.748 178.802 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 1 N--CA 1.377 -4.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 74.83 6.3 4.38 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 111.849 -2.432 . . . . 0.0 112.523 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.45 -34.68 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -62.4 -22.54 66.23 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.482 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -94.29 -38.04 11.21 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 28.3 t80 -56.83 -59.54 4.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.229 1.412 . . . . 0.0 111.204 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.6 mm -62.11 -35.59 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.854 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.48 -40.12 44.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.6 t -69.29 -28.44 66.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.418 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.45 -30.7 67.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.023 174.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -84.59 -57.37 3.16 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.02 97.46 0.26 Allowed Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.869 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -140.18 122.52 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.13 90.09 1.0 Allowed Glycine 1 C--N 1.241 -4.696 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.192 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 46.15 81.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.455 1.502 . . . . 0.0 112.554 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.43 -0.0 46.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.177 0.513 . . . . 0.0 111.791 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.607 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 57.8 m-85 -143.39 154.44 60.43 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 -42.52 67.41 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.459 2.773 . . . . 0.0 112.17 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -91.75 16.56 10.49 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 111.404 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -100.28 116.13 31.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -124.6 13.86 8.73 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.889 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.603 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.32 109.32 21.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.51 0.671 . . . . 0.0 112.799 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -90.64 127.48 36.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -100.66 139.04 36.9 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.273 0.559 . . . . 0.0 111.273 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -72.73 95.19 1.86 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.585 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.41 -0.82 2.08 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 173.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.34 -42.62 68.3 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 t -88.31 -13.45 40.76 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.346 21.0 pttp 43.94 57.81 3.95 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.929 1.692 . . . . 0.0 114.775 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--N 1.281 -2.378 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.903 177.298 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.383 -3.778 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.87 5.75 3.02 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.622 1.169 . . . . 0.0 113.137 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.9 t -108.42 -44.06 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -62.31 -13.3 27.28 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.724 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -105.61 -28.49 10.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.429 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 39.8 t80 -66.13 -66.63 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.892 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.7 mp -62.82 -31.67 53.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.903 0.859 . . . . 0.0 110.08 -175.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 mm-40 -68.49 -45.31 72.66 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.08 -33.12 75.28 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.15 -17.6 63.84 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.903 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -78.47 -33.06 48.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.399 0.618 . . . . 0.0 109.596 174.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.26 36.6 1.45 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.588 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 24' ' ' GLU . 1.9 pp -122.29 113.84 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.09 143.51 19.65 Favored Glycine 1 C--N 1.246 -4.445 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.499 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' CYS . 17.3 t-80 66.65 -99.76 0.06 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.213 1.005 . . . . 0.0 112.007 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 54.78 -62.41 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 126.69 1.996 . . . . 0.0 114.974 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -87.73 145.36 36.77 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 124.046 0.938 . . . . 0.0 109.878 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.94 -44.52 27.27 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 124.176 3.25 . . . . 0.0 113.313 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 17' ' ' GLU . 13.4 p90 -91.6 0.53 57.49 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.213 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.6 t -101.61 121.32 41.8 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.314 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -121.31 5.13 10.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.18 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.447 -0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.064 179.422 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.836 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.9 m -94.64 109.49 21.41 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -105.17 130.37 53.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -131.08 112.3 12.76 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.392 0.615 . . . . 0.0 109.758 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -162.11 -161.69 0.77 Allowed 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -70.84 5.5 1.93 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.325 0.65 . . . . 0.0 111.97 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.94 -45.51 92.39 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -112.28 -15.84 13.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.648 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 pttt 54.21 27.72 8.2 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.173 1.789 . . . . 0.0 111.712 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 C--N 1.294 -1.824 0 CA-C-N 112.317 -2.22 . . . . 0.0 107.245 -179.598 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 8.5 pt-20 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 122.516 1.15 . . . . 0.0 114.057 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.21 4.42 0.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.409 1.884 . . . . 0.0 114.468 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.58 -38.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.11 -29.3 68.52 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.624 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 53.1 t -104.76 -11.86 16.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.969 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 1.6 t80 -72.02 -66.52 0.63 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.749 0.785 . . . . 0.0 110.611 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -67.66 -24.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.314 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.45 -35.3 25.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.272 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 38.8 t -63.83 -33.64 76.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.77 -21.64 66.0 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.063 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -90.52 -47.49 7.67 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.35 90.19 0.93 Allowed Glycine 0 CA--C 1.475 -2.429 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.7 pp -139.39 130.36 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.867 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.33 -132.64 0.15 Allowed Glycine 1 C--N 1.243 -4.628 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.117 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -82.04 80.21 8.35 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.668 -0.901 . . . . 0.0 109.146 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.01 -24.06 21.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.148 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 50.9 m-85 -130.0 143.54 49.52 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.13 -21.57 28.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 124.01 3.14 . . . . 0.0 114.37 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -115.24 13.25 16.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.496 0.718 . . . . 0.0 111.162 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 39.6 t -99.04 121.68 41.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -115.34 33.84 5.22 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.98 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.7 t . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.343 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -95.52 110.77 22.8 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.976 0.511 . . . . 0.0 109.628 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.96 120.37 32.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.414 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 25.2 m -105.19 128.5 53.43 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.9 t -64.61 130.5 43.85 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 120.924 0.392 . . . . 0.0 110.835 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.17 24.27 14.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.449 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 3.1 tm? -63.95 -43.99 94.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -110.56 -17.08 13.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 57.7 13.82 2.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.171 1.789 . . . . 0.0 113.105 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 . . . . . 0 C--N 1.306 -1.324 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.193 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 1 N--CA 1.377 -4.097 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.88 5.45 0.97 Allowed 'General case' 0 C--N 1.25 -3.738 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.931 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.27 -49.26 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -72.91 -5.02 35.65 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 113.226 -1.807 . . . . 0.0 112.399 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 t -104.9 -31.16 9.39 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.1 t80 -66.34 -60.23 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.815 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.34 -32.4 56.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.5 0.667 . . . . 0.0 110.612 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.9 -37.2 62.15 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.197 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.3 t -66.08 -31.82 72.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.187 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 96.7 mt -63.62 -25.12 68.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.598 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -79.23 -55.16 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.15 78.46 0.24 Allowed Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.857 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -129.65 120.72 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.586 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.36 100.0 0.62 Allowed Glycine 1 C--N 1.244 -4.575 0 CA-C-N 113.396 -1.729 . . . . 0.0 111.562 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 64.8 m80 58.42 -83.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.758 1.623 . . . . 0.0 114.244 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 69.0 -67.82 0.2 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.379 1.472 . . . . 0.0 112.175 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 26.1 m-85 -83.01 142.37 44.47 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.76 -38.18 77.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 123.869 3.046 . . . . 0.0 112.809 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -94.5 3.61 54.91 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.145 0.978 . . . . 0.0 112.079 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -97.64 120.5 38.14 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.879 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -103.86 30.78 4.89 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.596 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.241 0.617 0 CA-C-O 121.093 0.473 . . . . 0.0 110.926 -179.871 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.1 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 m -101.53 108.46 20.04 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 121.629 0.728 . . . . 0.0 110.193 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.48 103.86 10.86 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.41 HG23 ' HB2' ' A' ' 10' ' ' LEU . 12.8 t -124.93 144.39 50.37 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 152.37 34.08 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 123.881 0.872 . . . . 0.0 109.797 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 78.61 -26.82 0.17 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.511 1.125 . . . . 0.0 111.453 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HB2' HG23 ' A' ' 7' ' ' THR . 2.7 tm? -65.97 -43.33 88.2 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -81.08 -15.92 54.65 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? 45.07 14.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 . . . . . 0 C--N 1.273 -2.739 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -175.258 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 44.9 mt-10 . . . . . 0 N--CA 1.397 -3.119 0 CA-C-O 122.569 1.175 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 73.87 5.36 4.8 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 111.437 -2.62 . . . . 0.0 111.737 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.01 -44.8 8.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -63.46 -12.0 28.06 Favored 'General case' 0 C--O 1.191 -1.989 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.616 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -105.03 -29.18 10.6 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.1 0.476 . . . . 0.0 110.019 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t80 -65.71 -59.28 4.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.918 -170.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mm -66.56 -29.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.526 0.679 . . . . 0.0 110.15 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HB3' HG12 ' A' ' 29' ' ' ILE . 7.3 mm-40 -75.02 -32.9 61.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.631 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -65.43 -32.64 74.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.319 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.0 -7.91 54.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.43 -49.59 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.42 79.48 0.21 Allowed Glycine 0 CA--C 1.471 -2.667 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.659 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.8 pp -136.0 134.51 50.67 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.019 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.17 -132.56 0.06 OUTLIER Glycine 1 C--N 1.234 -5.132 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.449 169.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -90.03 85.15 6.24 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.079 -1.248 . . . . 0.0 108.132 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -92.23 -34.39 14.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.78 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.693 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.4 m-85 -111.37 142.56 26.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -25.52 35.26 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 124.568 3.512 . . . . 0.0 114.187 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 33.4 p90 -115.09 18.92 16.06 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.739 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.693 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.3 t -85.96 114.68 23.05 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.935 0.874 . . . . 0.0 112.59 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -77.2 -4.44 44.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.959 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.378 0.609 . . . . 0.0 110.696 -175.605 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.726 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -112.05 109.49 19.26 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.143 0.497 . . . . 0.0 111.268 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -114.47 104.06 11.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -129.17 155.46 45.48 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.154 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' LEU . 38.8 m -48.98 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 126.413 1.885 . . . . 0.0 113.083 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 12' ' ' LYS . 11.7 m-20 -60.64 7.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.1 tt -63.31 -42.8 99.04 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.772 1.629 . . . . 0.0 107.853 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -102.83 -5.37 23.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.672 0.749 . . . . 0.0 109.426 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 25.6 pttm 55.2 19.42 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 127.388 2.275 . . . . 0.0 116.192 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.829 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 1.9 mp0 . . . . . 0 N--CA 1.396 -3.151 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 61.35 5.58 1.18 Allowed 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.636 1.575 . . . . 0.0 111.83 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.15 -23.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 17' ' ' GLU . 27.6 mmt180 -63.59 -34.29 77.5 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.912 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.5 t -106.08 -4.13 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.39 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -66.81 -51.45 55.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 26' ' ' LEU . 4.0 mp -79.88 -28.14 12.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.885 0.85 . . . . 0.0 109.076 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.58 -47.03 87.99 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.2 t -72.87 -18.02 61.47 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.058 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 61.3 tp -66.86 -26.68 67.02 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.5 -65.24 1.03 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.08 69.79 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.357 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.795 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.9 pp -134.13 114.08 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 115.12 4.37 Favored Glycine 1 C--N 1.244 -4.533 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.836 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 52.62 72.91 0.38 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.013 0.925 . . . . 0.0 112.295 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' CB ' HD13 ' A' ' 29' ' ' ILE . 62.8 tttp -99.66 -20.42 16.31 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.751 0.786 . . . . 0.0 110.645 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 15.6 m-85 -119.2 151.76 51.35 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.35 -37.49 71.68 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.956 3.104 . . . . 0.0 113.34 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -100.55 11.81 38.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.601 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.4 t -89.24 109.56 20.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 0.0 110.231 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -100.2 6.41 44.78 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.937 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.195 0.522 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.7 -171.68 36.44 Favored Glycine 0 C--O 1.246 0.851 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 84.19 7.72 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.122 0.963 . . . . 0.0 112.366 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.43 81.08 0.84 Allowed Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -94.9 109.23 21.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.303 0.573 . . . . 0.0 111.541 -171.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.32 113.23 25.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -90.15 144.77 25.58 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.574 0.702 . . . . 0.0 112.283 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m -123.84 79.52 1.72 Allowed 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.571 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 79.1 -15.57 0.75 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.731 2.012 . . . . 0.0 111.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.53 -44.68 81.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.303 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 50.9 m -112.91 -18.0 12.35 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.816 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HA ' ' CD ' ' A' ' 15' ' ' GLU . 61.4 tttm 41.37 59.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.313 1.054 . . . . 0.0 112.516 -174.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 11' ' ' SER . 96.3 mt-30 -135.22 -79.42 0.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.334 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -105.17 87.52 2.65 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' CD ' ' HA ' ' A' ' 12' ' ' LYS . 15.5 mm-40 -99.19 154.89 17.79 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.541 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.88 -45.66 3.6 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.416 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.43 153.88 29.35 Favored 'General case' 1 N--CA 1.37 -4.447 0 CA-C-O 122.739 1.257 . . . . 0.0 111.15 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 59.44 4.09 0.47 Allowed 'General case' 0 C--N 1.26 -3.3 0 C-N-CA 127.994 2.518 . . . . 0.0 113.699 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.14 -40.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.955 0.884 . . . . 0.0 109.148 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -71.63 -10.53 59.91 Favored 'General case' 0 C--O 1.197 -1.663 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.995 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.84 -34.73 7.97 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.6 t80 -54.57 -58.0 9.2 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.99 1.316 . . . . 0.0 111.886 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -67.34 -21.51 27.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.962 0.887 . . . . 0.0 111.09 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.87 -36.24 15.18 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.795 0.807 . . . . 0.0 109.479 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.22 -28.68 66.57 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.028 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.9 -36.92 85.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.244 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -73.87 -54.86 7.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.63 66.18 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.282 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.379 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.82 132.77 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.932 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.6 -132.27 0.04 OUTLIER Glycine 1 C--N 1.238 -4.899 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.416 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -83.74 84.0 7.71 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.684 -0.892 . . . . 0.0 111.482 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -89.97 -36.74 14.8 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.58 0.705 . . . . 0.0 109.705 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.1 m-85 -108.83 151.93 42.06 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.33 -46.27 32.34 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.584 2.856 . . . . 0.0 112.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -89.26 3.83 50.74 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.238 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 46.6 t -87.94 108.67 19.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.046 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -109.97 75.95 0.96 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.988 0.899 . . . . 0.0 109.455 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.9 t -112.05 145.66 39.31 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.816 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 . . . . . 0 C--N 1.315 -0.906 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.302 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 C--O 1.244 0.773 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.72 174.37 38.23 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.051 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 67.79 119.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.488 1.515 . . . . 0.0 111.08 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.84 -58.23 4.33 Favored Glycine 0 C--N 1.307 -1.037 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -95.36 108.52 20.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -114.36 108.21 16.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -89.31 129.31 35.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.2 t -103.99 149.71 24.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 67.09 22.24 9.95 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.806 0.842 . . . . 0.0 111.532 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.71 -43.14 26.53 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 p -89.78 -15.73 31.75 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.885 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE2' ' CE1' ' A' ' 35' ' ' PHE . 15.0 ttpp 56.9 30.58 18.2 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.421 1.488 . . . . 0.0 110.442 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -90.7 -16.06 29.19 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.863 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.3 tpt -64.04 -24.87 67.87 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -99.91 160.23 14.47 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.734 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 32.7 tt0 -99.01 134.36 41.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -93.02 163.58 13.6 Favored 'General case' 1 N--CA 1.373 -4.324 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.99 6.68 4.85 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.553 -1.658 . . . . 0.0 111.291 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.1 -43.94 7.55 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.4 mmm180 -61.18 -27.75 68.64 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.767 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.9 t -104.96 -4.63 21.86 Favored 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -66.61 -65.06 0.73 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.54 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.9 mp -66.07 -28.99 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 122.27 1.033 . . . . 0.0 108.793 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB3' HG12 ' A' ' 29' ' ' ILE . 13.8 mm-40 -66.69 -33.11 74.91 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.788 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -73.27 -31.12 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.33 -32.49 72.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.939 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.77 -52.37 21.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.941 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.67 92.57 2.27 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -135.25 121.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 122.509 1.147 . . . . 0.0 109.129 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.29 90.78 1.12 Allowed Glycine 1 C--N 1.236 -4.992 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.819 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 54.91 77.9 0.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.564 1.545 . . . . 0.0 113.759 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -90.89 -18.62 24.46 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 36.9 m-85 -135.79 147.84 62.87 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -58.01 -39.4 86.33 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 123.481 2.787 . . . . 0.0 111.855 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.439 ' CE1' ' HE2' ' A' ' 12' ' ' LYS . 24.7 p90 -98.82 16.76 21.26 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.387 -173.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.68 117.58 29.87 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -94.81 37.03 1.15 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.405 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 t -103.61 1.88 32.64 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.653 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 123.388 0.675 . . . . 0.0 111.679 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.1 m80 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.49 160.0 26.99 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.93 118.35 5.64 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.64 29.13 2.5 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.108 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -120.05 109.07 15.05 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.459 0.647 . . . . 0.0 111.533 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -116.49 120.81 39.95 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -115.16 113.97 24.66 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.969 0.414 . . . . 0.0 110.853 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 m -126.14 96.1 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.23 28.48 17.81 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.727 0.811 . . . . 0.0 110.576 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -69.17 -46.49 67.39 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -112.97 -14.15 13.04 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 62.75 21.38 12.73 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 125.701 1.6 . . . . 0.0 110.073 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -95.93 -38.6 10.18 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.251 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -68.09 -47.28 68.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.546 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 1.2 pm0 -82.14 73.16 9.19 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.233 1.016 . . . . 0.0 113.635 -177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -91.49 -17.92 24.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.996 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.32 -178.62 4.16 Favored 'General case' 0 N--CA 1.388 -3.562 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 49.23 4.74 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 127.44 2.296 . . . . 0.0 116.294 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 16.9 m -107.95 -32.65 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 121.963 0.887 . . . . 0.0 108.716 173.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.598 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -68.18 -13.96 62.62 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.372 170.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -105.08 -32.16 8.83 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.514 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 42.7 t80 -57.11 -58.33 8.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.003 0.921 . . . . 0.0 112.013 -173.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.471 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 34.9 mm -66.02 -24.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.879 0.847 . . . . 0.0 110.654 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -86.19 -39.65 16.41 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.498 0.666 . . . . 0.0 109.981 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -68.8 -27.11 65.57 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.191 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.4 tp -62.92 -29.47 70.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.645 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 60.0 mttp -83.98 -54.14 5.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.73 69.66 0.05 OUTLIER Glycine 0 CA--C 1.482 -1.998 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.332 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.37 125.57 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.438 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.68 -132.42 0.04 OUTLIER Glycine 1 C--N 1.251 -4.141 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.951 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -79.25 93.22 5.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.924 -0.75 . . . . 0.0 110.463 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -98.83 -42.41 7.19 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.696 0.76 . . . . 0.0 109.565 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.599 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 35.3 m-85 -104.85 146.45 32.67 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.29 -30.63 73.08 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.934 3.089 . . . . 0.0 112.616 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.62 20.85 18.22 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.854 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 53.4 t -91.93 94.99 9.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 122.3 1.048 . . . . 0.0 108.306 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -98.45 17.85 17.95 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.615 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.6 t -104.0 146.22 29.01 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.99 0 C-N-CA 122.57 0.348 . . . . 0.0 110.72 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 53.2 m80 . . . . . 0 C--O 1.241 0.628 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.99 160.46 23.62 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.694 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -150.01 155.39 39.85 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.35 -9.28 5.91 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.494 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -100.25 107.25 19.03 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -118.03 123.65 46.21 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -130.75 106.92 8.78 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.194 0.521 . . . . 0.0 111.528 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.5 m -84.14 92.88 8.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.521 0.677 . . . . 0.0 110.769 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 70.81 -0.65 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.681 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.2 -42.52 65.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -88.95 -17.12 30.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 tttp 54.78 20.27 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -137.03 -53.16 0.69 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.767 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 ttm -86.93 76.99 9.31 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -165.29 147.91 7.95 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -113.28 159.29 19.51 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.98 -174.7 3.87 Favored 'General case' 0 N--CA 1.393 -3.279 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 51.43 3.93 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 126.919 2.087 . . . . 0.0 114.324 -173.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.24 -32.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -64.57 -21.46 66.7 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.481 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 32.1 t -104.86 -24.26 12.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.664 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.3 t80 -61.36 -63.97 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.813 -173.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.51 -38.26 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.0 mm-40 -66.17 -44.9 82.71 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.472 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.24 -32.71 74.29 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.297 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.36 -20.56 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.319 0.58 . . . . 0.0 111.405 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -92.42 -54.6 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.77 98.45 0.47 Allowed Glycine 0 CA--C 1.484 -1.896 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.629 HD11 ' SG ' ' A' ' 36' ' ' CYS . 2.3 pp -137.84 126.07 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.65 107.67 3.55 Favored Glycine 1 C--N 1.238 -4.913 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.819 172.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.0 m80 50.91 89.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -126.9 -6.91 6.11 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.632 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 72.5 m-85 -145.78 147.49 32.83 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.53 -47.62 25.27 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 123.418 2.746 . . . . 0.0 111.992 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -92.01 12.9 20.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.818 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 49.0 t -95.32 110.84 22.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.761 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.75 75.29 0.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.352 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.1 t -69.28 170.28 10.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 . . . . . 0 C--N 1.289 -2.035 0 O-C-N 121.695 -0.628 . . . . 0.0 109.864 -175.54 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.464 0.65 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.91 169.52 13.34 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.931 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 130.62 20.79 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.58 4.52 17.3 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -100.01 109.4 21.73 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.08 103.9 11.02 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 t -131.69 139.98 49.19 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -112.66 152.92 28.43 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.33 13.28 7.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.857 1.263 . . . . 0.0 110.099 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -84.85 -42.76 14.77 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -88.22 -15.42 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.9 tttp 55.66 60.34 3.36 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 126.024 1.73 . . . . 0.0 114.308 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -133.04 171.6 13.77 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -75.75 98.06 4.02 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.132 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.06 98.89 10.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.506 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 40.1 tt0 -141.4 -76.82 0.29 Allowed 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.265 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.6 145.81 27.17 Favored 'General case' 1 N--CA 1.374 -4.239 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 71.53 6.14 5.63 Favored 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 127.093 2.157 . . . . 0.0 111.134 -174.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.26 -53.54 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 34.7 mmt180 -58.85 -28.08 65.75 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 114.717 -1.128 . . . . 0.0 112.683 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -100.14 -19.41 16.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.021 0.528 . . . . 0.0 110.725 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 24.3 t80 -60.1 -60.17 4.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.951 0.405 . . . . 0.0 111.072 -171.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.5 mp -67.71 -32.02 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -175.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' HG12 ' A' ' 29' ' ' ILE . 40.0 mm-40 -68.38 -39.21 81.83 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.914 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.5 t -64.97 -34.06 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.02 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -70.3 -19.0 63.11 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -80.53 -51.67 8.51 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.6 101.8 2.15 Favored Glycine 0 CA--C 1.468 -2.881 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.8 pp -137.23 129.15 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.657 0 CA-C-O 122.278 1.037 . . . . 0.0 109.829 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.12 111.1 3.21 Favored Glycine 1 C--N 1.235 -5.056 0 CA-C-N 112.873 -1.967 . . . . 0.0 111.915 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.74 -88.43 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.582 1.553 . . . . 0.0 113.867 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 63.23 -74.89 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.545 1.538 . . . . 0.0 113.389 -174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.551 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 39.6 m-85 -106.12 143.97 28.0 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -173.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.11 -33.04 95.05 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.808 3.005 . . . . 0.0 113.398 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -100.67 3.48 42.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.013 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.6 t -77.26 110.19 11.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.665 0.745 . . . . 0.0 110.683 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -93.37 75.22 4.53 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.409 1.099 . . . . 0.0 111.13 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 t -128.08 161.51 29.06 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.813 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 . . . . . 0 CA--C 1.501 -0.931 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.72 160.65 10.06 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.66 -45.43 17.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 123.632 0.773 . . . . 0.0 109.908 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.2 53.15 0.72 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 p -95.51 109.65 21.83 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.083 0.468 . . . . 0.0 110.558 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -105.45 111.22 23.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.142 0.496 . . . . 0.0 111.013 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -131.06 114.83 15.65 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -72.02 143.81 49.02 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.391 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 76.56 2.61 3.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.217 1.007 . . . . 0.0 111.555 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -70.69 -44.01 67.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -111.23 -15.78 13.57 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.262 20.7 pttp 42.98 58.94 3.07 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.708 1.203 . . . . 0.0 114.118 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.405 ' HB2' ' H ' ' A' ' 14' ' ' MET . 29.5 mt-30 -80.35 -72.38 0.41 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.028 -176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.405 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 55.6 ttp -119.36 17.21 13.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.578 ' HA ' HG21 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -80.83 73.14 7.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.696 -1.593 . . . . 0.0 112.537 -172.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -131.34 -83.51 0.51 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.74 147.66 35.26 Favored 'General case' 0 N--CA 1.381 -3.903 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.27 6.05 1.27 Allowed 'General case' 0 C--N 1.261 -3.244 0 C-N-CA 127.181 2.193 . . . . 0.0 112.578 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 15' ' ' GLU . 80.3 t -107.87 -38.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -66.11 -15.68 63.3 Favored 'General case' 0 C--O 1.188 -2.17 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.402 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -104.13 -23.28 13.3 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 48.0 t80 -69.07 -61.11 1.93 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.148 -173.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.73 -37.36 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.027 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB3' HG12 ' A' ' 29' ' ' ILE . 46.0 mm-40 -67.92 -41.01 83.29 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.867 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.3 -28.08 65.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.53 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.63 -12.59 60.24 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.51 -47.6 7.87 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 171.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.51 93.88 0.83 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.358 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.484 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.5 pp -138.25 123.31 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.698 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.97 90.68 1.67 Allowed Glycine 1 C--N 1.243 -4.625 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.556 172.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 56.72 90.93 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.25 1.42 . . . . 0.0 112.992 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -102.05 -26.7 13.29 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.242 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.9 m-85 -125.35 147.48 57.79 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.45 -28.36 63.52 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 123.7 2.934 . . . . 0.0 113.315 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -103.84 8.09 37.01 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.592 0.757 . . . . 0.0 111.535 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 42.6 t -88.12 112.87 23.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.47 35.43 4.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.685 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.7 t -87.84 -76.25 0.39 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 . . . . . 0 C--N 1.277 -2.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.204 -179.484 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.33 -153.21 17.54 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -84.01 -17.97 38.68 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.007 0.432 . . . . 0.0 110.795 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.59 138.12 14.62 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.1 m -94.82 109.23 21.22 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -77.65 103.88 7.85 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.275 0.56 . . . . 0.0 110.633 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 15.3 t -129.94 151.53 50.4 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 p -68.49 138.34 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.296 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 12' ' ' LYS . 8.8 m-20 61.78 29.91 18.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.964 0.906 . . . . 0.0 110.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.8 tt -60.11 -46.15 90.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 t -112.14 -18.3 12.6 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 45.1 tttp 51.36 23.97 1.95 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.623 1.569 . . . . 0.0 111.287 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -86.5 -45.21 11.32 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.056 0.943 . . . . 0.0 109.653 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 63.2 mtt -106.97 96.41 6.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.34 157.81 17.33 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.41 -31.88 5.78 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.115 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' ' CE1' ' A' ' 35' ' ' PHE . 42.8 mt-10 -67.34 124.87 24.37 Favored 'General case' 0 N--CA 1.399 -2.975 0 CA-C-O 122.095 0.95 . . . . 0.0 109.007 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 75.59 6.12 3.98 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.88 -2.418 . . . . 0.0 112.033 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.54 -42.77 7.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -54.24 -35.21 62.23 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.668 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.7 -4.27 31.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.824 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -67.83 -65.1 0.73 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.702 0.287 . . . . 0.0 111.544 -171.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.78 -23.08 27.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.279 0.562 . . . . 0.0 110.083 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -68.45 -43.96 75.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.99 -13.82 62.27 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.787 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.31 -10.9 55.5 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.886 -0.508 . . . . 0.0 111.281 170.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -121.1 176.79 5.41 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.18 92.91 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 pp -130.33 115.26 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.616 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.78 90.74 0.97 Allowed Glycine 1 C--N 1.245 -4.501 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.758 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 62.92 88.82 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.856 0.836 . . . . 0.0 112.632 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.99 -37.31 12.91 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.702 -0.624 . . . . 0.0 110.802 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 20.3 m-85 -118.88 154.1 52.86 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -51.9 -35.44 60.01 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.412 2.741 . . . . 0.0 113.298 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 17' ' ' GLU . 27.5 p90 -102.22 13.88 33.47 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.562 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.1 t -93.95 105.24 17.26 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -93.28 -1.68 55.82 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.537 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.54 122.11 16.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.73 162.35 10.44 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.373 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 74.71 172.6 0.27 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.744 1.218 . . . . 0.0 112.512 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.58 29.69 2.2 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.051 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 t -111.83 120.84 43.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -74.47 119.63 18.93 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.853 0.359 . . . . 0.0 110.512 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -117.19 123.65 47.2 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.462 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.3 m -62.4 138.17 58.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.932 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 77.8 -30.04 0.16 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.227 1.811 . . . . 0.0 111.785 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tt -71.34 -38.86 71.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -80.35 -15.45 56.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.105 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 47.75 58.77 4.68 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.845 1.658 . . . . 0.0 112.083 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -100.38 153.66 19.14 Favored 'General case' 0 C--N 1.27 -2.85 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.945 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.0 ttp -164.35 164.9 22.11 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . 9.8 pt-20 -73.27 84.74 1.4 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.621 1.201 . . . . 0.0 107.783 171.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.76 168.13 6.58 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 113.456 -1.702 . . . . 0.0 114.599 -169.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.1 162.32 23.76 Favored 'General case' 1 N--CA 1.379 -4.025 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.501 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.79 3.88 0.34 Allowed 'General case' 0 C--N 1.261 -3.262 0 C-N-CA 128.268 2.627 . . . . 0.0 114.298 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 14.6 p -108.62 -37.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' HD2' ' HB2' ' A' ' 15' ' ' GLU . 1.4 mmp_? -62.81 -20.4 65.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.582 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 52.8 t -105.54 -4.84 20.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.419 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 27.7 t80 -64.66 -59.71 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.836 0.351 . . . . 0.0 111.476 -170.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.581 ' H ' HD12 ' A' ' 23' ' ' ILE . 4.0 mp -75.1 -25.95 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 122.011 0.91 . . . . 0.0 108.769 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB3' HD11 ' A' ' 29' ' ' ILE . 7.0 mm-40 -67.95 -38.52 82.93 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.717 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -76.48 -18.02 58.98 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 94.3 mt -78.85 -6.55 56.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.307 0.575 . . . . 0.0 109.898 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -102.52 -54.39 2.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.0 78.54 0.64 Allowed Glycine 0 CA--C 1.488 -1.614 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.375 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.6 pp -136.1 121.16 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-O 123.078 1.418 . . . . 0.0 109.689 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.7 146.64 16.09 Favored Glycine 1 C--N 1.215 -6.142 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.437 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.545 ' H ' ' HA ' ' A' ' 37' ' ' HIS . 48.3 m-70 67.72 13.48 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HB2' HD13 ' A' ' 29' ' ' ILE . 75.5 mmtt -76.56 -39.12 53.69 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.207 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 43.8 m-85 -115.8 154.57 48.16 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.57 -21.39 18.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.878 3.052 . . . . 0.0 113.637 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -122.61 12.39 9.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.924 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.432 ' CB ' ' HB2' ' A' ' 33' ' ' TYR . 42.4 t -122.95 101.83 7.66 Favored 'General case' 0 CA--C 1.467 -2.222 0 C-N-CA 119.14 -1.024 . . . . 0.0 112.381 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.545 ' HA ' ' H ' ' A' ' 31' ' ' HIS . 9.1 m80 -128.96 75.69 1.67 Allowed 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -44.59 126.84 5.74 Favored 'General case' 0 C--N 1.368 1.408 0 CA-C-O 120.919 0.39 . . . . 0.0 110.092 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 . . . . . 0 N--CA 1.431 -1.383 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.264 -170.219 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.532 0.682 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.03 170.91 47.77 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.35 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.22 -19.59 18.49 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.271 -0.547 . . . . 0.0 110.139 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.28 116.39 4.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -95.15 109.06 21.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.106 0.479 . . . . 0.0 110.45 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -113.19 119.22 37.03 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 21.6 m -132.0 143.33 50.0 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -57.98 123.23 15.14 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.539 0.524 . . . . 0.0 110.574 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.8 t70 76.89 1.07 3.18 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.35 1.06 . . . . 0.0 112.429 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 20.0 tp -65.6 -44.03 87.87 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 121.851 -0.531 . . . . 0.0 111.782 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 t -86.52 -17.06 35.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 42.91 59.91 2.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.314 1.445 . . . . 0.0 112.132 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -111.37 151.71 28.15 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.865 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -61.99 134.69 56.96 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.56 78.13 4.07 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -98.83 166.63 11.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.656 -164.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -59.97 149.02 33.17 Favored 'General case' 0 N--CA 1.384 -3.736 0 C-N-CA 125.591 1.556 . . . . 0.0 109.472 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.5 3.31 1.85 Allowed 'General case' 0 C--N 1.251 -3.698 0 C-N-CA 127.738 2.415 . . . . 0.0 113.015 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.31 -39.33 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.943 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 171.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.8 mmp_? -68.33 -4.43 14.44 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 112.643 -2.071 . . . . 0.0 111.694 172.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.5 t -106.37 -45.17 4.34 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.046 0.451 . . . . 0.0 110.121 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HB3' HD12 ' A' ' 23' ' ' ILE . 18.1 t80 -51.31 -68.18 0.19 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.109 1.364 . . . . 0.0 113.772 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 22' ' ' PHE . 2.8 mp -66.26 -35.19 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 121.722 0.772 . . . . 0.0 110.345 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 17.9 mm-40 -58.81 -52.45 65.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.042 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.0 t -64.01 -29.45 70.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.874 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 84.1 mt -58.89 -22.92 60.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 65.4 pttt -94.0 -7.72 41.99 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.259 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.27 53.11 0.85 Allowed Glycine 0 N--CA 1.427 -1.9 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.442 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.91 123.2 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.16 -132.57 0.1 Allowed Glycine 1 C--N 1.247 -4.393 0 CA-C-N 113.191 -1.822 . . . . 0.0 114.108 175.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -76.8 83.98 3.39 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.128 -0.63 . . . . 0.0 111.33 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -101.71 -14.79 17.21 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.557 0.694 . . . . 0.0 110.025 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 78.2 m-85 -128.85 146.84 62.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -50.99 -44.22 43.38 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 123.703 2.935 . . . . 0.0 112.995 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -90.75 9.65 29.17 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.35 1.06 . . . . 0.0 112.13 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 31.4 t -94.28 101.84 13.82 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.741 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -97.29 -2.99 41.43 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.395 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -76.52 145.74 38.91 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 . . . . . 0 C--N 1.31 -1.14 0 C-N-CA 122.926 0.49 . . . . 0.0 111.229 -176.021 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 120.891 0.377 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.21 160.37 27.03 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.73 111.05 22.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.789 0.794 . . . . 0.0 111.063 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 151.86 7.79 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.9 m -142.1 123.44 14.8 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -70.59 118.79 13.83 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -117.13 107.55 14.62 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.241 0.543 . . . . 0.0 110.981 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 10' ' ' LEU . 51.4 m -144.33 128.39 17.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 73.75 -31.68 0.22 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.065 1.346 . . . . 0.0 111.889 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.3 tt -55.32 -44.67 76.05 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.357 1.063 . . . . 0.0 110.014 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -111.56 -17.57 13.02 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.2 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 56.34 18.38 3.37 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 124.85 1.26 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -83.71 -10.07 58.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 17.1 ptp -56.69 -47.47 79.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 32.0 tt0 66.5 -51.43 0.44 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.769 1.627 . . . . 0.0 114.596 172.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -42.38 -51.05 5.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.506 1.922 . . . . 0.0 114.047 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' CD ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 tp10 -143.22 158.23 43.8 Favored 'General case' 0 N--CA 1.393 -3.283 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 63.53 5.27 2.07 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 128.41 2.684 . . . . 0.0 112.95 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -110.07 -50.71 6.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 39.1 mmt180 -64.21 -28.89 70.05 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.368 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.6 t -105.41 -2.33 23.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.81 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 58.5 t80 -57.0 -62.87 1.44 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.601 0.964 . . . . 0.0 113.601 -169.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 3.2 mp -68.93 -34.67 65.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 2.9 mm-40 -56.31 -54.26 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.652 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.5 t -69.83 -29.79 67.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.54 1.136 . . . . 0.0 111.135 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.7 tp -66.04 -25.88 67.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.581 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 29.1 mmmt -97.71 -58.57 1.96 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.98 110.71 0.7 Allowed Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.9 pp -139.63 135.63 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.779 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.04 -131.69 0.03 OUTLIER Glycine 1 C--N 1.242 -4.689 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.036 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -96.79 88.92 4.73 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.77 -1.43 . . . . 0.0 109.599 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -107.05 -31.45 8.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.289 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 71.1 m-85 -116.19 133.57 22.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.896 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 -16.99 57.4 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.468 3.445 . . . . 0.0 113.496 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -112.69 -10.61 13.62 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.099 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 47.3 t -76.89 111.55 12.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.169 -171.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -99.43 -5.56 29.23 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.93 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.5 t -68.42 -36.84 79.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.971 0.891 . . . . 0.0 108.925 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 113.3 -1.773 . . . . 0.0 111.195 178.838 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.41 160.17 33.93 Favored Glycine 0 N--CA 1.428 -1.862 0 O-C-N 123.891 0.745 . . . . 0.0 112.585 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 -38.65 2.27 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.03 21.84 10.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 174.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.4 m -134.1 114.01 12.69 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.39 117.64 19.8 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.37 0.419 . . . . 0.0 110.101 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -100.25 111.07 23.33 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -77.2 138.37 39.4 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.045 0.938 . . . . 0.0 111.113 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 66.49 13.2 9.16 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 124.119 0.968 . . . . 0.0 111.838 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.8 -43.62 53.74 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 t -94.05 -12.44 28.56 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt 58.02 35.48 25.26 Favored 'General case' 0 C--N 1.348 0.53 0 CA-C-O 123.411 1.577 . . . . 0.0 110.197 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -97.53 165.07 12.17 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.097 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.5 ptm -97.24 126.42 42.43 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -83.39 90.31 7.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.58 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 40.9 tt0 -116.87 -82.88 0.63 Allowed 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.72 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.58 ' HG3' ' HG2' ' A' ' 16' ' ' GLU . 51.2 mt-10 -122.34 165.9 15.54 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.04 4.21 2.96 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 126.432 1.893 . . . . 0.0 111.261 -172.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 28.9 m -105.35 -6.24 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -82.93 -28.54 29.81 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.671 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.5 p -106.7 -4.14 19.79 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.257 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 41.0 t80 -56.72 -61.54 2.36 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.59 0.756 . . . . 0.0 112.582 -170.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.9 mp -72.62 -28.31 27.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 7.3 mm-40 -59.1 -43.57 91.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.966 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -71.44 -32.86 68.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.733 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 85.4 mt -65.67 -27.28 68.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.432 0.634 . . . . 0.0 109.714 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 24' ' ' GLU . 53.1 mtmt -83.39 -51.51 7.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.442 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.49 91.68 0.16 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.291 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.491 ' HB ' ' HG2' ' A' ' 32' ' ' LYS . 2.2 pp -140.02 117.63 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.12 88.97 1.57 Allowed Glycine 1 C--N 1.252 -4.091 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.464 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 57.85 92.74 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.538 1.135 . . . . 0.0 112.505 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HG2' ' HB ' ' A' ' 29' ' ' ILE . 75.4 mmtt -111.64 -11.33 14.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.966 0.413 . . . . 0.0 111.426 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 77.7 m-85 -135.97 141.69 37.51 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -59.54 -37.58 87.99 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.434 2.756 . . . . 0.0 112.559 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 17' ' ' GLU . 17.2 p90 -93.23 14.8 17.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 124.172 0.989 . . . . 0.0 111.466 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.6 t -91.74 125.68 36.55 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -115.37 2.58 13.98 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.698 0.623 . . . . 0.0 112.295 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -81.0 86.65 6.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.318 -174.125 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.542 ' HB3' ' O ' ' A' ' 5' ' ' THR . 59.0 t-80 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.38 168.11 22.87 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.783 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 66.94 19.91 10.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 111.875 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.62 89.94 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 1' ' ' HIS . 20.9 m -95.57 121.62 37.46 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -106.84 144.53 33.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.7 m -128.43 108.18 10.35 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.73 0.776 . . . . 0.0 112.011 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 t -140.04 94.51 2.77 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.69 30.97 16.89 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.645 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.85 -44.35 61.49 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -110.7 -9.74 14.5 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.3 tttm 56.1 45.17 24.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.322 1.849 . . . . 0.0 110.977 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -138.48 149.23 45.21 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.684 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -105.99 11.97 31.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 71.46 -62.26 0.46 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.681 1.592 . . . . 0.0 109.833 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 19' ' ' VAL . 33.1 tt0 -176.95 126.7 0.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 126.02 1.728 . . . . 0.0 106.825 174.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.46 142.22 36.06 Favored 'General case' 1 N--CA 1.377 -4.106 0 CA-C-O 122.493 1.14 . . . . 0.0 109.454 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.79 5.11 4.41 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 111.339 -2.664 . . . . 0.0 113.21 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 16' ' ' GLU . 7.7 p -104.19 -31.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 20.7 mmm180 -55.75 -35.05 65.76 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.56 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 29' ' ' ILE . 42.2 t -105.1 -2.82 23.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.007 0.432 . . . . 0.0 111.075 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' VAL . 34.0 t80 -56.58 -56.24 23.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.226 0.536 . . . . 0.0 110.537 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.2 mm -72.4 -27.68 26.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.1 mm-40 -65.21 -40.19 93.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.819 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.18 -37.91 75.24 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.821 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.58 -36.2 79.97 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.203 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -74.23 -55.55 5.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.28 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.54 95.75 0.89 Allowed Glycine 0 CA--C 1.487 -1.703 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.658 HD11 ' SG ' ' A' ' 21' ' ' CYS . 2.5 pp -139.49 125.25 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.07 89.34 1.08 Allowed Glycine 1 C--N 1.252 -4.106 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.457 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 42.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.666 1.986 . . . . 0.0 113.651 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -126.44 16.23 7.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.148 0.499 . . . . 0.0 111.691 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 65.0 m-85 -146.67 139.21 14.05 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.88 -42.33 59.9 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.802 3.002 . . . . 0.0 113.418 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 20' ' ' ARG . 4.6 p90 -90.93 10.78 25.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 124.135 0.974 . . . . 0.0 111.966 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 45.5 t -94.68 95.02 8.47 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.727 0.775 . . . . 0.0 110.846 -176.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 37' ' ' HIS . 6.8 p80 -82.34 50.45 1.62 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.35 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -98.02 166.59 11.36 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 . . . . . 0 C--N 1.31 -1.115 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 -176.882 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.06 -171.28 21.06 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 62.65 82.77 0.17 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.111 0.964 . . . . 0.0 112.123 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.23 49.51 3.75 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.41 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -102.36 109.4 21.05 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -96.94 144.57 26.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.7 m -88.96 106.87 18.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 10' ' ' LEU . 20.3 m -129.86 138.66 51.08 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 11.4 m-20 77.29 -43.03 0.41 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.415 1.486 . . . . 0.0 110.71 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.6 tt -57.07 -43.36 82.01 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.836 1.654 . . . . 0.0 111.324 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.0 t -110.57 -18.03 13.28 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.84 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.524 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 49.6 tttp 48.94 14.11 0.07 Allowed 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 126.66 1.984 . . . . 0.0 115.385 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -70.91 -57.41 4.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.344 -0.848 . . . . 0.0 112.03 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 28.1 ttt -94.06 -61.83 1.46 Allowed 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.526 ' OE1' ' HA ' ' A' ' 9' ' ' ASP . 32.1 tt0 63.33 102.05 0.03 OUTLIER 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.689 1.195 . . . . 0.0 113.552 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 17' ' ' GLU . 40.6 tt0 -106.29 148.37 28.07 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.724 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 44.0 mt-10 -105.14 171.2 7.45 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 61.37 4.0 0.87 Allowed 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 126.542 1.937 . . . . 0.0 112.401 -172.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . 7.1 p -97.03 -31.91 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 169.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -67.95 -16.82 64.23 Favored 'General case' 0 C--O 1.19 -2.063 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.474 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.1 t -105.82 -18.04 14.18 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.0 110.326 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 40.2 t80 -62.21 -61.81 2.2 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.253 0.621 . . . . 0.0 112.101 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 47.3 mm -71.0 -29.98 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.749 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB3' HG12 ' A' ' 29' ' ' ILE . 6.5 mm-40 -68.32 -41.99 80.0 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.82 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.69 -31.83 70.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.15 -33.17 72.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 35.8 mmtp -78.62 -55.85 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 90.77 0.79 Allowed Glycine 0 CA--C 1.484 -1.865 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.561 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -136.28 127.17 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.504 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.13 113.67 4.34 Favored Glycine 1 C--N 1.235 -5.073 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.344 175.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m80 44.92 88.05 0.02 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.433 1.893 . . . . 0.0 114.495 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -129.29 -0.97 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.402 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 54.4 m-85 -145.9 143.43 19.55 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -48.17 -49.33 14.36 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 124.037 3.158 . . . . 0.0 113.189 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -88.59 17.92 5.04 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.532 1.133 . . . . 0.0 111.529 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 48.6 t -114.01 101.84 9.61 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.008 0.432 . . . . 0.0 110.768 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -114.28 -2.11 13.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.609 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 t -79.6 102.72 9.05 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 . . . . . 0 C--N 1.288 -2.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.539 -174.336 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.84 -161.93 17.53 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.4 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -132.69 119.83 20.89 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.55 32.81 9.82 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.653 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.4 t -110.51 113.03 25.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -117.19 131.23 56.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -131.13 107.19 8.85 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -153.08 111.68 3.71 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 67.97 14.2 9.31 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.559 1.171 . . . . 0.0 109.786 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.12 -43.19 22.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.509 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -90.48 -16.1 29.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttp 59.28 27.52 16.6 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -84.43 142.3 30.2 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.946 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.6 tpp -146.51 87.27 1.71 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.65 97.86 0.48 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.698 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -114.76 -33.44 5.49 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.38 160.23 23.48 Favored 'General case' 1 N--CA 1.379 -4.011 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.44 5.65 0.47 Allowed 'General case' 0 C--N 1.282 -2.347 0 C-N-CA 126.284 1.834 . . . . 0.0 112.267 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -108.66 -21.92 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -64.33 -30.64 71.68 Favored 'General case' 0 C--O 1.203 -1.361 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.391 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' HB2' ' CD1' ' A' ' 33' ' ' TYR . 36.6 t -105.6 -8.19 18.11 Favored 'General case' 0 C--O 1.189 -2.101 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -67.36 -53.66 27.46 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.8 -30.32 46.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.335 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.86 -38.08 58.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.111 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 11.7 t -64.41 -29.43 70.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.185 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -75.28 -5.77 46.37 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.346 0.0 OUTLIER -147.78 71.29 1.18 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.46 -25.68 26.77 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 25' ' ' CYS 0.287 1.9 pp -115.02 115.35 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 119.991 1.895 . . . . 0.0 112.071 -172.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.43 102.93 2.79 Favored Glycine 1 C--N 1.233 -5.156 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.403 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 67.65 88.13 0.11 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.693 1.197 . . . . 0.0 112.829 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -119.06 -2.8 10.71 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.049 0.928 . . . . 0.0 108.689 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 61.3 m-85 -135.24 147.05 60.64 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.71 -36.21 98.52 Favored 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 123.532 2.821 . . . . 0.0 113.406 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -96.1 18.58 13.23 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.788 0.835 . . . . 0.0 111.01 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 44.2 t -91.09 96.3 10.53 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.891 0.853 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -94.43 -16.83 23.06 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.554 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.46 105.03 0.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.381 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 . . . . . 0 C--N 1.299 -1.618 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 -179.694 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.5 m80 . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 120.67 0.272 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.25 -149.6 37.56 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.114 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 73.11 142.26 0.06 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.66 1.184 . . . . 0.0 111.107 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.03 73.02 2.69 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.0 m -95.58 112.29 24.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -103.38 128.88 50.39 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.428 ' HB ' HD12 ' A' ' 10' ' ' LEU . 19.5 m -89.67 121.25 31.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.34 140.35 58.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.33 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 12' ' ' LYS . 24.0 t70 67.52 24.75 8.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.542 1.163 . . . . 0.0 110.637 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 7' ' ' THR . 4.9 tt -73.72 -44.65 55.82 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.133 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 p -107.57 -15.37 14.61 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 9' ' ' ASP . 32.3 tttp 68.3 14.01 9.13 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.798 1.639 . . . . 0.0 111.423 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -143.78 139.41 29.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.748 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.86 0.838 . . . . 0.0 108.977 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.45 125.06 23.46 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.996 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.58 -38.75 2.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.896 0.855 . . . . 0.0 108.847 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.96 133.11 35.28 Favored 'General case' 1 N--CA 1.377 -4.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 74.83 6.3 4.38 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 111.849 -2.432 . . . . 0.0 112.523 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.45 -34.68 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -62.4 -22.54 66.23 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.482 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -94.29 -38.04 11.21 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 28.3 t80 -56.83 -59.54 4.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.229 1.412 . . . . 0.0 111.204 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.6 mm -62.11 -35.59 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.854 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.48 -40.12 44.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.6 t -69.29 -28.44 66.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.418 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.45 -30.7 67.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.023 174.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -84.59 -57.37 3.16 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.02 97.46 0.26 Allowed Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.869 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -140.18 122.52 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.13 90.09 1.0 Allowed Glycine 1 C--N 1.241 -4.696 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.192 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 46.15 81.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.455 1.502 . . . . 0.0 112.554 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.43 -0.0 46.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.177 0.513 . . . . 0.0 111.791 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.607 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 57.8 m-85 -143.39 154.44 60.43 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 -42.52 67.41 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.459 2.773 . . . . 0.0 112.17 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -91.75 16.56 10.49 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 111.404 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -100.28 116.13 31.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -124.6 13.86 8.73 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.6 t -74.04 117.57 15.98 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.306 -1.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 -178.722 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.21 -170.22 13.39 Favored Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.09 -55.04 5.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.38 91.52 1.73 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.32 109.32 21.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.51 0.671 . . . . 0.0 112.799 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -90.64 127.48 36.3 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -100.66 139.04 36.9 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.273 0.559 . . . . 0.0 111.273 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -72.73 95.19 1.86 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.585 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.41 -0.82 2.08 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 173.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.34 -42.62 68.3 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 t -88.31 -13.45 40.76 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . 0.346 21.0 pttp 43.94 57.81 3.95 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.929 1.692 . . . . 0.0 114.775 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -86.28 133.24 33.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.903 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtt -133.24 100.6 4.9 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -87.31 88.33 7.66 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.48 -23.8 34.51 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -124.85 -159.52 0.89 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 113.611 -1.632 . . . . 0.0 106.874 175.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 64.87 5.75 3.02 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.622 1.169 . . . . 0.0 113.137 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.9 t -108.42 -44.06 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 1.4 mmp_? -62.31 -13.3 27.28 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.724 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -105.61 -28.49 10.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.429 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 39.8 t80 -66.13 -66.63 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.892 -169.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.7 mp -62.82 -31.67 53.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.903 0.859 . . . . 0.0 110.08 -175.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 mm-40 -68.49 -45.31 72.66 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.08 -33.12 75.28 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.15 -17.6 63.84 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.903 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -78.47 -33.06 48.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.399 0.618 . . . . 0.0 109.596 174.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.26 36.6 1.45 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.588 -177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 24' ' ' GLU . 1.9 pp -122.29 113.84 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.09 143.51 19.65 Favored Glycine 1 C--N 1.246 -4.445 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.499 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' CYS . 17.3 t-80 66.65 -99.76 0.06 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.213 1.005 . . . . 0.0 112.007 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 54.78 -62.41 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 126.69 1.996 . . . . 0.0 114.974 -177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -87.73 145.36 36.77 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 124.046 0.938 . . . . 0.0 109.878 -174.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.94 -44.52 27.27 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 124.176 3.25 . . . . 0.0 113.313 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 17' ' ' GLU . 13.4 p90 -91.6 0.53 57.49 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.213 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.6 t -101.61 121.32 41.8 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.314 -175.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -121.31 5.13 10.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.18 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 35.4 t -75.67 146.3 40.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.064 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 . . . . . 0 C--N 1.306 -1.29 0 C-N-CA 123.476 0.711 . . . . 0.0 109.446 -177.525 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 34.3 t60 . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.28 -158.45 21.1 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -85.64 169.62 13.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.897 0.349 . . . . 0.0 110.281 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.1 -179.38 17.03 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.9 m -94.64 109.49 21.41 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -105.17 130.37 53.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -131.08 112.3 12.76 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.392 0.615 . . . . 0.0 109.758 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -162.11 -161.69 0.77 Allowed 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -70.84 5.5 1.93 Allowed 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.325 0.65 . . . . 0.0 111.97 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.94 -45.51 92.39 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -112.28 -15.84 13.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.648 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 pttt 54.21 27.72 8.2 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.173 1.789 . . . . 0.0 111.712 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -140.95 166.65 24.21 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.317 -2.22 . . . . 0.0 107.245 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -127.82 164.75 21.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -54.94 -36.24 65.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.164 0.985 . . . . 0.0 111.677 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 23.6 tt0 -121.24 -177.71 3.59 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 16' ' ' GLU 0.267 8.5 pt-20 58.49 129.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.491 2.316 . . . . 0.0 114.057 -174.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.21 4.42 0.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.409 1.884 . . . . 0.0 114.468 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.58 -38.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.11 -29.3 68.52 Favored 'General case' 0 C--O 1.191 -1.999 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.624 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 53.1 t -104.76 -11.86 16.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.969 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 1.6 t80 -72.02 -66.52 0.63 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.749 0.785 . . . . 0.0 110.611 -171.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -67.66 -24.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.314 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.45 -35.3 25.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.272 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 38.8 t -63.83 -33.64 76.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.77 -21.64 66.0 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.063 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -90.52 -47.49 7.67 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.35 90.19 0.93 Allowed Glycine 0 CA--C 1.475 -2.429 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' O ' HD12 ' A' ' 29' ' ' ILE . 2.7 pp -139.39 130.36 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.867 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.33 -132.64 0.15 Allowed Glycine 1 C--N 1.243 -4.628 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.117 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -82.04 80.21 8.35 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.668 -0.901 . . . . 0.0 109.146 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.01 -24.06 21.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.148 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 50.9 m-85 -130.0 143.54 49.52 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.13 -21.57 28.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 124.01 3.14 . . . . 0.0 114.37 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -115.24 13.25 16.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.496 0.718 . . . . 0.0 111.162 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 39.6 t -99.04 121.68 41.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -115.34 33.84 5.22 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.98 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.7 t -65.68 161.23 21.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.4 mtt-85 . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.725 -0.609 . . . . 0.0 110.398 -175.406 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.053 0.454 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.83 160.63 10.03 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -88.58 106.83 18.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.51 83.96 0.88 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.9 m -95.52 110.77 22.8 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.976 0.511 . . . . 0.0 109.628 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.96 120.37 32.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.414 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 25.2 m -105.19 128.5 53.43 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.9 t -64.61 130.5 43.85 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 120.924 0.392 . . . . 0.0 110.835 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.17 24.27 14.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.449 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 3.1 tm? -63.95 -43.99 94.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -110.56 -17.08 13.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 57.7 13.82 2.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.171 1.789 . . . . 0.0 113.105 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -139.18 154.8 48.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.3 mtm -82.7 72.01 9.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.179 0.99 . . . . 0.0 111.636 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -147.96 91.93 1.99 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -108.33 153.36 23.37 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-O 122.219 1.009 . . . . 0.0 113.013 -168.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.04 154.19 40.18 Favored 'General case' 1 N--CA 1.377 -4.097 0 CA-C-N 113.974 -1.467 . . . . 0.0 107.866 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 60.88 5.45 0.97 Allowed 'General case' 0 C--N 1.25 -3.738 0 CA-C-N 113.066 -1.879 . . . . 0.0 112.931 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.27 -49.26 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -72.91 -5.02 35.65 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 113.226 -1.807 . . . . 0.0 112.399 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 t -104.9 -31.16 9.39 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 47.1 t80 -66.34 -60.23 2.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.815 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.34 -32.4 56.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.5 0.667 . . . . 0.0 110.612 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -74.9 -37.2 62.15 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.197 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.3 t -66.08 -31.82 72.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.187 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 22' ' ' PHE . 96.7 mt -63.62 -25.12 68.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.598 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -79.23 -55.16 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.15 78.46 0.24 Allowed Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.857 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.7 pp -129.65 120.72 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.586 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.36 100.0 0.62 Allowed Glycine 1 C--N 1.244 -4.575 0 CA-C-N 113.396 -1.729 . . . . 0.0 111.562 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 64.8 m80 58.42 -83.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.758 1.623 . . . . 0.0 114.244 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 69.0 -67.82 0.2 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.379 1.472 . . . . 0.0 112.175 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 26.1 m-85 -83.01 142.37 44.47 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.76 -38.18 77.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 123.869 3.046 . . . . 0.0 112.809 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -94.5 3.61 54.91 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.145 0.978 . . . . 0.0 112.079 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 41.8 t -97.64 120.5 38.14 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.879 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -103.86 30.78 4.89 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.596 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.0 t -70.98 106.57 3.71 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.093 0.473 . . . . 0.0 110.926 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 C--N 1.31 -1.14 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.263 -176.483 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 . . . . . 0 C--O 1.243 0.713 0 CA-C-O 122.046 0.927 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.13 162.56 24.68 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -84.0 -42.95 15.67 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.35 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.49 1.05 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 m -101.53 108.46 20.04 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 121.629 0.728 . . . . 0.0 110.193 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.48 103.86 10.86 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.41 HG23 ' HB2' ' A' ' 10' ' ' LEU . 12.8 t -124.93 144.39 50.37 Favored 'General case' 0 N--CA 1.407 -2.619 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 152.37 34.08 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 123.881 0.872 . . . . 0.0 109.797 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 78.61 -26.82 0.17 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.511 1.125 . . . . 0.0 111.453 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HB2' HG23 ' A' ' 7' ' ' THR . 2.7 tm? -65.97 -43.33 88.2 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -81.08 -15.92 54.65 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? 45.07 14.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -141.3 -34.83 0.48 Allowed 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 18.9 mmt 52.79 73.42 0.35 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.783 0.802 . . . . 0.0 110.727 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.04 118.23 27.46 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.668 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -103.62 -24.79 13.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.551 0.691 . . . . 0.0 109.891 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 44.9 mt-10 -68.14 132.11 46.62 Favored 'General case' 0 N--CA 1.397 -3.119 0 CA-C-O 122.569 1.175 . . . . 0.0 109.572 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 22' ' ' PHE . . . 73.87 5.36 4.8 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 111.437 -2.62 . . . . 0.0 111.737 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.01 -44.8 8.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -63.46 -12.0 28.06 Favored 'General case' 0 C--O 1.191 -1.989 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.616 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -105.03 -29.18 10.6 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.1 0.476 . . . . 0.0 110.019 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t80 -65.71 -59.28 4.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.918 -170.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mm -66.56 -29.02 45.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.526 0.679 . . . . 0.0 110.15 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HB3' HG12 ' A' ' 29' ' ' ILE . 7.3 mm-40 -75.02 -32.9 61.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.631 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -65.43 -32.64 74.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.319 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.0 -7.91 54.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.43 -49.59 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.42 79.48 0.21 Allowed Glycine 0 CA--C 1.471 -2.667 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.659 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.8 pp -136.0 134.51 50.67 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.019 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.17 -132.56 0.06 OUTLIER Glycine 1 C--N 1.234 -5.132 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.449 169.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -90.03 85.15 6.24 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.079 -1.248 . . . . 0.0 108.132 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -92.23 -34.39 14.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.78 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.693 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 44.4 m-85 -111.37 142.56 26.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -25.52 35.26 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 124.568 3.512 . . . . 0.0 114.187 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 33.4 p90 -115.09 18.92 16.06 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.739 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.693 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 50.3 t -85.96 114.68 23.05 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.935 0.874 . . . . 0.0 112.59 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -77.2 -4.44 44.73 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.959 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 t -69.13 140.39 54.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.378 0.609 . . . . 0.0 110.696 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 . . . . . 0 C--O 1.254 1.334 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.485 -175.635 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.8 m80 . . . . . 0 C--O 1.241 0.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.96 159.47 11.95 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.754 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.548 ' H ' HG21 ' A' ' 23' ' ' ILE . 44.5 tt0 -86.97 87.02 7.36 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.035 0.921 . . . . 0.0 109.161 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.08 156.65 7.25 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -112.05 109.49 19.26 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 121.143 0.497 . . . . 0.0 111.268 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -114.47 104.06 11.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -129.17 155.46 45.48 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.154 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' LEU . 38.8 m -48.98 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 126.413 1.885 . . . . 0.0 113.083 173.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 12' ' ' LYS . 11.7 m-20 -60.64 7.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' SER . 6.1 tt -63.31 -42.8 99.04 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.772 1.629 . . . . 0.0 107.853 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -102.83 -5.37 23.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.672 0.749 . . . . 0.0 109.426 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 25.6 pttm 55.2 19.42 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 127.388 2.275 . . . . 0.0 116.192 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -86.53 -173.62 4.6 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.6 tpt -84.13 123.04 29.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -90.29 94.78 9.89 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.64 179.95 5.91 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.682 0.753 . . . . 0.0 112.403 -171.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 1.9 mp0 -83.47 -172.25 4.04 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.767 177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 61.35 5.58 1.18 Allowed 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.636 1.575 . . . . 0.0 111.83 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.15 -23.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 17' ' ' GLU . 27.6 mmt180 -63.59 -34.29 77.5 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.912 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.5 t -106.08 -4.13 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.39 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -66.81 -51.45 55.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.548 HG21 ' H ' ' A' ' 3' ' ' GLU . 4.0 mp -79.88 -28.14 12.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.885 0.85 . . . . 0.0 109.076 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.58 -47.03 87.99 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.2 t -72.87 -18.02 61.47 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.058 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 61.3 tp -66.86 -26.68 67.02 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.5 -65.24 1.03 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.08 69.79 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.357 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.795 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 29' ' ' ILE . 2.9 pp -134.13 114.08 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 115.12 4.37 Favored Glycine 1 C--N 1.244 -4.533 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.836 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 52.62 72.91 0.38 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.013 0.925 . . . . 0.0 112.295 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' CB ' HD13 ' A' ' 29' ' ' ILE . 62.8 tttp -99.66 -20.42 16.31 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.751 0.786 . . . . 0.0 110.645 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 15.6 m-85 -119.2 151.76 51.35 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.35 -37.49 71.68 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.956 3.104 . . . . 0.0 113.34 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -100.55 11.81 38.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.601 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 33' ' ' TYR . 43.4 t -89.24 109.56 20.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 0.0 110.231 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -100.2 6.41 44.78 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.937 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.8 t -89.99 126.54 35.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 123.306 0.642 . . . . 0.0 109.388 177.826 . . . . . . . . 0 0 . 1 stop_ save_